IVERIC bio, Inc. 46583P102 US46583P1021 07/06/2023 To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated April 28, 2023, by and among IVERIC bio, Inc. ("IVERIC"), Astellas US Holding, Inc. ("Parent"), Berry Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Solely as provided by Section 8.10(b) of the Merger Agreement, Astellas Pharma Inc., pursuant to which Merger Sub will merge with and into IVERIC, and IVERIC will become a wholly owned subsidiary of Parent (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 395454.000000 0 FOR 395454.000000 FOR S000004450 IVERIC bio, Inc. 46583P102 US46583P1021 07/06/2023 To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 395454.000000 0 AGAINST 395454.000000 AGAINST S000004450 IVERIC bio, Inc. 46583P102 US46583P1021 07/06/2023 To approve the adjournment of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 395454.000000 0 FOR 395454.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 07/11/2023 Election of Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2026 Annual Meeting of Stockholders: John C. Jacobs DIRECTOR ELECTIONS ISSUER 9862.000000 264895.000000 FOR 9862.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 07/11/2023 Election of Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2026 Annual Meeting of Stockholders: Gregg H. Alton. J.D. DIRECTOR ELECTIONS ISSUER 9862.000000 264895.000000 FOR 9862.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 07/11/2023 Election of Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2026 Annual Meeting of Stockholders: Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 9862.000000 264895.000000 FOR 9862.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 07/11/2023 The approval, on an advisory basis, of the compensation paid to our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 9862.000000 264895.000000 FOR 9862.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 07/11/2023 The approval, on an advisory basis, of holding future executive compensation advisory votes every three years, every two years, or every year. SECTION 14A SAY-ON-PAY VOTES ISSUER 9862.000000 264895.000000 ONE YEAR 9862.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 07/11/2023 Amendment to the Second Amended and Restated Certificate of Incorporation of Novavax, Inc., as amended, to reflect Delaware law provisions allowing officer exculpation. CORPORATE GOVERNANCE ISSUER 9862.000000 264895.000000 FOR 9862.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 07/11/2023 Amendment and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentve Plan, as amended to increase the number of shares of common stock available for issuance thereunder by 6,170,000 shares. COMPENSATION ISSUER 9862.000000 264895.000000 FOR 9862.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 07/11/2023 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 9862.000000 264895.000000 FOR 9862.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Election of Directors: Sheila A. Hopkins DIRECTOR ELECTIONS ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Election of Directors: Juliane T. Park DIRECTOR ELECTIONS ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Election of Directors: Janet D. Widmann DIRECTOR ELECTIONS ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Election of Directors: Taylor Harris DIRECTOR ELECTIONS ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Election of Directors: Kevin Cameron DIRECTOR ELECTIONS ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Election of Directors: Nicholas Lewin DIRECTOR ELECTIONS ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Election of Directors: Keith Sullivan DIRECTOR ELECTIONS ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Ratification of BDO USA, LLP as the Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Non-binding advisory vote on the compensation of Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Non-binding advisory vote on the "Say-on-Pay-Frequency" proposal regarding the frequency of stockholder advisory votes on the compensation of Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 54343.000000 0 ONE YEAR 54343.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/13/2023 Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 1,300,000 shares. COMPENSATION ISSUER 54343.000000 0 FOR 54343.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 Election of Directors: Michael Rice DIRECTOR ELECTIONS ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 Election of Directors: Joydeep Goswami DIRECTOR ELECTIONS ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 Election of Directors: Joseph C. Schick DIRECTOR ELECTIONS ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 Election of Directors: Amy DuRoss DIRECTOR ELECTIONS ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 Election of Directors: Rachel Ellingson DIRECTOR ELECTIONS ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 Election of Directors: Timothy L. Moore DIRECTOR ELECTIONS ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 Election of Directors: Roderick de Greef DIRECTOR ELECTIONS ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public accounting firm for the Fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 To approve the BioLife Solutions, Inc. 2023 Omnibus Performance Incentive Plan. COMPENSATION ISSUER 111810.000000 0 FOR 111810.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Richard H. Carmona, M.D. DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: James H. Hinton DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Linda P. Mantia DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Maria Martinez DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Susan R. Salka DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2024. AUDIT-RELATED ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 491497.000000 0 FOR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Advisory vote on the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 491497.000000 0 ONE YEAR 491497.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Shareholder proposal requesting shareholder ratification of termination pay. COMPENSATION SECURITY HOLDER 491497.000000 0 AGAINST 491497.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 07/26/2023 To elect Class Il Directors to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Kevin Spain DIRECTOR ELECTIONS ISSUER 334260.000000 0 FOR 334260.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 07/26/2023 To elect Class Il Directors to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Timothy Cabral DIRECTOR ELECTIONS ISSUER 334260.000000 0 FOR 334260.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 07/26/2023 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending March 31, 2024. AUDIT-RELATED ISSUER 334260.000000 0 FOR 334260.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 07/26/2023 To hold a non-binding, advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 334260.000000 0 ONE YEAR 334260.000000 FOR S000004450 Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Election of Class III Director Nominees: Gino Santini DIRECTOR ELECTIONS ISSUER 750965.000000 0 FOR 750965.000000 FOR S000004450 Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Election of Class III Director Nominees: James Shannon, M.D. DIRECTOR ELECTIONS ISSUER 750965.000000 0 FOR 750965.000000 FOR S000004450 Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Election of Class III Director Nominees: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 750965.000000 0 FOR 750965.000000 FOR S000004450 Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Approval of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023, and authorization of the Audit Committee to determine the auditors' remuneration. AUDIT-RELATED ISSUER 750965.000000 0 FOR 750965.000000 FOR S000004450 Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 750965.000000 0 FOR 750965.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Esther M. Alegria DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Richard C. Breeden DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Daniel A. Carestio DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Christopher S. Holland DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Jacqueline B. Kosecoff DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Paul E. Martin DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Nirav R. Shah DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Mohsen M. Sohi DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Richard M. Steeves DIRECTOR ELECTIONS ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2024. AUDIT-RELATED ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's next annual general meeting. AUDIT-RELATED ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law. AUDIT-RELATED ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 7, 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To approve, on a non-binding advisory basis, whether the non-binding advisory vote on named executive officer compensation should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 346119.000000 0 ONE YEAR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To approve a proposal renewing the Board of Director's authority to issue shares under Irish law. CAPITAL STRUCTURE ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To approve a proposal renewing the Board of Director's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 346119.000000 0 FOR 346119.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 To elect seven directors to serve until the 2024 Annual Meeting of Stockholders: Ronald M. Lombardi DIRECTOR ELECTIONS ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 To elect seven directors to serve until the 2024 Annual Meeting of Stockholders: John E. Byom DIRECTOR ELECTIONS ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 To elect seven directors to serve until the 2024 Annual Meeting of Stockholders: Celeste A. Clark DIRECTOR ELECTIONS ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 To elect seven directors to serve until the 2024 Annual Meeting of Stockholders: James C. D'Arecca DIRECTOR ELECTIONS ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 To elect seven directors to serve until the 2024 Annual Meeting of Stockholders: Sheila A. Hopkins DIRECTOR ELECTIONS ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 To elect seven directors to serve until the 2024 Annual Meeting of Stockholders: Natale S. Ricciardi DIRECTOR ELECTIONS ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 To elect seven directors to serve until the 2024 Annual Meeting of Stockholders: Dawn M. Zier DIRECTOR ELECTIONS ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2024. AUDIT-RELATED ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 Say on Pay - An advisory vote on the resolution to approve the compensation of Prestige Consumer Healthcare Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 171406.000000 0 FOR 171406.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/01/2023 Frequency of Say on Pay Vote - An advisory vote to set the preferred frequency of the "Say on Pay" Vote for the compensation of Prestige Consumer Healthcare Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 171406.000000 0 ONE YEAR 171406.000000 FOR S000004450 Chinook Therapeutics, Inc. 16961L106 US16961L1061 08/02/2023 To consider and vote upon the proposal to adopt the Agreement and Plan of Merger, dated as of June 11, 2023 (which, as it may be amended from time to time, we refer to as the "Merger Agreement"), by and among Chinook Therapeutics, Inc., a Delaware corporation (the "Company") Novartis AG, a company organized under the laws of Switzerland ("Novartis"), and Cherry Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis ("Merger Sub"), pursuant to which Merger Sub will be merged with and into the Company (the "Merger"), with the Company to survive the Merger as an indirect wholly owned subsidiary of Novartis. EXTRAORDINARY TRANSACTIONS ISSUER 158616.000000 0 FOR 158616.000000 FOR S000004450 Chinook Therapeutics, Inc. 16961L106 US16961L1061 08/02/2023 To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to Chinook's named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 158616.000000 0 AGAINST 158616.000000 AGAINST S000004450 Chinook Therapeutics, Inc. 16961L106 US16961L1061 08/02/2023 To consider and vote upon the proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 158616.000000 0 FOR 158616.000000 FOR S000004450 Syneos Health, Inc. 87166B102 US87166B1026 08/02/2023 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of May 10, 2023, by and among Syneos Heath, Inc., a Delaware corporation (the "Company"), Star Parent, Inc. ("Parent"), and Star Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), and approve the transactions contemplated thereby, including the merger of Merger Sub with and into the Company (the "Merger"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 356869.000000 0 FOR 356869.000000 FOR S000004450 Syneos Health, Inc. 87166B102 US87166B1026 08/02/2023 To approve, on an advisory non-binding basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 356869.000000 0 FOR 356869.000000 FOR S000004450 Syneos Health, Inc. 87166B102 US87166B1026 08/02/2023 To approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to approve the Merger Proposal at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 356869.000000 0 FOR 356869.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 08/03/2023 To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Bruce C. Cozadd DIRECTOR ELECTIONS ISSUER 219402.000000 0 FOR 219402.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 08/03/2023 To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Heather Ann McSharry DIRECTOR ELECTIONS ISSUER 219402.000000 0 FOR 219402.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 08/03/2023 To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Anne O'Riordan DIRECTOR ELECTIONS ISSUER 219402.000000 0 FOR 219402.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 08/03/2023 To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Rick E. Winningham DIRECTOR ELECTIONS ISSUER 219402.000000 0 FOR 219402.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 08/03/2023 To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December 31, 2023 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration. AUDIT-RELATED ISSUER 219402.000000 0 FOR 219402.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 08/03/2023 To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 219402.000000 0 FOR 219402.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 08/03/2023 To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply. CAPITAL STRUCTURE ISSUER 219402.000000 0 FOR 219402.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 08/03/2023 To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the Annual General Meeting to approve Proposal 4. CORPORATE GOVERNANCE ISSUER 219402.000000 0 FOR 219402.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 Election of Directors: Robert E. Abernathy DIRECTOR ELECTIONS ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 Election of Directors: Michael J. Coyle DIRECTOR ELECTIONS ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 Election of Directors: Charles J. Dockendorff DIRECTOR ELECTIONS ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 Election of Directors: Lloyd E. Johnson DIRECTOR ELECTIONS ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 Election of Directors: Mark W. Kroll DIRECTOR ELECTIONS ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 Election of Directors: Claire Pomeroy DIRECTOR ELECTIONS ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 Election of Directors: Christopher A. Simon DIRECTOR ELECTIONS ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 Election of Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 175374.000000 0 ONE YEAR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 To approve an amendment and restatement of the Haemonetics Corporation 2019 Long term Incentive Compensation Plan. COMPENSATION ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 08/04/2023 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 30, 2024. AUDIT-RELATED ISSUER 175374.000000 0 FOR 175374.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Election of the four Class II named in this proxy statement to our Board of Directors: Glenn R. August DIRECTOR ELECTIONS ISSUER 769978.000000 0 WITHHOLD 769978.000000 AGAINST S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Election of the four Class II named in this proxy statement to our Board of Directors: Richard A. Clarke DIRECTOR ELECTIONS ISSUER 769978.000000 0 FOR 769978.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Election of the four Class II named in this proxy statement to our Board of Directors: Julie D. Klapstein DIRECTOR ELECTIONS ISSUER 769978.000000 0 FOR 769978.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Election of the four Class II named in this proxy statement to our Board of Directors: P. Hunter Philbrick DIRECTOR ELECTIONS ISSUER 769978.000000 0 FOR 769978.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Election of the four Class III named in this proxy statement to our Board of Directors: Anthony Colaluca, Jr. DIRECTOR ELECTIONS ISSUER 769978.000000 0 FOR 769978.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Election of the four Class III named in this proxy statement to our Board of Directors: Michael S. Klein DIRECTOR ELECTIONS ISSUER 769978.000000 0 FOR 769978.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Election of the four Class III named in this proxy statement to our Board of Directors: Allen R. Thorpe DIRECTOR ELECTIONS ISSUER 769978.000000 0 FOR 769978.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Election of the four Class III named in this proxy statement to our Board of Directors: Dale White DIRECTOR ELECTIONS ISSUER 769978.000000 0 FOR 769978.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 08/04/2023 Approval of the MultiPlan Corporation 2023 Employee Stock Purchase Plan COMPENSATION ISSUER 769978.000000 0 FOR 769978.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/08/2023 Election of Directors: Rajeev Singh DIRECTOR ELECTIONS ISSUER 226381.000000 0 FOR 226381.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/08/2023 Election of Directors: Peter Klein DIRECTOR ELECTIONS ISSUER 226381.000000 0 FOR 226381.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/08/2023 Election of Directors: Dawn Lepore DIRECTOR ELECTIONS ISSUER 226381.000000 0 FOR 226381.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/08/2023 Election of Directors: Patricia Wadors DIRECTOR ELECTIONS ISSUER 226381.000000 0 FOR 226381.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/08/2023 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement in accordance with SEC rules. SECTION 14A SAY-ON-PAY VOTES ISSUER 226381.000000 0 FOR 226381.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/08/2023 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending February 29, 2024. AUDIT-RELATED ISSUER 226381.000000 0 FOR 226381.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To elect six directors, each to serve until the 2024 annual meeting of stockholders or until his or her successor has been duly elected and qualified: V. Gordon Clemons DIRECTOR ELECTIONS ISSUER 32641.000000 0 FOR 32641.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To elect six directors, each to serve until the 2024 annual meeting of stockholders or until his or her successor has been duly elected and qualified: Steven J. Hamerslag DIRECTOR ELECTIONS ISSUER 32641.000000 0 FOR 32641.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To elect six directors, each to serve until the 2024 annual meeting of stockholders or until his or her successor has been duly elected and qualified: Alan R. Hoops DIRECTOR ELECTIONS ISSUER 32641.000000 0 FOR 32641.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To elect six directors, each to serve until the 2024 annual meeting of stockholders or until his or her successor has been duly elected and qualified: R. Judd Jessup DIRECTOR ELECTIONS ISSUER 32641.000000 0 WITHHOLD 32641.000000 AGAINST S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To elect six directors, each to serve until the 2024 annual meeting of stockholders or until his or her successor has been duly elected and qualified: Jean H. Macino DIRECTOR ELECTIONS ISSUER 32641.000000 0 FOR 32641.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To elect six directors, each to serve until the 2024 annual meeting of stockholders or until his or her successor has been duly elected and qualified: Jeffrey J. Michael DIRECTOR ELECTIONS ISSUER 32641.000000 0 FOR 32641.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To ratify the appointment of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2024; AUDIT-RELATED ISSUER 32641.000000 0 FOR 32641.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To approve on a non-binding advisory basis the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 32641.000000 0 FOR 32641.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/10/2023 To approve on a non-binding advisory basis the frequency of future stockholder advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 32641.000000 0 ONE YEAR 32641.000000 AGAINST S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/21/2023 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2024 Annual Meeting of Stockholders and until the successors are duly elected and qualified: Nominees: Peter Salzmann, M.D., M.B.A. DIRECTOR ELECTIONS ISSUER 180131.000000 0 WITHHOLD 180131.000000 AGAINST S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/21/2023 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2024 Annual Meeting of Stockholders and until the successors are duly elected and qualified: Nominees: Douglas Hughes DIRECTOR ELECTIONS ISSUER 180131.000000 0 FOR 180131.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/21/2023 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2024 Annual Meeting of Stockholders and until the successors are duly elected and qualified: Nominees: George Migausky DIRECTOR ELECTIONS ISSUER 180131.000000 0 FOR 180131.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/21/2023 To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31,2024. AUDIT-RELATED ISSUER 180131.000000 0 FOR 180131.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/21/2023 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 180131.000000 0 FOR 180131.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 To elect Patrick J. McEnany as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation. DIRECTOR ELECTIONS ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 To elect Richard J. Daly as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation. DIRECTOR ELECTIONS ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 To elect Donald A. Denkhaus as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation. DIRECTOR ELECTIONS ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 To elect Molly Harper as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until her earlier death, disability or resignation. DIRECTOR ELECTIONS ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation. DIRECTOR ELECTIONS ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 To elect Tamar Thompson as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until her earlier death, disability or resignation. DIRECTOR ELECTIONS ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation. DIRECTOR ELECTIONS ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 PROPOSAL TWO - To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares. COMPENSATION ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 PROPOSAL THREE - To approve, on an advisory basis, the 2022 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 PROPOSAL FOUR - To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 345554.000000 0 FOR 345554.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 08/22/2023 PROPOSAL FIVE - To transact such other business as may properly come before the meeting. CORPORATE GOVERNANCE ISSUER 345554.000000 0 AGAINST 345554.000000 AGAINST S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: Craig A. Barbarosh DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: George H. Bristol DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: Darnell Dent DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: Julie D. Klapstein DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: Jeffrey H. Margolis DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: Geraldine McGinty DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: Morris Panner DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: Pamela Puryear DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Election of Directors Nominees: David Sides DIRECTOR ELECTIONS ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2024. AUDIT-RELATED ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Advisory vote to approve the compensation for our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 08/22/2023 Amendment and Restatement of NextGen Healthcare, Inc. 2015 Equity Incentive Plan. COMPENSATION ISSUER 180552.000000 0 FOR 180552.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Election of directors: J. Alltoft DIRECTOR ELECTIONS ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Election of directors: S. Ladiwala DIRECTOR ELECTIONS ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Election of directors: S. Hall DIRECTOR ELECTIONS ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Election of directors: T. Tripeny DIRECTOR ELECTIONS ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Election of directors: G. Owens DIRECTOR ELECTIONS ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Election of directors: J. Sullivan DIRECTOR ELECTIONS ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 To ratify the appointment of Plante & Moran, PLLC as the Company's independent registered public accounting firm for the year ending March 31, 2024. AUDIT-RELATED ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 To approve the Amendment to the 2021 Equity Plan. COMPENSATION ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Remove the specific purposes of the Company. CORPORATE GOVERNANCE ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Amend the director exculpation provisions. CORPORATE GOVERNANCE ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 Make certain non-substantive amendments to eliminate provisions that are no longer necessary. CORPORATE GOVERNANCE ISSUER 18510.000000 0 FOR 18510.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/25/2023 To approve the shareholder proposal to measure and annually present scope 1 through 3 greenhouse gas emissions. ENVIRONMENT OR CLIMATE SECURITY HOLDER 18510.000000 0 AGAINST 18510.000000 FOR S000004450 23andMe Holding Co. 90138Q108 US90138Q1085 09/06/2023 Elect three Class II Director Nominees: Neal Mohan DIRECTOR ELECTIONS ISSUER 713136.000000 181217.000000 WITHHOLD 713136.000000 AGAINST S000004450 23andMe Holding Co. 90138Q108 US90138Q1085 09/06/2023 Elect three Class II Director Nominees: Valerie Montgomery Rice DIRECTOR ELECTIONS ISSUER 713136.000000 181217.000000 WITHHOLD 713136.000000 AGAINST S000004450 23andMe Holding Co. 90138Q108 US90138Q1085 09/06/2023 Elect three Class II Director Nominees: Richard Scheller DIRECTOR ELECTIONS ISSUER 713136.000000 181217.000000 FOR 713136.000000 FOR S000004450 23andMe Holding Co. 90138Q108 US90138Q1085 09/06/2023 A non-binding, advisory vote on the Fiscal 2023 compensation of the Company's named executive officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 713136.000000 181217.000000 FOR 713136.000000 FOR S000004450 23andMe Holding Co. 90138Q108 US90138Q1085 09/06/2023 Approve an amendment and restatement of the 23andMe Holding Co. 2021 Incentive Equity Plan to, among other things, increase the number of shares authorized for issuance thereunder. COMPENSATION ISSUER 713136.000000 181217.000000 AGAINST 713136.000000 AGAINST S000004450 23andMe Holding Co. 90138Q108 US90138Q1085 09/06/2023 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2024. AUDIT-RELATED ISSUER 713136.000000 181217.000000 FOR 713136.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/06/2023 Election of Directors: Paolo Pucci DIRECTOR ELECTIONS ISSUER 126375.000000 0 FOR 126375.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/06/2023 Election of Directors: Veleka Peeples-Dyer DIRECTOR ELECTIONS ISSUER 126375.000000 0 FOR 126375.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/06/2023 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune Group, Inc. for the fiscal year ending March 31, 2024. AUDIT-RELATED ISSUER 126375.000000 0 FOR 126375.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 09/08/2023 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of June 26, 2023, by and among UnitedHealth Group Incorporated ("Parent"), Amedisys, Inc. ("Amedisys") and Aurora Holdings Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into Amedisys, with Amedisys continuing as the surviving corporation and as a wholly owned subsidiary of Parent (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 112526.000000 0 FOR 112526.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 09/08/2023 To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Amedisys named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 112526.000000 0 FOR 112526.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 09/08/2023 To approve the adjournment of the Amedisys Special Meeting, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Amedisys Special Meeting to approve proposal 1 to adopt the Merger Agreement. CORPORATE GOVERNANCE ISSUER 112526.000000 0 FOR 112526.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: John D. Buck DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: Meenu Agarwal DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: Alex N. Blanco DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: Jody H. Feragen DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: Robert C. Frenzel DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: Philip G.J. McKoy DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: Ellen A. Rudnick DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: Neil A. Schrimsher DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To elect nine directors to have terms expiring in 2024, and until their successors shall be elected and duly qualified. Nominees: Donald J. Zurbay DIRECTOR ELECTIONS ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 Advisory approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 Advisory vote on frequency of shareholder votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 300832.000000 0 ONE YEAR 300832.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/11/2023 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 27, 2024. AUDIT-RELATED ISSUER 300832.000000 0 FOR 300832.000000 FOR S000004450 Reata Pharmaceuticals, Inc. 75615P103 US75615P1030 09/21/2023 To approve and adopt the Agreement and Plan of Merger, dated as of July 28, 2023, as such agreement may be amended from time to time (the "Merger Agreement"), by and among Biogen Inc., a Delaware corporation ("Biogen"), River Acquisition, Inc., a Delaware corporation and wholly-owned subsidiary of Biogen ("Merger Sub"), and Reata Pharmaceuticals, Inc. ("Reata"), pursuant to which Merger Sub will be merged with and into Reata, with Reata surviving as a wholly-owned subsidiary of Biogen (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 83801.000000 0 FOR 83801.000000 FOR S000004450 Reata Pharmaceuticals, Inc. 75615P103 US75615P1030 09/21/2023 To approve, on an advisory, non-binding basis, compensation that will or may be paid or become payable to Reata's named executive officers in connection with the Merger contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 83801.000000 0 AGAINST 83801.000000 AGAINST S000004450 Reata Pharmaceuticals, Inc. 75615P103 US75615P1030 09/21/2023 To approve to adjourn the Special Meeting to a later date if necessary and appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 83801.000000 0 FOR 83801.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: Mitchel Sayare, Ph.D. DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: Vipin K. Garg, Ph.D. DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: David J. Drutz, M.D. DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: John M. Gill DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: Philip L. Hodges DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: Diane Jorkasky, M.D. DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: Wayne Pisano DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: Klaus O. Schafer, M.D., MPH DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. Director of Nominees: Catherine Sohn, Pharm D DIRECTOR ELECTIONS ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023. AUDIT-RELATED ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Hold an advisory vote on the frequency of the advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 170962.000000 0 ONE YEAR 170962.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/28/2023 Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. CORPORATE GOVERNANCE ISSUER 170962.000000 0 FOR 170962.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Craig Arnold DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Scott C. Donnelly DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Lidia L. Fonseca DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Andrea J. Goldsmith, Ph.D. DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Randall J. Hogan, III DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Gregory P. Lewis DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Kevin E. Lofton DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Geoffrey S. Martha DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Elizabeth G. Nabel, M.D. DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Denise M. O'Leary DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Kendall J. Powell DIRECTOR ELECTIONS ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2024 and authorizing, in binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration; AUDIT-RELATED ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Approving the Company's 2024 Employee Stock Purchase Plan; COMPENSATION ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Renewing the Board of Directors' authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; and CAPITAL STRUCTURE ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. CAPITAL STRUCTURE ISSUER 4650810.000000 0 FOR 4650810.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 Election of Directors: Esther M. Alegria, PhD DIRECTOR ELECTIONS ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 Election of Directors: Joseph Carleone, PhD DIRECTOR ELECTIONS ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 Election of Directors: Nicholas S. Green DIRECTOR ELECTIONS ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 Election of Directors: Richard B. Hancock DIRECTOR ELECTIONS ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 Election of Directors: Catherine J. Mackey, PhD DIRECTOR ELECTIONS ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 Election of Directors: Gregory P. Sargen DIRECTOR ELECTIONS ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 Election of Directors: Jeanne A. Thoma DIRECTOR ELECTIONS ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2024. AUDIT-RELATED ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 To approve, by an advisory vote, a non-binding resolution approving the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 219547.000000 0 FOR 219547.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/23/2023 Proposal to approve, by an advisory vote, the frequency of holding future advisory votes on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 219547.000000 0 ONE YEAR 219547.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 10/24/2023 To approve the one-time approximately value neutral exchange of certain outstanding stock options issued pursuant to our 2014 Equity Incentive Plan or our 2019 Equity Incentive Plan that are held by our eligible employees into restricted stock units. COMPENSATION ISSUER 68818.000000 0 AGAINST 68818.000000 AGAINST S000004450 Neogen Corporation 640491106 US6404911066 10/25/2023 Election of Directors Nominees: Aashima Gupta DIRECTOR ELECTIONS ISSUER 718392.000000 0 FOR 718392.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/25/2023 Election of Directors Nominees: Raphael A. Rodriguez DIRECTOR ELECTIONS ISSUER 718392.000000 0 FOR 718392.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/25/2023 Election of Directors Nominees: Catherine E. Woteki, Ph.D. DIRECTOR ELECTIONS ISSUER 718392.000000 0 FOR 718392.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/25/2023 To Approve, by Non-Binding Vote, the Compensation of Executives. SECTION 14A SAY-ON-PAY VOTES ISSUER 718392.000000 0 FOR 718392.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/25/2023 Advisory vote on the frequency of holding future advisory votes to approve our named executive officers' compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 718392.000000 0 ONE YEAR 718392.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/25/2023 To Approve the Establishment of the Neogen Corporation 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 718392.000000 0 FOR 718392.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/25/2023 Ratification of Appointment of BDO USA P.A. as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 718392.000000 0 FOR 718392.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 To set the number of Directors at nine. CORPORATE GOVERNANCE ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Robert V. Baumgartner DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Julie L. Bushman DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: John L. Higgins DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Joseph D. Keegan DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Roeland Nusse DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Alpna Seth DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Randolph Steer DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Rupert Vessey DIRECTOR ELECTIONS ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Approve, on an advisory bass, the frequency of advisory votes on executive compensation to occur every (1) year. SECTION 14A SAY-ON-PAY VOTES ISSUER 546525.000000 0 ONE YEAR 546525.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED ISSUER 546525.000000 0 FOR 546525.000000 FOR S000004450 Cano Health, Inc. 13781Y202 US13781Y2028 11/02/2023 To vote on the amendment to the Company's Certificate of Incorporation to effect the Reverse Stock Split. CAPITAL STRUCTURE ISSUER 732759.000000 0 FOR 732759.000000 FOR S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/06/2023 Election of Class I Directors: Daniel M. Bendheim DIRECTOR ELECTIONS ISSUER 69909.000000 0 WITHHOLD 69909.000000 AGAINST S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/06/2023 Election of Class I Directors: Jonathan Bendheim DIRECTOR ELECTIONS ISSUER 69909.000000 0 WITHHOLD 69909.000000 AGAINST S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/06/2023 Election of Class I Directors: Sam Gejdenson DIRECTOR ELECTIONS ISSUER 69909.000000 0 WITHHOLD 69909.000000 AGAINST S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/06/2023 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024. AUDIT-RELATED ISSUER 69909.000000 0 FOR 69909.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 11/07/2023 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of September 5, 2023, by and among NextGen Healthcare, Inc. ("NextGen"), Next Holdco, LLC ("Parent") and Next Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will be merged with and into NextGen, with NextGen surviving as a wholly owned subsidiary of Parent (the "Merger"); EXTRAORDINARY TRANSACTIONS ISSUER 182825.000000 0 FOR 182825.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 11/07/2023 To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to NextGen's named executive officers that is based on or otherwise relates to the Merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 182825.000000 0 FOR 182825.000000 FOR S000004450 NextGen Healthcare, Inc. 65343C102 US65343C1027 11/07/2023 To approve the adjournment of the special meeting to a later date or dates if necessary to solicit additional proxies if there are insufficient votes in person or by proxy to approve the proposal to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 182825.000000 0 FOR 182825.000000 FOR S000004450 EQRx, Inc. 26886C107 US26886C1071 11/08/2023 To adopt the Agreement and Plan of Merger, dated July 31, 2023 (as it may be amended from time to time) (the "merger agreement"), by and among EQRX, Inc. ("EQRX"), Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub I, Inc., a wholly owned subsidiary of Revolution Medicines and Equinox Merger Sub LLC, a wholly owned subsidiary of Revolution Medicines (the "EQRX merger agreement proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 759937.000000 0 FOR 759937.000000 FOR S000004450 EQRx, Inc. 26886C107 US26886C1071 11/08/2023 To approve, on a non-binding, advisory basis, the compensation that will or may be payable to EQRX's named executive officers that is based on or otherwise relates to the transactions contemplated by the merger agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 759937.000000 0 AGAINST 759937.000000 AGAINST S000004450 EQRx, Inc. 26886C107 US26886C1071 11/08/2023 To approve the adjournment of the EQRX special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the EQRX special meeting to approve the EQRX merger agreement proposal. CORPORATE GOVERNANCE ISSUER 759937.000000 0 FOR 759937.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 11/08/2023 To approve the issuance of shares of Revolution Medicines common stock (including securities convertible into or exercisable for shares of Revolution Medicines common stock) to certain equityholders of EQRX, Inc., which is referred to as EQRX, pursuant to the Agreement and Plan of Merger, dated as of July 31, 2023 (as it may be amended from time to time), by and among Revolution Medicines, Equinox Merger Sub I, Inc., Equinox Merger Sub II LLC, and EQRX, which proposal is referred to as the Revolution Medicines share issuance proposal; and EXTRAORDINARY TRANSACTIONS ISSUER 258676.000000 0 FOR 258676.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 11/08/2023 To approve the adjournment of the Revolution Medicines special meeting, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Revolution Medicines special meeting to approve the Revolution Medicines share issuance proposal. CORPORATE GOVERNANCE ISSUER 258676.000000 0 FOR 258676.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/14/2023 Proposal to elect four Class II directors, for a term of three years: Eileen O. Auen DIRECTOR ELECTIONS ISSUER 132938.000000 0 FOR 132938.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/14/2023 Proposal to elect four Class II directors, for a term of three years: James C. Clemmer DIRECTOR ELECTIONS ISSUER 132938.000000 0 FOR 132938.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/14/2023 Proposal to elect four Class II directors, for a term of three years: Howard W. Donnelly DIRECTOR ELECTIONS ISSUER 132938.000000 0 FOR 132938.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/14/2023 Proposal to elect four Class II directors, for a term of three years: Jan Stern Reed DIRECTOR ELECTIONS ISSUER 132938.000000 0 FOR 132938.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/14/2023 To ratify the appointment of Deloitte & Touche LLP as AngioDynamics, Inc. independent registered public accounting firm for the fiscal year ending May 31, 2024. AUDIT-RELATED ISSUER 132938.000000 0 FOR 132938.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/14/2023 Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132938.000000 0 FOR 132938.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/14/2023 Approval of a "Say-On-Pay Frequency" advisory vote on a non-binding resolution to determine the frequency our shareholders will be asked to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 132938.000000 0 ONE YEAR 132938.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/14/2023 Approval of an amendment to, among other things, increase the number of shares available for issuance under the AngioDynamics, Inc. 2020 Equity Incentive Plan COMPENSATION ISSUER 132938.000000 0 FOR 132938.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Steven K. Barg DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Michelle M. Brennan DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Sujatha Chandrasekaran DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Sheri H. Edison DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: David C. Evans DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Patricia A. Hemingway Hall DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Akhil Johri DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Gregory B. Kenny DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Nancy Killefer DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Election of Directors: Christine A. Mundkur DIRECTOR ELECTIONS ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2024 AUDIT-RELATED ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 882953.000000 0 FOR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 To vote, on a non-binding advisory basis, on the frequency of future advisory votes to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 882953.000000 0 ONE YEAR 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Shareholder proposal regarding executives retaining significant stock, if properly presented COMPENSATION SECURITY HOLDER 882953.000000 0 AGAINST 882953.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/15/2023 Shareholder proposal regarding shareholder ratification of excessive termination pay, if properly presented COMPENSATION SECURITY HOLDER 882953.000000 0 AGAINST 882953.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 11/15/2023 Resolution to approve the amendment and restatement of the Company's 2014 Share Incentive Plan. COMPENSATION ISSUER 157977.000000 0 FOR 157977.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 11/15/2023 If Voting Proposal No. 1 is adopted, resolution to approve an increase in the number of authorized shares under the amendment and restatement of the Company's 2014 Share Incentive Plan and to authorize the Board as the competent body to issue ordinary shares and grant rights to subscribe for ordinary shares pursuant to such Plan. COMPENSATION ISSUER 157977.000000 0 FOR 157977.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Carol Burt DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Jan De Witte DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Karen Drexler DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Michael Farrell DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Peter Farrell DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Harjit Gill DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: John Hernandez DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Richard Sulpizio DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Desney Tan DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Elect ten directors, each to serve until our 2024 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2023 annual meeting are: Ronald Taylor DIRECTOR ELECTIONS ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2024. AUDIT-RELATED ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 508872.000000 0 FOR 508872.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/16/2023 Approve, on an advisory basis, the frequency of future say-on-pay votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 508872.000000 0 ONE YEAR 508872.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/21/2023 Election of Directors: David F. Clanachan DIRECTOR ELECTIONS ISSUER 71004.000000 2225105.000000 FOR 71004.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/21/2023 Election of Directors: Renah Persofsky DIRECTOR ELECTIONS ISSUER 71004.000000 2225105.000000 WITHHOLD 71004.000000 AGAINST S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/21/2023 Election of Directors: Irwin D. Simon DIRECTOR ELECTIONS ISSUER 71004.000000 2225105.000000 FOR 71004.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/21/2023 The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2024; AUDIT-RELATED ISSUER 71004.000000 2225105.000000 FOR 71004.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/21/2023 Approval of the non-binding advisory resolution on the named executive officer compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 71004.000000 2225105.000000 FOR 71004.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/21/2023 Approval to increase the number of shares of common stock the Company is authorized to issue from 990,000,000 shares of capital stock to 1,208,000,000 shares of capital stock (the "Authorized Shares Proposal"); CAPITAL STRUCTURE ISSUER 71004.000000 2225105.000000 FOR 71004.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/21/2023 Approval of the governance changes to the Company's Third Amended and Restated Certificate of Incorporation (the "Charter") to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the "Governance Proposal"); and CORPORATE GOVERNANCE ISSUER 71004.000000 2225105.000000 FOR 71004.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/01/2023 Election of Directors: John T. Bigalke DIRECTOR ELECTIONS ISSUER 413678.000000 0 FOR 413678.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/01/2023 Election of Directors: Helen M. Boudreau DIRECTOR ELECTIONS ISSUER 413678.000000 0 FOR 413678.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/01/2023 Election of Directors: Marc D. Miller DIRECTOR ELECTIONS ISSUER 413678.000000 0 FOR 413678.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/01/2023 Ratification of the appointment of Ernst & Young LLP to serve as our independent registered public accountant firm for fiscal year 2024. AUDIT-RELATED ISSUER 413678.000000 0 FOR 413678.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/01/2023 Approval of Premier, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 413678.000000 0 FOR 413678.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/01/2023 Approval, on an advisory basis, of the compensation of our Named Executive Officers as disclosed in the proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 413678.000000 0 FOR 413678.000000 FOR S000004450 Mirati Therapeutics, Inc. 60468T105 US60468T1051 12/13/2023 To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated October 8, 2023, by and among Mirati Therapeutics, Inc. ("Mirati"), Bristol-Myers Squibb Company ("Parent") and Vineyard Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the form of contingent value rights agreement to be entered into at or immediately prior to the effective time of the Merger by Parent and a rights agent reasonably acceptable to Mirati, pursuant to which Merger Sub will merge with and into Mirati (the "Merger "), with Mirati surviving the Merger as a wholly owned subsidiary of Parent. EXTRAORDINARY TRANSACTIONS ISSUER 174411.000000 0 FOR 174411.000000 FOR S000004450 Mirati Therapeutics, Inc. 60468T105 US60468T1051 12/13/2023 To approve, by non-binding, advisory vote, compensation that may be paid or become payable by Mirati to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 174411.000000 0 FOR 174411.000000 FOR S000004450 Mirati Therapeutics, Inc. 60468T105 US60468T1051 12/13/2023 To approve the adjournment of the special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 174411.000000 0 FOR 174411.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: W. Don Cornwell DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: Leo Groothuis DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: Melina Higgins DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: James M. Kilts DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: Harry A. Korman DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: Rajiv Malik DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: Richard A. Mark, C.P.A. DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: Mark W. Parrish DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Election of the following 11 directors, each to hold office until the 2024 annual meeting of shareholders: Scott A. Smith DIRECTOR ELECTIONS ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Approval of, on a non-binding advisory basis, the 2022 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Approval of amendment to our Amended and Restated Certificate of Incorporation to add a federal forum selection provision. SHAREHOLDER RIGHTS AND DEFENSES CORPORATE GOVERNANCE ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/15/2023 Approval of amendment to our Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 4164785.000000 0 FOR 4164785.000000 FOR S000004450 SomaLogic, Inc. 83444K105 US83444K1051 01/04/2024 To adopt the Agreement and Plan of Merger, dated as of October 4, 2023, by and between SomaLogic, Inc., Standard BioTools Inc. and Martis Merger Sub, Inc., and thereby approve the merger and the other transactions contemplated thereby (the "SomaLogic Merger Proposal"); and EXTRAORDINARY TRANSACTIONS ISSUER 541381.000000 0 FOR 541381.000000 FOR S000004450 SomaLogic, Inc. 83444K105 US83444K1051 01/04/2024 To approve adjournments of the SomaLogic Special Meeting from time to time, if necessary or appropriate to solicit additional proxies in favor of the SomaLogic Merger Proposal if there are insufficient votes at the time of such adjournment to approve such proposal or to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to SomaLogic stockholders. CORPORATE GOVERNANCE ISSUER 541381.000000 0 FOR 541381.000000 FOR S000004450 SomaLogic, Inc. 83444K105 US83444K1051 01/04/2024 Company Proposal: To adopt the Agreement and Plan of Merger, dated as of October 4, 2023, by and between SomaLogic, Inc., Standard BioTools Inc. and Martis Merger Sub, Inc., and thereby approve the merger and other transactions contemplated thereby. EXTRAORDINARY TRANSACTIONS ISSUER 0.000000 0 S000004450 SomaLogic, Inc. 83444K105 US83444K1051 01/04/2024 Company Proposal: To approve adjournments of the Special Meeting from time to time, if necessary or appropriate to solicit additional proxies in favor of Proposal 1 if there are insufficient votes at the time of such adjournment to approve such proposal or to ensure that any supplement or amendment to the Company's joint proxy statement/prospectus is timely provided to the Company's stockholders. CORPORATE GOVERNANCE ISSUER 0.000000 0 S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 01/12/2024 To approve and adopt an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from 1-for 10 shares up to a ratio of 1-for 50 shares, which ratio will be selected by the Company's Board of Directors and set forth in a public announcement. CAPITAL STRUCTURE ISSUER 920677.000000 0 FOR 920677.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 01/12/2024 To approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt Proposal 1. CORPORATE GOVERNANCE ISSUER 920677.000000 0 FOR 920677.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: William M. Brown DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Catherine M. Burzik DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Carrie L. Byington DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: R. Andrew Eckert DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Claire M. Fraser DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Christopher Jones DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Thomas E. Polen DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Bertram L. Scott DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Joanne Waldstreicher DIRECTOR ELECTIONS ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Ratification of the selection of the independent registered public accounting firm. AUDIT-RELATED ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 941093.000000 0 FOR 941093.000000 FOR S000004450 CareMax, Inc. 14171W202 US14171W2026 01/23/2024 To adopt and approve an amendment to our Third Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of Class A common stock, at a reverse stock split ratio range of 1-for-10 through 1-for-40, as determined by our Board of Directors at a later date, together with a corresponding reduction in the authorized number of shares of our common stock. CAPITAL STRUCTURE ISSUER 203842.000000 0 FOR 203842.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Michael J. Barber DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Steven K. Barg DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: J. Martin Carroll DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Rolf Classon DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: John J. Greisch DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Alessandro Maselli DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Donald E. Morel, Jr. DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Stephanie Okey DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Michelle R. Ryan DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Jack Stahl DIRECTOR ELECTIONS ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Ratification of Appointment of Ernst & Young LLP as Independent Auditor for Fiscal 2024 AUDIT-RELATED ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Advisory Vote to Approve Our Executive Compensation. (Say-on-Pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 01/25/2024 Approval of Amendment to Catalent, Inc. 2018 Omnibus Incentive Plan. COMPENSATION ISSUER 609670.000000 0 FOR 609670.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Edward P. Bousa DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Frank E. Casal DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Robyn C. Davis DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Didier Hirsch DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Martin Madaus DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Erica J. McLaughlin DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Tina S. Nova DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Michael Rosenblatt DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 Election of Directors: Stephen S. Schwartz DIRECTOR ELECTIONS ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 To approve by a non-binding advisory vote the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 To recommend, on an advisory basis, the frequency of holding an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 193134.000000 0 ONE YEAR 193134.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2024 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered accounting firm for the 2024 fiscal year. AUDIT-RELATED ISSUER 193134.000000 0 FOR 193134.000000 FOR S000004450 ImmunoGen, Inc. 45253H101 US45253H1014 01/31/2024 A proposal to approve the Agreement and Plan of Merger, dated November 30, 2023 (as may be amended, modified or supplemented from time to time, the "Merger Agreement"), by and among ImmunoGen, Inc., a Massachusetts corporation ("ImmunoGen"), AbbVie Inc., a Delaware corporation ("AbbVie"), Athene Subsidiary LLC, a Delaware limited liability company and wholly owned subsidiary of AbbVie ("Intermediate Sub"), and Athene Merger Sub Inc., a Massachusetts corporation and wholly owned subsidiary of Intermediate Sub ("Purchaser"). Upon the terms and subject to the conditions of the Merger Agreement, Purchaser will merge with and into ImmunoGen, and the separate corporate existence of Purchaser will thereupon cease, with ImmunoGen continuing as the surviving corporation and as a wholly owned subsidiary of Intermediate Sub in accordance with the Massachusetts Business Corporation Act; EXTRAORDINARY TRANSACTIONS ISSUER 796203.000000 0 FOR 796203.000000 FOR S000004450 ImmunoGen, Inc. 45253H101 US45253H1014 01/31/2024 A proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to ImmunoGen's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement; and SECTION 14A SAY-ON-PAY VOTES ISSUER 796203.000000 0 AGAINST 796203.000000 AGAINST S000004450 ImmunoGen, Inc. 45253H101 US45253H1014 01/31/2024 A proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the Merger Agreement if there are insufficient votes to approve the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 796203.000000 0 FOR 796203.000000 FOR S000004450 SAGE Therapeutics, Inc. 78667J108 US78667J1088 01/31/2024 To approve a one-time stock option exchange program for non-executive officer employees of Sage (the ''Option Exchange Proposal''). COMPENSATION ISSUER 181935.000000 0 FOR 181935.000000 FOR S000004450 SAGE Therapeutics, Inc. 78667J108 US78667J1088 01/31/2024 To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Exchange Proposal. CORPORATE GOVERNANCE ISSUER 181935.000000 0 FOR 181935.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/06/2024 Election of Class III Directors: Emily M. Leproust, Ph.D. DIRECTOR ELECTIONS ISSUER 193148.000000 0 FOR 193148.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/06/2024 Election of Class III Directors: Robert Chess DIRECTOR ELECTIONS ISSUER 193148.000000 0 FOR 193148.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/06/2024 To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation." SECTION 14A SAY-ON-PAY VOTES ISSUER 193148.000000 0 FOR 193148.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/06/2024 Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2024. AUDIT-RELATED ISSUER 193148.000000 0 FOR 193148.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/07/2024 Election of Directors: Dr. Milton M. Morris DIRECTOR ELECTIONS ISSUER 193906.000000 0 FOR 193906.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/07/2024 Election of Directors: Dr. Claire Pomeroy DIRECTOR ELECTIONS ISSUER 193906.000000 0 FOR 193906.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/07/2024 Election of Directors: Ms. Karen N. Prange DIRECTOR ELECTIONS ISSUER 193906.000000 0 FOR 193906.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/07/2024 Ratification of selection of independent registered public accounting firm AUDIT-RELATED ISSUER 193906.000000 0 FOR 193906.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/07/2024 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 193906.000000 0 FOR 193906.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/07/2024 Approval of an amendment to the Embecta 2022 Employee and Director Equity-Based Compensation Plan COMPENSATION ISSUER 193906.000000 0 FOR 193906.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/08/2024 Election of Directors: Dr. Walter S. Woltosz DIRECTOR ELECTIONS ISSUER 53613.000000 0 FOR 53613.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/08/2024 Election of Directors: Dr. John K. Paglia DIRECTOR ELECTIONS ISSUER 53613.000000 0 FOR 53613.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/08/2024 Election of Directors: Dr. Daniel Weiner DIRECTOR ELECTIONS ISSUER 53613.000000 0 FOR 53613.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/08/2024 Election of Directors: Dr. Lisa LaVange DIRECTOR ELECTIONS ISSUER 53613.000000 0 FOR 53613.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/08/2024 Election of Directors: Sharlene Evans DIRECTOR ELECTIONS ISSUER 53613.000000 0 FOR 53613.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/08/2024 Ratification of the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the Company for the fiscal year ending August 31, 2024. AUDIT-RELATED ISSUER 53613.000000 0 FOR 53613.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/08/2024 Approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended, to increase the number of shares authorized for issuance thereunder from 1,550,000 shares to 2,500,000 shares of common stock of the Company. COMPENSATION ISSUER 53613.000000 0 FOR 53613.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/08/2024 Election of Directors: David R. Dantzker, M.D. DIRECTOR ELECTIONS ISSUER 47586.000000 0 FOR 47586.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/08/2024 Election of Directors: Lisa Wipperman Heine DIRECTOR ELECTIONS ISSUER 47586.000000 0 FOR 47586.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/08/2024 Set the number of directors at six (6); CORPORATE GOVERNANCE ISSUER 47586.000000 0 FOR 47586.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/08/2024 Ratify the appointment of Deloitte & Touche LLP as Surmodics' independent registered public accounting firm for fiscal year 2024; and AUDIT-RELATED ISSUER 47586.000000 0 FOR 47586.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/08/2024 Approve in a non-binding advisory vote, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 47586.000000 0 FOR 47586.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders. Kathleen L. Bardwell DIRECTOR ELECTIONS ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders. Jocelyn D. Chertoff, M.D. DIRECTOR ELECTIONS ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders. Timothy E. Guertin DIRECTOR ELECTIONS ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders. Jay K. Kunkel DIRECTOR ELECTIONS ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders. Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders. Sunny S. Sanyal DIRECTOR ELECTIONS ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders. Christine A. Tsingos DIRECTOR ELECTIONS ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To approve an advisory basis, our executive compensation as described in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To approve the Varex Imaging Corporation 2020 Omnibus Plan as Amended and Restated. COMPENSATION ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/08/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2024. AUDIT-RELATED ISSUER 135871.000000 0 FOR 135871.000000 FOR S000004450 Cerevel Therapeutics Holdings, Inc. 15678U128 US15678U1280 02/16/2024 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the ''Merger Agreement''), dated as of December 6, 2023, by and among AbbVie Inc., a Delaware corporation (''AbbVie''), Symphony Harlan LLC, a Delaware limited liability company and a wholly owned subsidiary of AbbVie (''Intermediate Holdco''), Symphony Harlan Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Intermediate Holdco (''Merger Sub''), and Cerevel Therapeutics Holdings, Inc. (''Cerevel''), pursuant to which Merger Sub will be merged with and into Cerevel, with Cerevel surviving as a wholly owned subsidiary of AbbVie (the ''Merger''); EXTRAORDINARY TRANSACTIONS ISSUER 237971.000000 0 FOR 237971.000000 FOR S000004450 Cerevel Therapeutics Holdings, Inc. 15678U128 US15678U1280 02/16/2024 To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Cerevel's named executive officers that is based on or otherwise relates to the Merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 237971.000000 0 AGAINST 237971.000000 AGAINST S000004450 Cerevel Therapeutics Holdings, Inc. 15678U128 US15678U1280 02/16/2024 To approve the adjournment of the special meeting to a later date or dates if necessary to solicit additional proxies if there are insufficient votes in person or by proxy to approve the proposal to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 237971.000000 0 FOR 237971.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/06/2024 To elect three Class II directors to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Yujiro S. Hata DIRECTOR ELECTIONS ISSUER 67014.000000 0 FOR 67014.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/06/2024 To elect three Class II directors to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Kristine Peterson DIRECTOR ELECTIONS ISSUER 67014.000000 0 FOR 67014.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/06/2024 To elect three Class II directors to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Terry C. Vance DIRECTOR ELECTIONS ISSUER 67014.000000 0 FOR 67014.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/06/2024 To approve an amendment to our 2019 Equity Incentive Plan. COMPENSATION ISSUER 67014.000000 0 FOR 67014.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/06/2024 To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 67014.000000 0 FOR 67014.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/06/2024 To ratify the appointment of PricewaterhouseCoopers LLP as Enanta's independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED ISSUER 67014.000000 0 FOR 67014.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Stephen P. MacMillan DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Sally W. Crawford DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Charles J. Dockendorff DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Scott T. Garrett DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Ludwig N. Hantson DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Nanaz Mohtashami DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Christiana Stamoulis DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Stacey D. Stewart DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Election of Directors: Amy M. Wendell DIRECTOR ELECTIONS ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 03/07/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2024. AUDIT-RELATED ISSUER 824952.000000 0 FOR 824952.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Ornella Barra DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Werner Baumann DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Steven H. Collis DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: D. Mark Durcan DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Richard W. Gochnauer DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Lon R. Greenberg DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Kathleen W. Hyle DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Lorence H. Kim, M.D. DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Redonda G. Miller, M.D. DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Dennis M. Nally DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Lauren M. Tyler DIRECTOR ELECTIONS ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Advisory vote to approve the compensation of the Company's names executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2024 AUDIT-RELATED ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Approval of an amendment of the certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Approval of miscellaneous amendments to the certificate of incorporation. CORPORATE GOVERNANCE ISSUER 575079.000000 0 FOR 575079.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Shareholder proposal regarding voting standard for election of directors. CORPORATE GOVERNANCE SECURITY HOLDER 575079.000000 0 AGAINST 575079.000000 FOR S000004450 Karuna Therapeutics, Inc. 48576A100 US48576A1007 03/12/2024 To adopt the Agreement and Plan of Merger, dated as of December 22, 2023 (the "merger agreement"), among Karuna Therapeutics, Inc. ("Karuna"), Bristol-Myers Squibb Company ("Bristol-Myers Squibb"), and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers Squibb Company ("Merger Sub"), pursuant to which, subject to the terms and conditions set forth therein, Merger Sub will be merged with and into Karuna, and Karuna will survive the merger as a wholly owned subsidiary of Bristol-Myers Squibb. EXTRAORDINARY TRANSACTIONS ISSUER 107653.000000 0 FOR 107653.000000 FOR S000004450 Karuna Therapeutics, Inc. 48576A100 US48576A1007 03/12/2024 To approve, on an advisory, non-binding basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger of Merger Sub with and into Karuna pursuant to the merger agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 107653.000000 0 FOR 107653.000000 FOR S000004450 Karuna Therapeutics, Inc. 48576A100 US48576A1007 03/12/2024 To adjourn the special meeting from time to time, if necessary or appropriate, as determined in good faith by the board of directors of Karuna including for the purpose of soliciting additional votes for the approval of the proposal to adopt the merger agreement if there are insufficient votes at the time of the special meeting to approve the proposal to adopt the merger agreement. CORPORATE GOVERNANCE ISSUER 107653.000000 0 FOR 107653.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Mala Anand DIRECTOR ELECTIONS ISSUER 984374.000000 0 FOR 984374.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Koh Boon Hwee DIRECTOR ELECTIONS ISSUER 984374.000000 0 FOR 984374.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 984374.000000 0 FOR 984374.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Daniel K. Podolsky, M.D DIRECTOR ELECTIONS ISSUER 984374.000000 0 FOR 984374.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 984374.000000 0 FOR 984374.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 984374.000000 0 FOR 984374.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 To vote on a shareholder proposal regarding simple majority vote, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 984374.000000 0 FOR 984374.000000 NONE S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 Election of Directors: Douglass Given DIRECTOR ELECTIONS ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 Election of Directors: Michael S. Perry DIRECTOR ELECTIONS ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 Election of Directors: Christopher Anzalone DIRECTOR ELECTIONS ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 Election of Directors: Mauro Ferrari DIRECTOR ELECTIONS ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 Election of Directors: Adeoye Olukotun DIRECTOR ELECTIONS ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 Election of Directors: William Waddill DIRECTOR ELECTIONS ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 Election of Directors: Victoria Vakiener DIRECTOR ELECTIONS ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/14/2024 To ratify the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2024. AUDIT-RELATED ISSUER 414164.000000 0 FOR 414164.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: William A. Kozy DIRECTOR ELECTIONS ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Albert G. White III DIRECTOR ELECTIONS ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2024. AUDIT-RELATED ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers ("Say on Pay Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 166600.000000 0 FOR 166600.000000 FOR S000004450 Axonics, Inc. 05465P101 US05465P1012 03/22/2024 To adopt the Agreement and Plan of Merger, dated January 8, 2024 (such agreement, as it may be amended, modified or supplemented from time to time, the "Merger Agreement"), by and among Axonics, Inc., a Delaware corporation ("Axonics"), Boston Scientific Corporation, a Delaware corporation ("Boston Scientific"), and Sadie Merger Sub, Inc., a Delaware corporation ("Merger Sub"). Upon the terms and subject to the conditions of the Merger Agreement, Boston Scientific will acquire Axonics via a merger of Merger Sub with and into Axonics, with the separate corporate existence of Merger Sub thereupon ceasing and Axonics continuing as the surviving company and a wholly owned subsidiary of Boston Scientific. EXTRAORDINARY TRANSACTIONS ISSUER 171168.000000 0 FOR 171168.000000 FOR S000004450 Axonics, Inc. 05465P101 US05465P1012 03/22/2024 To approve on an advisory (non-binding) basis, the compensation that may be paid or become payable to Axonics' named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 171168.000000 0 FOR 171168.000000 FOR S000004450 Axonics, Inc. 05465P101 US05465P1012 03/22/2024 To adjourn the special meeting of the Axonics stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 171168.000000 0 FOR 171168.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard M. Krasno, Ph.D. DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman. M.D. DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr. DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 AGAINST 291755.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 291755.000000 1153400.000000 FOR 291755.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To approve an amendment to the Company's amended and restated certificate of incorporation to increase the number of authorized shares of the common stock that may be issued from 1,000,000,000 to 1,250,000,000; CAPITAL STRUCTURE ISSUER 291755.000000 1153400.000000 FOR 291755.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 291755.000000 1153400.000000 FOR 291755.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 03/28/2024 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 291755.000000 1153400.000000 FOR 291755.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 04/03/2024 To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued outstanding common stock at a ratio of 1-for-20. CAPITAL STRUCTURE ISSUER 1108893.000000 0 FOR 1108893.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R102 US81750R1023 04/04/2024 Election of Directors: Paul R. Biondi DIRECTOR ELECTIONS ISSUER 352488.000000 0 FOR 352488.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R102 US81750R1023 04/04/2024 Election of Directors: Kurt C. Graves DIRECTOR ELECTIONS ISSUER 352488.000000 0 FOR 352488.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R102 US81750R1023 04/04/2024 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 352488.000000 0 FOR 352488.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R102 US81750R1023 04/04/2024 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 352488.000000 0 FOR 352488.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R102 US81750R1023 04/04/2024 Approval of an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 240,000,000 to 360,000,000. CAPITAL STRUCTURE ISSUER 352488.000000 0 FOR 352488.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R102 US81750R1023 04/04/2024 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 4. CORPORATE GOVERNANCE ISSUER 352488.000000 0 FOR 352488.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R102 US81750R1023 04/04/2024 A stockholder proposal on Simple Majority Vote, if properly presented. CORPORATE GOVERNANCE SECURITY HOLDER 352488.000000 0 FOR 352488.000000 AGAINST S000004450 Scilex Holding Company 04/05/2024 Election of Directors: Jay Chun, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 219844.000000 0 FOR 219844.000000 FOR S000004450 Scilex Holding Company 04/05/2024 Election of Directors: Yue Alexander Wu, Ph.D. DIRECTOR ELECTIONS ISSUER 219844.000000 0 FOR 219844.000000 FOR S000004450 Scilex Holding Company 04/05/2024 Proposal to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 219844.000000 0 FOR 219844.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Ari Bousbib DIRECTOR ELECTIONS ISSUER 621000.000000 0 FOR 621000.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Carol J. Burt DIRECTOR ELECTIONS ISSUER 621000.000000 0 FOR 621000.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 621000.000000 0 FOR 621000.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 621000.000000 0 FOR 621000.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Todd B. Sisitsky DIRECTOR ELECTIONS ISSUER 621000.000000 0 FOR 621000.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 621000.000000 0 FOR 621000.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 621000.000000 0 FOR 621000.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 If properly presented, a stockholder proposal concerning political spending. OTHER SOCIAL ISSUES SECURITY HOLDER 621000.000000 0 AGAINST 621000.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 621000.000000 0 FOR 621000.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Raquel C.Bono, M.D. DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Bruce D. Broussard DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: John W. Garratt DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Brad D. Smith DIRECTOR ELECTIONS ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2024 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 The approval of the amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 The approval of the amendment to the Company's Restated Certificate of Incorporation to eliminate supermajority voting requirement in connection with certain transactions. CORPORATE GOVERNANCE ISSUER 421626.000000 0.000000 FOR 421626.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/18/2024 The stockholder proposal on simple majority vote, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 421626.000000 0.000000 AGAINST 421626.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 Election of Directors: Jorge A. Caballero DIRECTOR ELECTIONS ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 Election of Directors: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 Election of Directors: Teri G. Fontenot DIRECTOR ELECTIONS ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 Election of Directors: Cary S. Grace DIRECTOR ELECTIONS ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 Election of Directors: R. Jeffrey Harris DIRECTOR ELECTIONS ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 Election of Directors: Daphne E. Jones DIRECTOR ELECTIONS ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 Election of Directors: Sylvia D. Trent-Adams DIRECTOR ELECTIONS ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 Election of Directors: Douglas D. Wheat DIRECTOR ELECTIONS ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 To ratify the appointment of KPMG LLP to be our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 04/19/2024 To approve a proposed amendment and restatement of our certificate of incorporation to provide for exculpation of certain officers of the Company from personal liability under certain circumstances as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 128748.000000 0 FOR 128748.000000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/23/2024 Nominees: Melinda Litherland DIRECTOR ELECTIONS ISSUER 73331.000000 0 FOR 73331.000000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/23/2024 Nominees: Arnold A. Pinkston DIRECTOR ELECTIONS ISSUER 73331.000000 0 FOR 73331.000000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/23/2024 Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. AUDIT-RELATED ISSUER 73331.000000 0 FOR 73331.000000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/23/2024 Approval of the amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. COMPENSATION ISSUER 73331.000000 0 FOR 73331.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Peter Barrett, PhD DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Samuel R. Chapin DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Michael A. Klobuchar DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Michelle McMurry-Heath, MD, PhD DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Alexis P. Michas DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Prahlad R. Singh, PhD DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Frank Witney, PhD DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To elect ten nominees for director for terms of one year each: Pascale Witz DIRECTOR ELECTIONS ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To ratify the selection of Deloitte & Touche LLP as Revvity's independent registered public accounting firm for the current fiscal year. AUDIT-RELATED ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To approve, by non-binding advisory vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 420890.000000 0 FOR 420890.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/23/2024 To approve the shareholder proposal regarding simple majority voting, if properly presented at the annual meeting. CORPORATE GOVERNANCE SECURITY HOLDER 420890.000000 0 FOR 420890.000000 AGAINST S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Mark A. Buthman DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: William F. Feehery DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Robert F. Friel DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Eric M. Green DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Thomas W. Hofmann DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Molly E. Joseph DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Deborah L. V. Keller DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Myla P. Lai-Goldman DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Douglas A. Michels DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Paolo Pucci DIRECTOR ELECTIONS ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Advisory vote to approve named executive officer compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Transaction Requirement; CORPORATE GOVERNANCE ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Amendment Requirement; CORPORATE GOVERNANCE ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for 2024; and AUDIT-RELATED ISSUER 251337.000000 0 FOR 251337.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Shareholder Proposal Entitled "Simple Majority Vote" CORPORATE GOVERNANCE SECURITY HOLDER 251337.000000 0 AGAINST 251337.000000 FOR S000004450 Inari Medical, Inc. 45332Y109 US45332Y1091 04/24/2024 To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rebecca Chambers DIRECTOR ELECTIONS ISSUER 175475.000000 0 FOR 175475.000000 FOR S000004450 Inari Medical, Inc. 45332Y109 US45332Y1091 04/24/2024 To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Hoffman DIRECTOR ELECTIONS ISSUER 175475.000000 0 FOR 175475.000000 FOR S000004450 Inari Medical, Inc. 45332Y109 US45332Y1091 04/24/2024 To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Andrew Hykes DIRECTOR ELECTIONS ISSUER 175475.000000 0 FOR 175475.000000 FOR S000004450 Inari Medical, Inc. 45332Y109 US45332Y1091 04/24/2024 To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Donald Milder DIRECTOR ELECTIONS ISSUER 175475.000000 0 FOR 175475.000000 FOR S000004450 Inari Medical, Inc. 45332Y109 US45332Y1091 04/24/2024 To ratify the appointment of BDO USA, P.C. as the independent registered public accounting firm for the Company's fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 175475.000000 0 FOR 175475.000000 FOR S000004450 Inari Medical, Inc. 45332Y109 US45332Y1091 04/24/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 175475.000000 0 FOR 175475.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 04/24/2024 Election of the four Class I nominees named in the proxy statement to our Board of Directors: Michael K. Attal DIRECTOR ELECTIONS ISSUER 883396.000000 0 FOR 883396.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 04/24/2024 Election of the four Class I nominees named in the proxy statement to our Board of Directors: Travis S. Dalton DIRECTOR ELECTIONS ISSUER 883396.000000 0 FOR 883396.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 04/24/2024 Election of the four Class I nominees named in the proxy statement to our Board of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 883396.000000 0 FOR 883396.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 04/24/2024 Election of the four Class I nominees named in the proxy statement to our Board of Directors: John M. Prince DIRECTOR ELECTIONS ISSUER 883396.000000 0 FOR 883396.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 04/24/2024 Ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2024. AUDIT-RELATED ISSUER 883396.000000 0 FOR 883396.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 04/24/2024 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 883396.000000 0 FOR 883396.000000 FOR S000004450 MultiPlan Corporation 62548M100 US62548M1009 04/24/2024 Approval of the Amendment to the MultiPlan Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 883396.000000 0 FOR 883396.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: David M. Cordani DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: William J. DeLaney DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Eric J. Foss DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Retired Maj. Gen. Elder Granger, M.D. DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Neesha Hathi DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: George Kurian DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Mark B. McClellan, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Philip O. Ozuah, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Advisory approval of The Cigna Group's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 998184.000000 0 FOR 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Shareholder proposal - improve the shareholder right to call a special shareholder meeting. CORPORATE GOVERNANCE SECURITY HOLDER 998184.000000 0 AGAINST 998184.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/24/2024 Shareholder proposal - Report to shareholders on risks created by the The Cigna Group's diversity, equity, and inclusion efforts. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 998184.000000 0 AGAINST 998184.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/25/2024 Election of Directors (to serve until the 2025 Annual Meeting): Gary D. Blackford DIRECTOR ELECTIONS ISSUER 159613.000000 0 FOR 159613.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/25/2024 Election of Directors (to serve until the 2025 Annual Meeting): Dr. Lisa Egbuonu-Davis DIRECTOR ELECTIONS ISSUER 159613.000000 0 FOR 159613.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/25/2024 Election of Directors (to serve until the 2025 Annual Meeting): Patrick J. O'Leary DIRECTOR ELECTIONS ISSUER 159613.000000 0 FOR 159613.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/25/2024 Election of Directors (to serve until the 2025 Annual Meeting): Dr. Julie Shimer DIRECTOR ELECTIONS ISSUER 159613.000000 0 FOR 159613.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/25/2024 Election of Directors (to serve until the 2025 Annual Meeting): Joseph F. Woody DIRECTOR ELECTIONS ISSUER 159613.000000 0 FOR 159613.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/25/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 159613.000000 0 FOR 159613.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/25/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 159613.000000 0 FOR 159613.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 04/25/2024 Election of Class II Directors: Barbara Duncan DIRECTOR ELECTIONS ISSUER 447932.000000 0 FOR 447932.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 04/25/2024 Election of Class II Directors: Mahesh Krishnan DIRECTOR ELECTIONS ISSUER 447932.000000 0 FOR 447932.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 04/25/2024 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 447932.000000 0 FOR 447932.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 04/25/2024 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to reflect Delaware law provisions regarding exculpation of officers. CORPORATE GOVERNANCE ISSUER 447932.000000 0 FOR 447932.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 04/25/2024 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 447932.000000 0 FOR 447932.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Meg G. Crofton DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Robert J. Dennis DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Wayne J. Riley M.D. DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 691963.000000 0 FOR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Advisory vote to approve the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 691963.000000 0 ONE YEAR 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Stockholder proposal, if properly presented at the meeting, regarding report on risk mitigation regarding state restrictions for emergency abortions. OTHER SOCIAL ISSUES SECURITY HOLDER 691963.000000 0 AGAINST 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Stockholder proposal, if properly presented at the meeting, regarding report on patient feedback regarding quality of care. OTHER SOCIAL ISSUES SECURITY HOLDER 691963.000000 0 AGAINST 691963.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Stockholder proposal, if property presented at the meeting, regarding report on maternal health outcomes. OTHER SOCIAL ISSUES SECURITY HOLDER 691963.000000 0 AGAINST 691963.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Amal M. Johnson DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Mark J. Rubash DIRECTOR ELECTIONS ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 The amendment and restatement of the Amended and Restated 2000 Employee Stock Purchase Plan. COMPENSATION ISSUER 1195694.000000 0 FOR 1195694.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 The stockholder proposal requesting a racial and gender pay gap report, if properly presented at the Annual Meeting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 1195694.000000 0 AGAINST 1195694.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Darius Adamczyk DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: D. Scott Davis DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Anne M. Mulcahy DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 8185461.000000 0 FOR 8185461.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/25/2024 Gender-based compensation gaps and associated risks ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 8185461.000000 0 AGAINST 8185461.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/25/2024 The election of three Class III directors to our Board of Directors: Mr. Brian Markison DIRECTOR ELECTIONS ISSUER 233276.000000 0 FOR 233276.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/25/2024 The election of three Class III directors to our Board of Directors: Mr. Gary Pruden DIRECTOR ELECTIONS ISSUER 233276.000000 0 FOR 233276.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/25/2024 The election of three Class III directors to our Board of Directors: Dr. James H. Thrall DIRECTOR ELECTIONS ISSUER 233276.000000 0 FOR 233276.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/25/2024 The approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 233276.000000 0 FOR 233276.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/25/2024 The approval of an amendment to the Lantheus Holdings, Inc. 2015 Equity Incentive Plan to increase the number of Shares reserved for issuance thereunder. COMPENSATION ISSUER 233276.000000 0 FOR 233276.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/25/2024 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 233276.000000 0 FOR 233276.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Albert Bourla DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Helen H. Hobbs DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Susan Hockfield DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Dan R. Littman DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: James Quincey DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: James C. Smith DIRECTOR ELECTIONS ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Approval of the Amended and Restated Pfizer Inc. 2019 Stock Plan COMPENSATION ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 2024 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 19212303.000000 0 FOR 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Adopt an Independent Board Chair Policy CORPORATE GOVERNANCE SECURITY HOLDER 19212303.000000 0 AGAINST 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Publish a Congruency Report on Political, Lobbying, Electioneering Expenditures OTHER SOCIAL ISSUES SECURITY HOLDER 19212303.000000 0 AGAINST 19212303.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/25/2024 Publish a Report on Corporate Contributions OTHER SOCIAL ISSUES SECURITY HOLDER 19212303.000000 0 AGAINST 19212303.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/25/2024 Vote to elect three Class III directors, each for a term of three years or until their respective successors have been elected and qualified: James S. Ely III DIRECTOR ELECTIONS ISSUER 368194.000000 0 FOR 368194.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/25/2024 Vote to elect three Class III directors, each for a term of three years or until their respective successors have been elected and qualified: Rocco A. Ortenzio DIRECTOR ELECTIONS ISSUER 368194.000000 0 FOR 368194.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/25/2024 Vote to elect three Class III directors, each for a term of three years or until their respective successors have been elected and qualified: Thomas A. Scully DIRECTOR ELECTIONS ISSUER 368194.000000 0 FOR 368194.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/25/2024 Non-binding advisory vote on the compensation of our Named Executive Officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 368194.000000 0 FOR 368194.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/25/2024 Vote to amend the Company's 2020 Equity Incentive Compensation Plan; COMPENSATION ISSUER 368194.000000 0 FOR 368194.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/25/2024 Vote to ratify the appointment of PriceWaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 368194.000000 0 FOR 368194.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/25/2024 Vote to amend the Company's Amended and Restated Certificate of Incorporation to permit Exculpation of Officers; and CORPORATE GOVERNANCE ISSUER 368194.000000 0 FOR 368194.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/25/2024 Vote on Stockholder's Proposal to Amend the Company's Charter and Bylaws to Provide for Simple Majority Vote. CORPORATE GOVERNANCE SECURITY HOLDER 368194.000000 0 FOR 368194.000000 AGAINST S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: R. J. Alpern DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 5904331.000000 0 AGAINST 5904331.000000 AGAINST S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/26/2024 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5904331.000000 0 FOR 5904331.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/30/2024 Election of Directors for a term expiring at the 2027 Annual Meeting of shareholders: Julia P. Gregory DIRECTOR ELECTIONS ISSUER 246306.000000 0 FOR 246306.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/30/2024 Election of Directors for a term expiring at the 2027 Annual Meeting of shareholders: John W. Childs DIRECTOR ELECTIONS ISSUER 246306.000000 0 FOR 246306.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/30/2024 Election of Directors for a term expiring at the 2027 Annual Meeting of shareholders: Gregory H. Bailey, M.D. DIRECTOR ELECTIONS ISSUER 246306.000000 0 FOR 246306.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/30/2024 Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2024. AUDIT-RELATED ISSUER 246306.000000 0 FOR 246306.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/30/2024 A non-binding advisory vote on the frequency of future advisory votes on the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 246306.000000 0 ONE YEAR 246306.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Daniel Cooperman DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Steven J. Orlando DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Ronna E. Romney DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Dale B. Wolf DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To elect nine directors to hold office until the 2025 Annual Meeting: Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To consider and approve, on a non-binding, advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 198783.000000 0.000000 FOR 198783.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/01/2024 Shareholder proposal regarding simple majority voting, if properly presented. CORPORATE GOVERNANCE SECURITY HOLDER 198783.000000 0.000000 AGAINST 198783.000000 FOR S000004450 Revance Therapeutics, Inc. 761330109 US7613301099 05/01/2024 Election of Directors: Angus C. Russell DIRECTOR ELECTIONS ISSUER 336338.000000 0 FOR 336338.000000 FOR S000004450 Revance Therapeutics, Inc. 761330109 US7613301099 05/01/2024 Election of Directors: Julian S. Gangolli DIRECTOR ELECTIONS ISSUER 336338.000000 0 FOR 336338.000000 FOR S000004450 Revance Therapeutics, Inc. 761330109 US7613301099 05/01/2024 Election of Directors: Olivia C. Ware DIRECTOR ELECTIONS ISSUER 336338.000000 0 FOR 336338.000000 FOR S000004450 Revance Therapeutics, Inc. 761330109 US7613301099 05/01/2024 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 336338.000000 0 FOR 336338.000000 FOR S000004450 Revance Therapeutics, Inc. 761330109 US7613301099 05/01/2024 Approval of, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement.. SECTION 14A SAY-ON-PAY VOTES ISSUER 336338.000000 0 FOR 336338.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 Election of Directors: Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 Election of Directors: Alan L. Rubino DIRECTOR ELECTIONS ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 Election of Directors: Heidi Hagen DIRECTOR ELECTIONS ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 Election of Directors: Steven C. Gilman DIRECTOR ELECTIONS ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 Election of Directors: Kevin F. McLaughlin DIRECTOR ELECTIONS ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 Election of Directors: Paul K. Wotton DIRECTOR ELECTIONS ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 Election of Directors: Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 Election of Directors: Lisa Wright DIRECTOR ELECTIONS ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 To approve, on an advisory basis, the frequency of future named executive officer compensation advisory votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 154981.000000 0 ONE YEAR 154981.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 05/01/2024 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 154981.000000 0 FOR 154981.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Emily Peterson Alva DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Deb Autor DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: J. Kevin Buchi DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Jeff George DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: John Kiely DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Paul Meister DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Ted Nark DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Chintu Patel DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Chirag Patel DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Gautam Patel DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Election of Directors: Shlomo Yanai DIRECTOR ELECTIONS ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/02/2024 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2024. AUDIT-RELATED ISSUER 418423.000000 0 FOR 418423.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Charles J. Dockendorff DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Yoshiaki Fujimori DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: John E. Sununu DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 To approve an amendment and restatement of our By-Laws to provide for advance notice and universal proxy rule updates. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/02/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED ISSUER 4995501.000000 0 FOR 4995501.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Joan E. Herman DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Patricia A. Maryland DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Election of ten nominees to the Board of Directors to serve until our 2025 Annual Meeting of Stockholders: Terrance Williams DIRECTOR ELECTIONS ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 341977.000000 0 FOR 341977.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/02/2024 A vote on a resolution requesting a report on the effectiveness of the Company's diversity, equity, and inclusion efforts. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 341977.000000 0 AGAINST 341977.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Election of Class III Directors: Shelley G. Broader DIRECTOR ELECTIONS ISSUER 100737.000000 0 FOR 100737.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Election of Class III Directors: Myriam J. Curet, M.D. DIRECTOR ELECTIONS ISSUER 100737.000000 0 FOR 100737.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Election of Class III Directors: Casey M. Tansey DIRECTOR ELECTIONS ISSUER 100737.000000 0 FOR 100737.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 100737.000000 0 FOR 100737.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 100737.000000 0 FOR 100737.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Bradley A. Alford DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Julia M. Brown DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Katherine C. Doyle DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Adriana Karaboutis DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Jeffrey B. Kindler DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Albert A. Manzone DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Donal O'Connor DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To elect ten director nominees to serve until the 2025 Annual General Meeting of Shareholders; Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor; AUDIT-RELATED ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To provide advisory approval of the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To renew the Board's authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/02/2024 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 461624.000000 0 FOR 461624.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Roxanne S. Austin DIRECTOR ELECTIONS ISSUER 6022622.000000 0 FOR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Richard A. Gonzalez DIRECTOR ELECTIONS ISSUER 6022622.000000 0 FOR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Susan E. Quaggin DIRECTOR ELECTIONS ISSUER 6022622.000000 0 FOR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Rebecca B. Roberts DIRECTOR ELECTIONS ISSUER 6022622.000000 0 FOR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Glenn F. Tilton DIRECTOR ELECTIONS ISSUER 6022622.000000 0 FOR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 6022622.000000 0 FOR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 6022622.000000 0 FOR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Say on Pay - An advisory vote on the frequency of the advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 6022622.000000 0 ONE YEAR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 6022622.000000 0 FOR 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Stockholder Proposal - to Implement Simple Majority Vote CORPORATE GOVERNANCE SECURITY HOLDER 6022622.000000 0 AGAINST 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Stockholder Proposal - to Issue Annual Report on Lobbying OTHER SOCIAL ISSUES SECURITY HOLDER 6022622.000000 0 AGAINST 6022622.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Stockholder Proposal - to Issue a Report on Patent Process OTHER SOCIAL ISSUES SECURITY HOLDER 6022622.000000 0 AGAINST 6022622.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Election of Directors: Candace H. Duncan DIRECTOR ELECTIONS ISSUER 160265.000000 0 FOR 160265.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Election of Directors: Gretchen R. Haggerty DIRECTOR ELECTIONS ISSUER 160265.000000 0 FOR 160265.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Election of Directors: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 160265.000000 0 FOR 160265.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Election of Directors: Stephen K. Klasko DIRECTOR ELECTIONS ISSUER 160265.000000 0 FOR 160265.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Election of Directors: Stuart A. Randle DIRECTOR ELECTIONS ISSUER 160265.000000 0 FOR 160265.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Election of Directors: Jaewon Ryu DIRECTOR ELECTIONS ISSUER 160265.000000 0 FOR 160265.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Approval, on an advisory basis, of named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 160265.000000 0 FOR 160265.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 160265.000000 0 FOR 160265.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/03/2024 Stockholder proposal, if properly presented at the Annual Meeting, to reduce the ownership threshold to call a special stockholder meeting. CORPORATE GOVERNANCE SECURITY HOLDER 160265.000000 0 AGAINST 160265.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Election of the following directors, each to serve a three-year term: Katherine Baicker, Ph.D. DIRECTOR ELECTIONS ISSUER 2745695.000000 0 FOR 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Election of the following directors, each to serve a three-year term: J. Erik Fyrwald DIRECTOR ELECTIONS ISSUER 2745695.000000 0 FOR 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Election of the following directors, each to serve a three-year term: Jamere Jackson DIRECTOR ELECTIONS ISSUER 2745695.000000 0 FOR 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Election of the following directors, each to serve a three-year term: Gabrielle Sulzberger DIRECTOR ELECTIONS ISSUER 2745695.000000 0 FOR 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2745695.000000 0 FOR 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2024. AUDIT-RELATED ISSUER 2745695.000000 0 FOR 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 2745695.000000 0 FOR 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 2745695.000000 0 FOR 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Shareholder proposal to publish an annual report disclosing lobbying activities. OTHER SOCIAL ISSUES SECURITY HOLDER 2745695.000000 0 AGAINST 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Shareholder proposal to report on effectiveness of the company's diversity, equity, and inclusion efforts. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 2745695.000000 0 AGAINST 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Shareholder proposal to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents. OTHER SOCIAL ISSUES SECURITY HOLDER 2745695.000000 0 AGAINST 2745695.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/06/2024 Shareholder proposal to adopt a comprehensive human rights policy HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 2745695.000000 0 AGAINST 2745695.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Election of Directors (Proposal One): Irene Chang Britt DIRECTOR ELECTIONS ISSUER 283226.000000 0 FOR 283226.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Election of Directors (Proposal One): Bruce L. Claflin DIRECTOR ELECTIONS ISSUER 283226.000000 0 FOR 283226.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Election of Directors (Proposal One): Asha S. Collins, PhD DIRECTOR ELECTIONS ISSUER 283226.000000 0 FOR 283226.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Election of Directors (Proposal One): Sam Samad DIRECTOR ELECTIONS ISSUER 283226.000000 0 FOR 283226.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 283226.000000 0 FOR 283226.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 283226.000000 0 FOR 283226.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Shareholder proposal regarding simple majority vote (Proposal Four). CORPORATE GOVERNANCE SECURITY HOLDER 283226.000000 0 FOR 283226.000000 NONE S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Robert Langer DIRECTOR ELECTIONS ISSUER 1105579.000000 0 FOR 1105579.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Elizabeth Nabel, M.D. DIRECTOR ELECTIONS ISSUER 1105579.000000 0 FOR 1105579.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Elizabeth Tallett DIRECTOR ELECTIONS ISSUER 1105579.000000 0 FOR 1105579.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1105579.000000 0 FOR 1105579.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 1105579.000000 0 FOR 1105579.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To approve an amendment to the Amended and Restated Certificate of Incorporation to provide shareholders the right to call a special meeting. CORPORATE GOVERNANCE ISSUER 1105579.000000 0 FOR 1105579.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To approve an amendment to the Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 1105579.000000 0 FOR 1105579.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Jose (Joe) E. Almeida DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: William A. Ampofo II DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Stephen N. Oesterle, M.D. DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Stephen H. Rusckowski DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Brent Shafer DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Cathy R. Smith DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Peter M. Wilver DIRECTOR ELECTIONS ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Advisory vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Approve the Company's Amended and Restated 2021 Incentive Plan COMPENSATION ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Approve an Amendment to the Amended and Restated Certificate of Incorporation to Permit Officer Exculpation CORPORATE GOVERNANCE ISSUER 1732691.000000 0 FOR 1732691.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/07/2024 Shareholder Proposal - Executives to Retain Significant Stock COMPENSATION SECURITY HOLDER 1732691.000000 0 AGAINST 1732691.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Deepak L. Bhatt, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Approval of an Amendment to the Company's Amended and Restated Certificate of Incorporation to Provide for Limited Officer Exculpation CORPORATE GOVERNANCE ISSUER 6943155.000000 0 FOR 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 6943155.000000 0 AGAINST 6943155.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/07/2024 Shareholder Proposal on Executive Retention of Significant Stock COMPENSATION SECURITY HOLDER 6943155.000000 0 AGAINST 6943155.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: Susan W. Brooks DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: Ronald L. Burgess, Jr. DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: John A. Clerico DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: Michael Dinkins DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: James S. Ely III DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: John A. Fry DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: Joseph A. Hastings, D.M.D. DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: Tim L. Hingtgen DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: Elizabeth T. Hirsch DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: William Norris Jennings, M.D. DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: K. Ranga Krishnan, MBBS DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: Fawn D. Lopez DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: Wayne T. Smith DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Election of Directors: H. James Williams, Ph.D. DIRECTOR ELECTIONS ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/07/2024 Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 443206.000000 0 FOR 443206.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri List DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Jessica L. Mega, MD, MPH DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Pardis C. Sabeti, MD, D. PHIL DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: John T. Schwieters DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2393808.000000 0 FOR 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 15%. CORPORATE GOVERNANCE SECURITY HOLDER 2393808.000000 0 AGAINST 2393808.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/07/2024 To act upon a shareholder proposal requesting a report to shareholders on the effectiveness of the Company's diversity, equity and inclusion efforts. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 2393808.000000 0 AGAINST 2393808.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Bernard J. Zovighian DIRECTOR ELECTIONS ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Approval of the Amended and Restated Long-Term Stock Incentive Compensation COMPENSATION ISSUER 2068246.000000 0 FOR 2068246.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Adoption of Merus N.V.'s Dutch statutory annual accounts in the English language for the financial year 2023, CORPORATE GOVERNANCE ISSUER 127669.000000 0 FOR 127669.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Appointment of KPMG Accountants N.V. as Merus N.V.'s external auditor for the financial year 2024 for purposes of Dutch law. AUDIT-RELATED ISSUER 127669.000000 0 FOR 127669.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Release of each member of Merus N.V.'s board of directors from liability for the exercise of their duties during the financial year 2023. CORPORATE GOVERNANCE ISSUER 127669.000000 0 FOR 127669.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Re-appointment of Mark Iwicki as non-executive director. DIRECTOR ELECTIONS ISSUER 127669.000000 0 AGAINST 127669.000000 AGAINST S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Re-appointment of Paolo Pucci as non-executive director. DIRECTOR ELECTIONS ISSUER 127669.000000 0 AGAINST 127669.000000 AGAINST S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Appointment of Jason Haddock as non-executive director. DIRECTOR ELECTIONS ISSUER 127669.000000 0 FOR 127669.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Articles Amendment A - Approval of the amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment. CAPITAL STRUCTURE ISSUER 127669.000000 0 AGAINST 127669.000000 AGAINST S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Articles Amendment B - Approval of the amendment of the Articles of Association to reflect the Large Company Regime and authorization to implement such amendment. CORPORATE GOVERNANCE ISSUER 127669.000000 0 FOR 127669.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Granting authorization to Menus N.V.'s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.'s capital. CAPITAL STRUCTURE ISSUER 127669.000000 0 FOR 127669.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 127669.000000 0 FOR 127669.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Approval of the amendment of the Merus N.V.'s Non- Executive Director Compensation Program ("NED Program") to allow the board of directors to determine the number of common shares that may be awarded to a non-executive director for initial and annual awards under the NED Program to more closely align with the 50th percentile of the Company's peer group. COMPENSATION ISSUER 127669.000000 0 FOR 127669.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/07/2024 Approval of the amendment and restatement of the Merus NV. 2016 Incentive Award Plan (the "2016 Plan"), to extend the term of the 2016 Plan to December 31, 2031, which includes a corresponding extension to the annual "evergreen" feature from and including January 1, 2026, to January 1, 2029, along with other minor amendments updated for best practices. COMPENSATION ISSUER 127669.000000 0 AGAINST 127669.000000 AGAINST S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: James C. Foster DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: Robert Bertolini DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: Deborah T. Kochevar DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: George Llado, Sr. DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: Martin W. Mackay DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: George E. Massaro DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: Richard F. Wallman DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Election of Directors: Virginia M. Wilson DIRECTOR ELECTIONS ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Advisory Approval of 2023 Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 175064.000000 0 FOR 175064.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/08/2024 Proposal to publish a report on non-human primates imported by Charles River Laboratories International, Inc. OTHER SOCIAL ISSUES SECURITY HOLDER 175064.000000 0 AGAINST 175064.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To approve an amendment to our Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 4254581.000000 0 FOR 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To vote on a stockholder proposal requesting that the Board include one member from the Company's non-management employees. CORPORATE GOVERNANCE SECURITY HOLDER 4254581.000000 0 AGAINST 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To vote on a stockholder proposal requesting that the Board issue a report detailing the risks and costs to the Company caused by opposing or otherwise altering Company policy in response to state policies regulating abortion, and detailing any strategies beyond litigation and legal compliance that the Company may deploy to minimize or mitigate these risks. OTHER SOCIAL ISSUES SECURITY HOLDER 4254581.000000 0 AGAINST 4254581.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To vote on a stockholder proposal requesting that the Board adopt a policy requiring the Company's named executive officers to retain at least 25% of net-after tax shares of stock acquired through equity pay programs until reaching normal retirement age (at least age 60). COMPENSATION SECURITY HOLDER 4254581.000000 0 AGAINST 4254581.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/08/2024 Election of Directors: Eran Broshy DIRECTOR ELECTIONS ISSUER 127208.000000 0 FOR 127208.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/08/2024 Election of Directors: James Kelly DIRECTOR ELECTIONS ISSUER 127208.000000 0 FOR 127208.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/08/2024 Election of Directors: Laurie Smaldone Alsup DIRECTOR ELECTIONS ISSUER 127208.000000 0 FOR 127208.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/08/2024 To ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 127208.000000 0 FOR 127208.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/08/2024 To vote on a non-binding advisory resolution regarding the compensation of Theravance Biopharma Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 127208.000000 0 FOR 127208.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Roy Baynes DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Suzanne Bruhn DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Timothy Coughlin DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Eric Dube DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Gary Lyons DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Jeffrey Meckler DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: John Orwin DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Sandra Poole DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Ron Squarer DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 2,700,000 shares. COMPENSATION ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/08/2024 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 254748.000000 0 FOR 254748.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Juan Andres DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: John Carethers DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Lan Kang DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Joseph Massaro DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Mala Murthy DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Jonathan Peacock DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Michael Severino DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Michael Stubblefield DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Gregory Summe DIRECTOR ELECTIONS ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Approve the Officer Exculpation Amendment and Other Immaterial Amendments to our Certificate of Incorporation. CORPORATE GOVERNANCE ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Ratification of the Appointment of Deloitte & Touche LLP as the Company's independent registered accounting firm for 2024. AUDIT-RELATED ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Approve, on an Advisory Basis, Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2310205.000000 0 FOR 2310205.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/09/2024 Re-elect three (3) Class III Directors to serve for three-year terms as of the date of the Annual Meeting of Stockholders and until their successors are duly elected and qualified: Remi Barbier DIRECTOR ELECTIONS ISSUER 6426.000000 131100.000000 FOR 6426.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/09/2024 Re-elect three (3) Class III Directors to serve for three-year terms as of the date of the Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sanford R. Robertson DIRECTOR ELECTIONS ISSUER 6426.000000 131100.000000 WITHHOLD 6426.000000 AGAINST S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/09/2024 Re-elect three (3) Class III Directors to serve for three-year terms as of the date of the Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick J. Scannon, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 6426.000000 131100.000000 FOR 6426.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/09/2024 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 6426.000000 131100.000000 FOR 6426.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/09/2024 To approve, by a non-binding advisory vote, the 2023 executive compensation for the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 6426.000000 131100.000000 FOR 6426.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/09/2024 To elect the three nominees for director named below to hold office as Class I members of the Board of Directors until the 2027 annual meeting of stockholders: John F. McDonald DIRECTOR ELECTIONS ISSUER 1390001.000000 0 FOR 1390001.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/09/2024 To elect the three nominees for director named below to hold office as Class I members of the Board of Directors until the 2027 annual meeting of stockholders: John A. Scarlett, M.D. DIRECTOR ELECTIONS ISSUER 1390001.000000 0 FOR 1390001.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/09/2024 To elect the three nominees for director named below to hold office as Class I members of the Board of Directors until the 2027 annual meeting of stockholders: Robert J. Spiegel, M.D., FACP DIRECTOR ELECTIONS ISSUER 1390001.000000 0 FOR 1390001.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/09/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1390001.000000 0 FOR 1390001.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/09/2024 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1390001.000000 0 FOR 1390001.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Keith Bradley DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Shaundra D. Clay DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Jan De Witte DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Stuart M. Essig DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Jeffrey A. Graves DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Renee W. Lo DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Raymond G. Murphy DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 Election of Directors: Christian S. Schade DIRECTOR ELECTIONS ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2024. AUDIT-RELATED ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to reflect new Delaware Law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2024 To approve Amendment No. 1 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan. COMPENSATION ISSUER 226852.000000 0 FOR 226852.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Roland Diggelmann DIRECTOR ELECTIONS ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Domitille Doat-Le Bigot DIRECTOR ELECTIONS ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Richard Francis DIRECTOR ELECTIONS ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Thomas P. Salice DIRECTOR ELECTIONS ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Wolfgang Wienand DIRECTOR ELECTIONS ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Ingrid Zhang DIRECTOR ELECTIONS ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AUDIT-RELATED ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION SECTION 14A SAY-ON-PAY VOTES ISSUER 73960.000000 0 FOR 73960.000000 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/09/2024 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified: J. Paul Abernathy, MD DIRECTOR ELECTIONS ISSUER 47076.000000 0 FOR 47076.000000 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/09/2024 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified: Robert G. Adams DIRECTOR ELECTIONS ISSUER 47076.000000 0 FOR 47076.000000 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/09/2024 To consider an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 47076.000000 0 FOR 47076.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Mark A. Beck DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Gwendolyn M. Bingham DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Kenneth Gardner-Smith DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Robert J. Henkel DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Rita F. Johnson-Mills DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Stephen W. Klemash DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Teresa L. Kline DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Edward A. Pesicka DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Carissa L. Rollins DIRECTOR ELECTIONS ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Approval of Amendment No. 1 to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/09/2024 Advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 235156.000000 0 FOR 235156.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Laura A. Linynsky DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Thomas A. McEachin DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Mark S. Ordan DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Michael A. Rucker DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr. DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: James D. Swift, M.D. DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Shirley A. Weis DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Sylvia J. Young DIRECTOR ELECTIONS ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2024 fiscal year; AUDIT-RELATED ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/09/2024 Conduct an advisory vote regarding the compensation of our named executive officers for the 2023 fiscal year; and SECTION 14A SAY-ON-PAY VOTES ISSUER 269958.000000 0 FOR 269958.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Allan C. Golston DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Rachel Ruggeri DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2024. AUDIT-RELATED ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1166053.000000 0 FOR 1166053.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/09/2024 Shareholder Proposal on Transparency in Political Spending. OTHER SOCIAL ISSUES SECURITY HOLDER 1166053.000000 0 AGAINST 1166053.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Christopher B. Begley DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Betsy J. Bernard DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Michael J. Farrell DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Robert A. Hagemann DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Arthur J. Higgins DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Syed Jafry DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Louis Shapiro DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Election of Directors: Ivan Tornos DIRECTOR ELECTIONS ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/10/2024 Approve the amended Employee Stock Purchase Plan. COMPENSATION ISSUER 712554.000000 0 FOR 712554.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: Michael H. Carrel DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: Regina E. Groves DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: B. Kristine Johnson DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: Shlomo Nachman DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: Karen N. Prange DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: Deborah H. Telman DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: Sven A. Wehrwein DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: Robert S. White DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Election of Directors: Maggie Yuen DIRECTOR ELECTIONS ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Proposal to amend the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,800,000. COMPENSATION ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/13/2024 Proposal to approve an Amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company. CORPORATE GOVERNANCE ISSUER 161281.000000 0 FOR 161281.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2024 Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: David R. Brennan DIRECTOR ELECTIONS ISSUER 463549.000000 0 FOR 463549.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2024 Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Leo Lee DIRECTOR ELECTIONS ISSUER 463549.000000 0 FOR 463549.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2024 Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Carol A. Schafer DIRECTOR ELECTIONS ISSUER 463549.000000 0 FOR 463549.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2024 Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Melvin Sharoky, M.D. DIRECTOR ELECTIONS ISSUER 463549.000000 0 FOR 463549.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2024 An advisory vote on the 2023 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 463549.000000 0 FOR 463549.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 463549.000000 0 FOR 463549.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2024 Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan. COMPENSATION ISSUER 463549.000000 0 FOR 463549.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: Thomas F. Ackerman DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: Daniel J. Bevevino DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: Marna P. Borgstrom DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: James W. Bullock DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: Jeffrey H. Burbank DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: Elizabeth A. Hoff DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: J. Patrick Mackin DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: Jon W. Salveson DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 ELECTION OF DIRECTORS: Anthony B. Semedo DIRECTOR ELECTIONS ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 To ratify the preliminary approval of Ernst & Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/14/2024 To approve the amendment and restatement of Artivion's Certificate of Incorporation to allow for officer exculpation as provided for under Delaware law. CORPORATE GOVERNANCE ISSUER 125510.000000 0 FOR 125510.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: H. James Dallas DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Wayne S. DeVeydt DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Monte E. Ford DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Sarah M. London DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Lori J. Robinson DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024. AUDIT-RELATED ISSUER 1823777.000000 0.000000 FOR 1823777.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/14/2024 STOCKHOLDER PROPOSAL FOR MANAGING CLIMATE RISK THROUGH SCIENCE-BASED TARGETS AND TRANSITION PLANNING. ENVIRONMENT OR CLIMATE SECURITY HOLDER 1823777.000000 0.000000 AGAINST 1823777.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO ELECT EIGHT DIRECTORS FOR TERMS EXPIRING AT THE 2025 ANNUAL MEETING: Kevin C. Clark DIRECTOR ELECTIONS ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO ELECT EIGHT DIRECTORS FOR TERMS EXPIRING AT THE 2025 ANNUAL MEETING: Dwayne Allen DIRECTOR ELECTIONS ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO ELECT EIGHT DIRECTORS FOR TERMS EXPIRING AT THE 2025 ANNUAL MEETING: Venkat Bhamidipati DIRECTOR ELECTIONS ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO ELECT EIGHT DIRECTORS FOR TERMS EXPIRING AT THE 2025 ANNUAL MEETING: W. Larry Cash DIRECTOR ELECTIONS ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO ELECT EIGHT DIRECTORS FOR TERMS EXPIRING AT THE 2025 ANNUAL MEETING: Gale Fitzgerald DIRECTOR ELECTIONS ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO ELECT EIGHT DIRECTORS FOR TERMS EXPIRING AT THE 2025 ANNUAL MEETING: John A. Martins DIRECTOR ELECTIONS ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO ELECT EIGHT DIRECTORS FOR TERMS EXPIRING AT THE 2025 ANNUAL MEETING: Janice E. Nevin, M.D., MPH DIRECTOR ELECTIONS ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO ELECT EIGHT DIRECTORS FOR TERMS EXPIRING AT THE 2025 ANNUAL MEETING: Mark Perlberg, JD DIRECTOR ELECTIONS ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECMBER 31, 2024. AUDIT-RELATED ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO APPROVE, ON AN ADVISORY BASIS, COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/14/2024 PROPOSAL TO APPROVE THE CROSS COUNTRY HEALTHCARE, INC. 2024 OMNIBUS INCENTIVE PLAN. COMPENSATION ISSUER 112722.000000 0 FOR 112722.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 05/14/2024 Election of Directors: Edward Pesicka DIRECTOR ELECTIONS ISSUER 287722.000000 0 FOR 287722.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 05/14/2024 Election of Directors: David Smith DIRECTOR ELECTIONS ISSUER 287722.000000 0 FOR 287722.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 05/14/2024 Ratification of the appointment of Deloitte & Touche LLP. AUDIT-RELATED ISSUER 287722.000000 0 FOR 287722.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 05/14/2024 Advisory vote to approve compensation for our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 287722.000000 0 FOR 287722.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 05/14/2024 Advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 287722.000000 0 ONE YEAR 287722.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: D. Gary Gilliland, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 To approve, by non-binding vote, the compensation of the Laboratory Corporation of America Holdings' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 290136.000000 0 FOR 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Shareholder proposal regarding shareholder opportunity to vote on excessive golden parachutes. COMPENSATION SECURITY HOLDER 290136.000000 0 AGAINST 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Shareholder proposal regarding a Board report on transport of nonhuman primates within the U.S. OTHER SOCIAL ISSUES SECURITY HOLDER 290136.000000 0 AGAINST 290136.000000 FOR S000004450 Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Shareholder proposal regarding a Board report on risks of fulfilling information requests. OTHER SOCIAL ISSUES SECURITY HOLDER 290136.000000 0 AGAINST 290136.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2024 ELECTION OF DIRECTORS CLASS III (Expiring 2027): Nancy J. Gagliano, M.D. DIRECTOR ELECTIONS ISSUER 250033.000000 0 FOR 250033.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2024 ELECTION OF DIRECTORS CLASS III (Expiring 2027): Lelio Marmora DIRECTOR ELECTIONS ISSUER 250033.000000 0 FOR 250033.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2024 Ratification of Appointment of Grant Thornton LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2024. AUDIT-RELATED ISSUER 250033.000000 0 FOR 250033.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2024 Advisory (Non-Binding) Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 250033.000000 0 FOR 250033.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2024 Approval of an Amendment to the Company's Certificate of incorporation. CORPORATE GOVERNANCE ISSUER 250033.000000 0 FOR 250033.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2024 Approval of Amendment and Restatement of the Company's Stock Award Plan to Increase the Shares Authorized for Issuance Thereunder. COMPENSATION ISSUER 250033.000000 0 FOR 250033.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2024 Approval to Adjourn Annual Meeting to a Later Date or Dates, if Necessary, or Appropriate, to Permit Further Solicitation and Vote of Proxies In the Event that there are Insufficient Votes for, or Otherwise, In Connection Connection with the Approval of the Foregoing Proposals. CORPORATE GOVERNANCE ISSUER 250033.000000 0 FOR 250033.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2024 To elect, by separate resolutions, four directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2027, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Richard T. Collier DIRECTOR ELECTIONS ISSUER 138210.000000 0 FOR 138210.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2024 To elect, by separate resolutions, four directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2027, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 138210.000000 0 FOR 138210.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2024 To elect, by separate resolutions, four directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2027, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: William H. Dunn, Jr. DIRECTOR ELECTIONS ISSUER 138210.000000 0 FOR 138210.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2024 To elect, by separate resolutions, four directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2027, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Daniel G. Welch DIRECTOR ELECTIONS ISSUER 138210.000000 0 FOR 138210.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2024 To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2024 and to authorize, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve the remuneration of that auditor. AUDIT-RELATED ISSUER 138210.000000 0 FOR 138210.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2024 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 138210.000000 0 FOR 138210.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2024 To approve an amendment to the Company's 2018 Long Term Incentive Plan to increase the number of ordinary shares available for issuance under that Plan by 2,000,000 ordinary shares. COMPENSATION ISSUER 138210.000000 0 FOR 138210.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Kenneth F. Buechler, Ph.D. DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Edward L. Michael DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Mary Lake Polan, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: James R. Prutow DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Robert R. Schmidt DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Matthew W. Strobeck, Ph.D. DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Kenneth J. Widder, M.D. DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Election of Directors: To be elected for terms expiring in 2025: Joseph D. Wilkins Jr. DIRECTOR ELECTIONS ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Ratification of the selection of Ernst & Young LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending December 29, 2024. AUDIT-RELATED ISSUER 170801.000000 0 FOR 170801.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/15/2024 To elect two Class II Directors: Robert I. Blum DIRECTOR ELECTIONS ISSUER 300602.000000 0 FOR 300602.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/15/2024 To elect two Class II Directors: Robert A. Hammington, M.D. DIRECTOR ELECTIONS ISSUER 300602.000000 0 FOR 300602.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/15/2024 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance under such plan by 300,000 shares of common stock. COMPENSATION ISSUER 300602.000000 0 FOR 300602.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/15/2024 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 300602.000000 0 FOR 300602.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/15/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 300602.000000 0 FOR 300602.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Election of Directors: Lewis Hay, III DIRECTOR ELECTIONS ISSUER 802685.000000 0.000000 FOR 802685.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Election of Directors: Antonio F. Neri DIRECTOR ELECTIONS ISSUER 802685.000000 0.000000 FOR 802685.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Election of Directors: Ramiro G. Peru DIRECTOR ELECTIONS ISSUER 802685.000000 0.000000 FOR 802685.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 802685.000000 0.000000 FOR 802685.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/15/2024 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 802685.000000 0.000000 FOR 802685.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Shareholder proposal to adopt a policy to require certain third-party organizations to annually report political activity expenditures prior to Elevance Health donating to the organizations. OTHER SOCIAL ISSUES SECURITY HOLDER 802685.000000 0.000000 AGAINST 802685.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 Election of Directors: Vivek Jain DIRECTOR ELECTIONS ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 Election of Directors: David C. Greenberg DIRECTOR ELECTIONS ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 Election of Directors: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 Election of Directors: David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 Election of Directors: Donald M. Abbey DIRECTOR ELECTIONS ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 Election of Directors: Laurie Hernandez DIRECTOR ELECTIONS ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 Election of Directors: Kolleen T. Kennedy DIRECTOR ELECTIONS ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2024. AUDIT-RELATED ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/15/2024 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 69775.000000 0 FOR 69775.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: James S. Shannon, MD, MRCP (UK) DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Michael E. Castagna, Pharm.D. DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Ronald J. Consiglio DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Michael A. Friedman, M.D. DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Jennifer Grancio DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Anthony Hooper DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Sabrina Kay, Ed. D. DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Kent Kresa DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Christine Mundkur DIRECTOR ELECTIONS ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in Mannkind's proxy statement for the Annual Meeting; SECTION 14A SAY-ON-PAY VOTES ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/15/2024 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 926425.000000 0 FOR 926425.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/15/2024 The election of three (3) directors to the Merit Medical Systems, Inc. Board of Directors for a three (3) year term or until their successors are elected and qualified: Fred P. Lampropoulos DIRECTOR ELECTIONS ISSUER 197026.000000 0 FOR 197026.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/15/2024 The election of three (3) directors to the Merit Medical Systems, Inc. Board of Directors for a three (3) year term or until their successors are elected and qualified: Stephen C. Evans DIRECTOR ELECTIONS ISSUER 197026.000000 0 FOR 197026.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/15/2024 The election of three (3) directors to the Merit Medical Systems, Inc. Board of Directors for a three (3) year term or until their successors are elected and qualified: Silvia M. Perez DIRECTOR ELECTIONS ISSUER 197026.000000 0 FOR 197026.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/15/2024 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 197026.000000 0 FOR 197026.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/15/2024 Approval of an amendment to increase the number of shares authorized for issuance under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan by 3,000,000 shares. COMPENSATION ISSUER 197026.000000 0 FOR 197026.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/15/2024 Ratification of the Audit Committee's appointment of Deloitte & Touche LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2024. AUDIT-RELATED ISSUER 197026.000000 0 FOR 197026.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: John J. Arlotta DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: Elizabeth Q. Betten DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: Eric K. Brandt DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: Natasha Deckmann DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: David W. Golding DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: Harry M. Jansen Kraemer, Jr. DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: R. Carter Pate DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: John C. Rademacher DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To elect twelve nominees identified in the accompanying proxy statement to serve as directors: Norman L. Wright DIRECTOR ELECTIONS ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/15/2024 To approve the Amended and Restated Option Care Health, Inc. 2018 Equity Incentive Plan. COMPENSATION ISSUER 603515.000000 0 FOR 603515.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Jeffrey Hawkins DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Paula Dowdy DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Ruth Fattori DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Amir Jafri DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Jack Kenny DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Brigid A. Makes DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Kevin Rakin DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To elect nine directors to serve one-year terms expiring in 2025: Scott Mendel DIRECTOR ELECTIONS ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To approve, by a non-binding, advisory vote, of the compensation of our named executive officers, as described in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To approve the proposed amendments to our second amended and restated certificate of incorporation, as amended (our "Certificate of Incorporation"), to remove the cap on the number of directors to serve on our board of directors and make related changes to the process for filling newly created directorships or board vacancies. CORPORATE GOVERNANCE ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2024 To approve the proposed amendment to our Certificate of Incorporation to add a provision with respect to the automatic conversion of our Class B common stock effective June 10, 2028, which is seven years from the date of the closing of our business combination. CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 343680.000000 0 FOR 343680.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/15/2024 Election of Directors: Martin H. Huber, M.D. DIRECTOR ELECTIONS ISSUER 260164.000000 0 FOR 260164.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/15/2024 Election of Directors: Jennifer Jarrett DIRECTOR ELECTIONS ISSUER 260164.000000 0 FOR 260164.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/15/2024 Election of Directors: William Meury DIRECTOR ELECTIONS ISSUER 260164.000000 0 FOR 260164.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/15/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2024 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 260164.000000 0 FOR 260164.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/15/2024 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 260164.000000 0 FOR 260164.000000 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/15/2024 To approve of an amendment of the Company's Amended and Restated 2020 Omnibus Stock and Incentive Plan. COMPENSATION ISSUER 208618.000000 0 FOR 208618.000000 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/15/2024 Proposal to approve an amendment of the Company's Employee Stock Purchase Plan. COMPENSATION ISSUER 208618.000000 0 FOR 208618.000000 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/15/2024 Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 208618.000000 0 FOR 208618.000000 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/15/2024 To act on a stockholder proposal to elect each director annually, if properly presented at the meeting. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 208618.000000 0 FOR 208618.000000 AGAINST S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Lloyd Carney DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Advisory vote to approve named executive office compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 880399.000000 0 FOR 880399.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Shareholder proposal, if properly presented at the meeting, regarding special shareholder meeting improvement. CORPORATE GOVERNANCE SECURITY HOLDER 880399.000000 0 FOR 880399.000000 AGAINST S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Shareholder proposal, if properly presented at the meeting, regarding a report on racial and gender pay gaps. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 880399.000000 0 AGAINST 880399.000000 FOR S000004450 ZimVie Inc. 98888T107 US98888T1079 05/15/2024 Election of Directors: Sally Crawford DIRECTOR ELECTIONS ISSUER 90018.000000 0 FOR 90018.000000 FOR S000004450 ZimVie Inc. 98888T107 US98888T1079 05/15/2024 Election of Directors: Karen Matusinec DIRECTOR ELECTIONS ISSUER 90018.000000 0 FOR 90018.000000 FOR S000004450 ZimVie Inc. 98888T107 US98888T1079 05/15/2024 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 90018.000000 0 FOR 90018.000000 FOR S000004450 ZimVie Inc. 98888T107 US98888T1079 05/15/2024 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 90018.000000 0 FOR 90018.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To elect the following nominees as Class II directors of Alnylam: Dennis A. Ausiello, M.D. DIRECTOR ELECTIONS ISSUER 403977.000000 0 FOR 403977.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To elect the following nominees as Class II directors of Alnylam: Olivier Brandicourt, M.D. DIRECTOR ELECTIONS ISSUER 403977.000000 0 FOR 403977.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To elect the following nominees as Class II directors of Alnylam: Peter N. Kellogg DIRECTOR ELECTIONS ISSUER 403977.000000 0 FOR 403977.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To elect the following nominees as Class II directors of Alnylam: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 403977.000000 0 FOR 403977.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 403977.000000 0 FOR 403977.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 403977.000000 0 FOR 403977.000000 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/16/2024 To elect the three Class III director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2027 Annual Meeting of the Company's stockholders: Sheldon M. Retchin DIRECTOR ELECTIONS ISSUER 194636.000000 0 FOR 194636.000000 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/16/2024 To elect the three Class III director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2027 Annual Meeting of the Company's stockholders: Erica G. Schwartz DIRECTOR ELECTIONS ISSUER 194636.000000 0 FOR 194636.000000 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/16/2024 To elect the three Class III director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2027 Annual Meeting of the Company's stockholders: Jeff Shaner DIRECTOR ELECTIONS ISSUER 194636.000000 0 WITHHOLD 194636.000000 AGAINST S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/16/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending December 28, 2024. AUDIT-RELATED ISSUER 194636.000000 0 FOR 194636.000000 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/16/2024 To approve, on an advisory, non-binding basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 194636.000000 0 FOR 194636.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Rita Balice-Gordon, Ph.D. DIRECTOR ELECTIONS ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Garen Bohlin DIRECTOR ELECTIONS ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Gwen Melincoff DIRECTOR ELECTIONS ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: John Fallon M.D. DIRECTOR ELECTIONS ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: John Freund, M.D. DIRECTOR ELECTIONS ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Neil F. Mcfarlane DIRECTOR ELECTIONS ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Michael Heffernan, R.Ph. DIRECTOR ELECTIONS ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Gino Santini DIRECTOR ELECTIONS ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Approval of, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/16/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 111022.000000 0 FOR 111022.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Nancy-Ann M. DeParle DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Roger N. Farah DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Jean-Pierre Millon DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Election of Directors: Mary L. Schapiro DIRECTOR ELECTIONS ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2024. AUDIT-RELATED ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Proposal to Amend the Company's 2017 Incentive Compensation Plan to Increase the Number of Shares Authorized to be Issued under the Plan. COMPENSATION ISSUER 4396992.000000 0.000000 FOR 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Stockholder Proposal Requesting an Independent, Third Party Worker Rights Assessment and Report. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 4396992.000000 0.000000 AGAINST 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Stockholder Proposal to Prohibit the Re-nomination of Any Director Who Fails to Receive a Majority Vote. CORPORATE GOVERNANCE SECURITY HOLDER 4396992.000000 0.000000 AGAINST 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Stockholder Proposal for a Stockholder Right to Vote on "Excessive" Golden Parachutes. COMPENSATION SECURITY HOLDER 4396992.000000 0.000000 AGAINST 4396992.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/16/2024 Stockholder Proposal Requesting a Policy Requiring Our Directors to Disclose Their Expected Allocation of Hours Among All Formal Commitments. CORPORATE GOVERNANCE SECURITY HOLDER 4396992.000000 0.000000 AGAINST 4396992.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/16/2024 Election of Directors: Ming Hsieh DIRECTOR ELECTIONS ISSUER 65950.000000 0 FOR 65950.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/16/2024 Election of Directors: Linda Marsh DIRECTOR ELECTIONS ISSUER 65950.000000 0 FOR 65950.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/16/2024 Election of Directors: Michael Nohaile, Ph.D. DIRECTOR ELECTIONS ISSUER 65950.000000 0 FOR 65950.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/16/2024 Election of Directors: Regina Groves DIRECTOR ELECTIONS ISSUER 65950.000000 0 FOR 65950.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/16/2024 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 65950.000000 0 FOR 65950.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/16/2024 To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 65950.000000 0 FOR 65950.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Frances Arnold, Ph.D. DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Robert S. Epstein, M.D. DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Stephen P. MacMillan DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Anna Richo DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Philip W. Schiller DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 Election of Directors: Scott B. Ullem DIRECTOR ELECTIONS ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2024. AUDIT-RELATED ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/16/2024 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 542887.000000 0 FOR 542887.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/16/2024 Election of Directors: Glendon E. French DIRECTOR ELECTIONS ISSUER 116212.000000 0 FOR 116212.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/16/2024 Election of Directors: Tiffany Sullivan DIRECTOR ELECTIONS ISSUER 116212.000000 0 FOR 116212.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/16/2024 To ratify the selection by the Audit Committee of our Board of Directors of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 116212.000000 0 FOR 116212.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/16/2024 To conduct a non-binding advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 116212.000000 0 FOR 116212.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: James E. Davis DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Luis A. Diaz, Jr., M.D. DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Tracey C. Doi DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Wright L. Lassiter, III DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Timothy L. Main DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Denise M. Morrison DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Gary M. Pfeiffer DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2024 proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Ratification of the appointment of our independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Approval of an amendment to Company's Restated Certificate of Incorporation to provide for the exculpation of officers of the Company as permitted by law CORPORATE GOVERNANCE ISSUER 383924.000000 0 FOR 383924.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Stockholder proposal regarding managing climate risk through science-based targets and transition planning ENVIRONMENT OR CLIMATE SECURITY HOLDER 383924.000000 0 AGAINST 383924.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Tony J. Hunt DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/16/2024 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 181433.000000 0 FOR 181433.000000 FOR S000004450 SpringWorks Therapeutics, Inc. 85205L107 US85205L1070 05/16/2024 Election of Class II Director: Freda Lewis-Hall DIRECTOR ELECTIONS ISSUER 159983.000000 0 FOR 159983.000000 FOR S000004450 SpringWorks Therapeutics, Inc. 85205L107 US85205L1070 05/16/2024 Ratification of the appointment of Ernst & Young LLP as SpringWorks Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 159983.000000 0 FOR 159983.000000 FOR S000004450 SpringWorks Therapeutics, Inc. 85205L107 US85205L1070 05/16/2024 Non-binding advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 159983.000000 0 FOR 159983.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/16/2024 ELECTION OF CLASS II DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Mr. Christopher R. Christensen DIRECTOR ELECTIONS ISSUER 192841.000000 0 FOR 192841.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/16/2024 ELECTION OF CLASS II DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Mr. Daren J. Shaw DIRECTOR ELECTIONS ISSUER 192841.000000 0 FOR 192841.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/16/2024 Approval of the Amendment of the Certificate of Incorporation to increase the size of the board of directors to nine from eight. CORPORATE GOVERNANCE ISSUER 192841.000000 0 FOR 192841.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/16/2024 Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 192841.000000 0 FOR 192841.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/16/2024 Approval, on an advisory basis, of our named executive officers' compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 192841.000000 0 FOR 192841.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Adoption of Dutch statutory annual account over fiscal year 2023. CORPORATE GOVERNANCE ISSUER 30331.000000 382500.000000 FOR 30331.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Appointment of Deloitte & Touche LLP and Deloitte Accountants B.V. as our external auditors for fiscal year 2024. AUDIT-RELATED ISSUER 30331.000000 382500.000000 FOR 30331.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Release of each member of our board of supervisory directors and our board of managing directors form liability for the exercise of their duties during fiscal year 2023. CORPORATE GOVERNANCE ISSUER 30331.000000 382500.000000 FOR 30331.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Re-appointment of Christian Angermayer as a supervisory director. DIRECTOR ELECTIONS ISSUER 30331.000000 382500.000000 FOR 30331.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Appointment of Scott Braunstein, M.D. as a supervisory director, effective upon his registration with the Trade Register held by the Dutch Chamber of Commerce. DIRECTOR ELECTIONS ISSUER 30331.000000 382500.000000 AGAINST 30331.000000 AGAINST S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Appointment of Laurent Fischer, M.D. as a supervisory director, effective upon his registration with the Trade Register held by the Dutch Chamber of Commerce. DIRECTOR ELECTIONS ISSUER 30331.000000 382500.000000 AGAINST 30331.000000 AGAINST S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Appointment of Raymond Sanchez, M.D. as a supervisory director, effective upon his registration with the Trade Register held by the Dutch Chamber of Commerce. DIRECTOR ELECTIONS ISSUER 30331.000000 382500.000000 FOR 30331.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Appointment of Anne Johnson as a managing director. CORPORATE GOVERNANCE ISSUER 30331.000000 382500.000000 FOR 30331.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Extension of the authorization of our management board to issue shares and grant rights to subscribe for shares. CAPITAL STRUCTURE ISSUER 30331.000000 382500.000000 AGAINST 30331.000000 AGAINST S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Extension of the authorization of our management board to limit and exclude pre-emption rights. CAPITAL STRUCTURE ISSUER 30331.000000 382500.000000 AGAINST 30331.000000 AGAINST S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/17/2024 Extension of the authorization of our management board to acquire shares (or depositary receipts for such shares) in our capital. CAPITAL STRUCTURE ISSUER 30331.000000 382500.000000 FOR 30331.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: Gregg Alton DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: G. Leonard Baker, Jr. DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: Joseph K. Belanoff, M.D. DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: Gillian M. Cannon, Ph.D. DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: David L. Mahoney DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: Joshua M. Murray DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: Kimberly Park DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: Daniel N. Swisher, Jr. DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 Election of Directors: James N. Wilson DIRECTOR ELECTIONS ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/17/2024 To approve the Corcept Therapeutics Incorporated 2024 Incentive Award Plan. COMPENSATION ISSUER 298194.000000 0 FOR 298194.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To elect seven directors: Linda Baddour DIRECTOR ELECTIONS ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To elect seven directors: Richard Berman DIRECTOR ELECTIONS ISSUER 166410.000000 0 WITHHOLD 166410.000000 AGAINST S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To elect seven directors: Daniel Hancock DIRECTOR ELECTIONS ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To elect seven directors: Robert Hariri, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To elect seven directors: Ram M. Jagannath DIRECTOR ELECTIONS ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To elect seven directors: Ramkumar Mandalam, Ph.D. DIRECTOR ELECTIONS ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To elect seven directors: Jerrell W. Shelton DIRECTOR ELECTIONS ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2024; AUDIT-RELATED ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in in this Proxy Statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 05/17/2024 To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 7,850,000 to a total of 10,350,000; and COMPENSATION ISSUER 166410.000000 0 FOR 166410.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/17/2024 Election of Class I Directors: Suma M. Krishnan DIRECTOR ELECTIONS ISSUER 62727.000000 0 FOR 62727.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/17/2024 Election of Class I Directors: Julian S. Gangolli DIRECTOR ELECTIONS ISSUER 62727.000000 0 FOR 62727.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/17/2024 Election of Class I Directors: Catherine Mazzacco DIRECTOR ELECTIONS ISSUER 62727.000000 0 FOR 62727.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/17/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 62727.000000 0 FOR 62727.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/17/2024 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 62727.000000 0 FOR 62727.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/17/2024 Election of Directors: Fred B. Davenport, Jr. DIRECTOR ELECTIONS ISSUER 83874.000000 0 FOR 83874.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/17/2024 Election of Directors: Cornelius P. McCarthy III DIRECTOR ELECTIONS ISSUER 83874.000000 0 FOR 83874.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/17/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 83874.000000 0 FOR 83874.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/17/2024 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 83874.000000 0 FOR 83874.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/17/2024 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 83874.000000 0 FOR 83874.000000 FOR S000004450 Paragon 28, Inc. 69913P105 US69913P1057 05/17/2024 Election of Directors: Meghan Scanlon DIRECTOR ELECTIONS ISSUER 127474.000000 0 FOR 127474.000000 FOR S000004450 Paragon 28, Inc. 69913P105 US69913P1057 05/17/2024 Election of Directors: Thomas Schnettler DIRECTOR ELECTIONS ISSUER 127474.000000 0 FOR 127474.000000 FOR S000004450 Paragon 28, Inc. 69913P105 US69913P1057 05/17/2024 Election of Directors: Kristina Wright DIRECTOR ELECTIONS ISSUER 127474.000000 0 FOR 127474.000000 FOR S000004450 Paragon 28, Inc. 69913P105 US69913P1057 05/17/2024 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 127474.000000 0 FOR 127474.000000 FOR S000004450 Paragon 28, Inc. 69913P105 US69913P1057 05/17/2024 Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 127474.000000 0 ONE YEAR 127474.000000 FOR S000004450 Paragon 28, Inc. 69913P105 US69913P1057 05/17/2024 Ratify the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024. AUDIT-RELATED ISSUER 127474.000000 0 FOR 127474.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 05/17/2024 To elect two Class III Directors: Mihael H. Polymeropoulos, M.D. DIRECTOR ELECTIONS ISSUER 196900.000000 0 FOR 196900.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 05/17/2024 To elect two Class III Directors: Phaedra S. Chrousos DIRECTOR ELECTIONS ISSUER 196900.000000 0 FOR 196900.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 05/17/2024 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024. AUDIT-RELATED ISSUER 196900.000000 0 FOR 196900.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 05/17/2024 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 196900.000000 0 FOR 196900.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 05/17/2024 To approve an amendment to the Company's amended and restated 2016 Equity Incentive Plan, as amended (the "2016 Plan"), to increase the aggregate number of shares authorized for issuance under the 2016 Plan. COMPENSATION ISSUER 196900.000000 0 FOR 196900.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: Kevin J. McNamara DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: Ron DeLyons DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: Patrick P. Grace DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: Christopher J. Heaney DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: Thomas C. Hutton DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: Andrea R. Lindell DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: Eileen P. McCarthy DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: John M. Mount, Jr. DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: Thomas P. Rice DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Election of directors: George J. Walsh III DIRECTOR ELECTIONS ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2024. AUDIT-RELATED ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 48851.000000 0 FOR 48851.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/20/2024 Stockholder opportunity to vote on Excessive Golden Parachutes. COMPENSATION SECURITY HOLDER 48851.000000 0 AGAINST 48851.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Matthew L. Trerotola DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Angela S. Lalor DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Philip A. Okala DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Christine Ortiz DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: A. Clayton Perfall DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Brady Shirley DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Rajiv Vinnakota DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 Election of Directors: Sharon Wienbar DIRECTOR ELECTIONS ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 To approve on an advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/20/2024 To approve an amendment to our Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding the exculpation of officers. CORPORATE GOVERNANCE ISSUER 167615.000000 0 FOR 167615.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/20/2024 Election of Directors: Julia P. Gregory DIRECTOR ELECTIONS ISSUER 131544.000000 0 FOR 131544.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/20/2024 Election of Directors: David L. Lacey, M.D. DIRECTOR ELECTIONS ISSUER 131544.000000 0 FOR 131544.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/20/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2024. AUDIT-RELATED ISSUER 131544.000000 0 FOR 131544.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/20/2024 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 131544.000000 0 FOR 131544.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 Election of Directors: Thomas Haughey DIRECTOR ELECTIONS ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 Election of Directors: Nikhil Lalwani DIRECTOR ELECTIONS ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 Election of Directors: Matthew J. Leonard, R.Ph. DIRECTOR ELECTIONS ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 Election of Directors: Antonio R. Pera DIRECTOR ELECTIONS ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 Election of Directors: Muthusamy Shanmugam DIRECTOR ELECTIONS ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 Election of Directors: Renee P. Tannenbaum, Pharm.D. DIRECTOR ELECTIONS ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 Election of Directors: Jeanne A. Thoma DIRECTOR ELECTIONS ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 Election of Directors: Patrick D. Walsh DIRECTOR ELECTIONS ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 To ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024; AUDIT-RELATED ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 To approve the compensation of the Company's named executive officers, on an advisory basis; SECTION 14A SAY-ON-PAY VOTES ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2024 To approve the Amended and Restated 2022 Stock Incentive Plan. COMPENSATION ISSUER 55612.000000 0 FOR 55612.000000 FOR S000004450 Atrion Corporation 049904105 US0499041053 05/21/2024 Election of Director: Preston G. Athey DIRECTOR ELECTIONS ISSUER 4813.000000 0 FOR 4813.000000 FOR S000004450 Atrion Corporation 049904105 US0499041053 05/21/2024 Approval of an amendment of the Company's Certificate of Incorporation to provide for exculpation of officers of the Company as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 4813.000000 0 FOR 4813.000000 FOR S000004450 Atrion Corporation 049904105 US0499041053 05/21/2024 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year 2024. AUDIT-RELATED ISSUER 4813.000000 0 FOR 4813.000000 FOR S000004450 Atrion Corporation 049904105 US0499041053 05/21/2024 Approval, on an advisory basis, of executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4813.000000 0 FOR 4813.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Elizabeth M. Anderson DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Athena Countouriotis DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Willard Dere DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Mark J. Enyedy DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Alexander Hardy DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Elaine J. Heron DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Maykin Ho DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Richard A. Meier DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 643714.000000 0 FOR 643714.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 Election of Directors To elect Richard J. Daly as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 Election of Directors To elect Patrick J. McEnany as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 Election of Directors To elect Donald A. Denkhaus as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 Election of Directors To elect Molly Harper as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until her earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 Election of Directors To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 Election of Directors To elect Tamar Thompson as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until her earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 Election of Directors To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 Election of Directors To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares. COMPENSATION ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 To approve, on an advisory basis, the 2023 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 360253.000000 0 FOR 360253.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/21/2024 To transact such other business as may properly come before the meeting. CORPORATE GOVERNANCE ISSUER 360253.000000 0 AGAINST 360253.000000 AGAINST S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2024 To elect the three Class 1 directors named in our Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: James Cashman III DIRECTOR ELECTIONS ISSUER 379704.000000 0 AGAINST 379704.000000 AGAINST S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2024 To elect the three Class 1 directors named in our Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: Nancy Killefer DIRECTOR ELECTIONS ISSUER 379704.000000 0 FOR 379704.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2024 To elect the three Class 1 directors named in our Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: David Spaight DIRECTOR ELECTIONS ISSUER 379704.000000 0 FOR 379704.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2024 To approve two separate proposals to amend our Amended and Restated Certificate of Incorporation (our "Certificate of Incorporation"): Amend our Certificate of Incorporation to limit the liability of certain officers of Certara as permitted pursuant to the Delaware General Corporation Law; and CORPORATE GOVERNANCE ISSUER 379704.000000 0 FOR 379704.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2024 Amend our Certificate of Incorporation to make certain technical changes, including to remove inoperative provisions related to our former majority stockholder and other immaterial changes. CORPORATE GOVERNANCE ISSUER 379704.000000 0 FOR 379704.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2024 Ratification of the selection of RSM US LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 379704.000000 0 FOR 379704.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2024 A non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 379704.000000 0 FOR 379704.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Wendy Carruthers DIRECTOR ELECTIONS ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Kieran Gallahue DIRECTOR ELECTIONS ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Scott Huennekens DIRECTOR ELECTIONS ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Barbara Hulit DIRECTOR ELECTIONS ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Vivek Jain DIRECTOR ELECTIONS ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Daniel Raskas DIRECTOR ELECTIONS ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Christine Tsingos DIRECTOR ELECTIONS ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To approve on an advisory basis Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To approve a proposal to amend our Second Amended and Restated Certificate of Incorporation to include an officer exculpation provision. CORPORATE GOVERNANCE ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect Paul Keel as a director, for a one-year term expiring at the 2025 annual meeting: Paul Keel DIRECTOR ELECTIONS ISSUER 586742.000000 0 FOR 586742.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Lloyd W. Howell, Jr. DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Risa Lavizzo-Mourey DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Anne T. Madden DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Tomislav Mihaljevic DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: William J. Stromberg DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Approval of our named executive officers' compensation in an advisory vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1399541.000000 0 FOR 1399541.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Mohamad Ali DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Stanley M. Bergman DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Deborah Derby DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Carole T. Faig DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Joseph L. Herring DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Kurt P. Kuehn DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Philip A. Laskawy DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Anne H. Margulies DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Mark E. Mlotek DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Carol Raphael DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Scott Serota DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Bradley T. Sheares, Ph. D. DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Election of Directors: Reed V. Tuckson, M.D., FACP DIRECTOR ELECTIONS ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Proposal to amend and restate the Company's 2020 Stock Incentive Plan. COMPENSATION ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Proposal to approve, by non-binding vote, the 2023 compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2024 Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 28, 2024. AUDIT-RELATED ISSUER 444234.000000 0 FOR 444234.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To elect the following directors to serve for a term ending upon the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified: Jacqueline E. Shea, Ph.D. DIRECTOR ELECTIONS ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To elect the following directors to serve for a term ending upon the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified: Simon X. Benito DIRECTOR ELECTIONS ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To elect the following directors to serve for a term ending upon the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified: Roger D. Dansey, M.D. DIRECTOR ELECTIONS ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To elect the following directors to serve for a term ending upon the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified: Ann C. Miller, M.D. DIRECTOR ELECTIONS ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To elect the following directors to serve for a term ending upon the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified: Jay P. Shepard DIRECTOR ELECTIONS ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To elect the following directors to serve for a term ending upon the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified: David B. Weiner, Ph.D. DIRECTOR ELECTIONS ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To elect the following directors to serve for a term ending upon the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified: Wendy L. Yarno DIRECTOR ELECTIONS ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To elect the following directors to serve for a term ending upon the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified: Lota S. Zoth DIRECTOR ELECTIONS ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 05/21/2024 To approve, on a non-binding advisory basis, the resolution regarding compensation of our named executive officers described in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 76908.000000 0 FOR 76908.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2024 To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Scott Jackson DIRECTOR ELECTIONS ISSUER 158496.000000 0 FOR 158496.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2024 To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Margaret Liu, M.D. DIRECTOR ELECTIONS ISSUER 158496.000000 0 FOR 158496.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2024 To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: David Stump, M.D. DIRECTOR ELECTIONS ISSUER 158496.000000 0 FOR 158496.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2024 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 158496.000000 0 FOR 158496.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 158496.000000 0 FOR 158496.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2024 To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. COMPENSATION ISSUER 158496.000000 0 FOR 158496.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2024 Proposal to elect Class II Directors to hold office until the 2027 Annual Meeting of Stockholders: Randall A. Lipps DIRECTOR ELECTIONS ISSUER 155487.000000 0 FOR 155487.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2024 Proposal to elect Class II Directors to hold office until the 2027 Annual Meeting of Stockholders: Mark W. Parrish DIRECTOR ELECTIONS ISSUER 155487.000000 0 FOR 155487.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2024 Proposal to elect Class II Directors to hold office until the 2027 Annual Meeting of Stockholders: Kaushik "Bobby" Ghoshal DIRECTOR ELECTIONS ISSUER 155487.000000 0 FOR 155487.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2024 Say on Pay - An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 155487.000000 0 FOR 155487.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2024 Proposal to approve the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 2,462,000 shares to the number of shares of common stock authorized for issuance under such plan. COMPENSATION ISSUER 155487.000000 0 FOR 155487.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2024 Proposal to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024. AUDIT-RELATED ISSUER 155487.000000 0 FOR 155487.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/21/2024 Election of Directors: John K. Bakewell DIRECTOR ELECTIONS ISSUER 157035.000000 0 FOR 157035.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/21/2024 Election of Directors: Richard W. Mott DIRECTOR ELECTIONS ISSUER 157035.000000 0 FOR 157035.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/21/2024 Election of Directors: John T. Treace DIRECTOR ELECTIONS ISSUER 157035.000000 0 FOR 157035.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/21/2024 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157035.000000 0 FOR 157035.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/21/2024 Approval, on an advisory, non-binding basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157035.000000 0 ONE YEAR 157035.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/21/2024 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 157035.000000 0 FOR 157035.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Election of seven directors to serve until the next annual meeting of stockholders: Christopher J. Reading DIRECTOR ELECTIONS ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Election of seven directors to serve until the next annual meeting of stockholders: Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Election of seven directors to serve until the next annual meeting of stockholders: Kathleen A. Gilmartin DIRECTOR ELECTIONS ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Election of seven directors to serve until the next annual meeting of stockholders: Regg E. Swanson DIRECTOR ELECTIONS ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Election of seven directors to serve until the next annual meeting of stockholders: Clayton K. Trier DIRECTOR ELECTIONS ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Election of seven directors to serve until the next annual meeting of stockholders: Anne B. Motsenbocker DIRECTOR ELECTIONS ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Election of seven directors to serve until the next annual meeting of stockholders: Nancy J. Ham DIRECTOR ELECTIONS ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Advisory vote to approve the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/21/2024 Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 51619.000000 0 FOR 51619.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Brian Lian, Ph.D. DIRECTOR ELECTIONS ISSUER 289713.000000 0 FOR 289713.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Lawson Macartney, DVM, Ph.D. DIRECTOR ELECTIONS ISSUER 289713.000000 0 FOR 289713.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 RATIFICATION OF THE SELECTION OF MARCUM LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2024. AUDIT-RELATED ISSUER 289713.000000 0 FOR 289713.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 289713.000000 0 FOR 289713.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 TO APPROVE OUR 2024 EQUITY INCENTIVE PLAN. COMPENSATION ISSUER 289713.000000 0 FOR 289713.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 TO APPROVE OUR 2024 EMPLOYEE STOCK PURCHASE PLAN. COMPENSATION ISSUER 289713.000000 0 FOR 289713.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Joseph Lacob DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: C. Raymond Larkin, Jr DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: George J. Morrow DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Anne M. Myong DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 ADVISORY VOTE ON NAMED EXECUTIVES' COMPENSATION Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 248601.000000 0 FOR 248601.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/22/2024 STOCKHOLDER PROPOSAL REGARDING SIMPLE MAJORITY VOTE CORPORATE GOVERNANCE SECURITY HOLDER 248601.000000 0 FOR 248601.000000 AGAINST S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To elect eight directors to serve on the Company's Board of Directors: David Bronson DIRECTOR ELECTIONS ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To elect eight directors to serve on the Company's Board of Directors: Brian P. Concannon DIRECTOR ELECTIONS ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To elect eight directors to serve on the Company's Board of Directors: LaVerne Council DIRECTOR ELECTIONS ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To elect eight directors to serve on the Company's Board of Directors: Charles M. Farkas DIRECTOR ELECTIONS ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To elect eight directors to serve on the Company's Board of Directors: Martha Goldberg Aronson DIRECTOR ELECTIONS ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To elect eight directors to serve on the Company's Board of Directors: Curt R. Hartman DIRECTOR ELECTIONS ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To elect eight directors to serve on the Company's Board of Directors: Barbara J. Schwarzentraub DIRECTOR ELECTIONS ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To elect eight directors to serve on the Company's Board of Directors: John L. Workman DIRECTOR ELECTIONS ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 Advisory Vote on Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/22/2024 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 104620.000000 0 FOR 104620.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 05/22/2024 To elect the Board of Directors' three nominees for Class III directors of Definitive Healthcare Corp. named in the Proxy Statement, each to serve a three-year term expiring at the 2027 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Jeff Haywood DIRECTOR ELECTIONS ISSUER 178511.000000 0 FOR 178511.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 05/22/2024 To elect the Board of Directors' three nominees for Class III directors of Definitive Healthcare Corp. named in the Proxy Statement, each to serve a three-year term expiring at the 2027 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Scott Stephenson DIRECTOR ELECTIONS ISSUER 178511.000000 0 FOR 178511.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 05/22/2024 To elect the Board of Directors' three nominees for Class III directors of Definitive Healthcare Corp. named in the Proxy Statement, each to serve a three-year term expiring at the 2027 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Kathleen A. Winters DIRECTOR ELECTIONS ISSUER 178511.000000 0 FOR 178511.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 05/22/2024 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 178511.000000 0 FOR 178511.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 05/22/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 178511.000000 0 FOR 178511.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Simon D. Campion DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Willie A. Deese DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Brian T. Gladden DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Betsy D. Holden DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Clyde R. Hosein DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Leslie F. Varon DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Janet S. Vergis DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Election of Directors: Dorothea Wenzel DIRECTOR ELECTIONS ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2024. AUDIT-RELATED ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Approval, by non-binding vote, of the Company's executive compensation for 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Approval of the 2024 Omnibus Incentive Plan. COMPENSATION ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/22/2024 Approval of the Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 724140.000000 0 FOR 724140.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Kevin R. Sayer DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Steven R. Altman DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Richard A. Collins DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Karen Dahut DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Bridgette P. Heller DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Eric J. Topol, M.D. DIRECTOR ELECTIONS ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 1316342.000000 0 FOR 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To provide a non-binding, advisory vote on pay equity disclosure. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 1316342.000000 0 AGAINST 1316342.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/22/2024 To provide a non-binding, advisory vote on transparency in lobbying. OTHER SOCIAL ISSUES SECURITY HOLDER 1316342.000000 0 AGAINST 1316342.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2024 Election of Directors: Wayne A.I. Frederick DIRECTOR ELECTIONS ISSUER 237934.000000 0 FOR 237934.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2024 Election of Directors: Flavia H. Pease DIRECTOR ELECTIONS ISSUER 237934.000000 0 FOR 237934.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2024 Election of Directors: Timothy J. Scannell DIRECTOR ELECTIONS ISSUER 237934.000000 0 FOR 237934.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2024 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 237934.000000 0 FOR 237934.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2024 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 237934.000000 0 FOR 237934.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: Sheila Antrum DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: Pamela G. Bailey DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: Cheryl C. Capps DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: Joseph W. Dziedzic DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: James F. Hinrichs DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: Jean Hobby DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: Alvin (Tyrone) Jeffers DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: M. Craig Maxwell DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: Filippo Passerini DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: Donald J. Spence DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To elect 11 directors for a one-year term until their successors have been elected and qualified: William B. Summers, Jr. DIRECTOR ELECTIONS ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2024. AUDIT-RELATED ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/22/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 113568.000000 0 FOR 113568.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Election of Directors: William H. Rastetter, Ph.D. DIRECTOR ELECTIONS ISSUER 335656.000000 0 FOR 335656.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Election of Directors: George J. Morrow DIRECTOR ELECTIONS ISSUER 335656.000000 0 FOR 335656.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 335656.000000 0 FOR 335656.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Election of Directors: Christine A. Poon DIRECTOR ELECTIONS ISSUER 335656.000000 0 FOR 335656.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Advisory vote on the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 335656.000000 0 FOR 335656.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 To approve an amendment of the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 3,635,000 shares; and COMPENSATION ISSUER 335656.000000 0 FOR 335656.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 335656.000000 0 FOR 335656.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/22/2024 To elect each of the four nominees listed in the accompanying proxy statement as Class II directors to the Board of Directors to serve until our 2027 annual meeting and until their respective successors have been duly elected and qualified: Thomas McCarthy DIRECTOR ELECTIONS ISSUER 321868.000000 0 FOR 321868.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/22/2024 To elect each of the four nominees listed in the accompanying proxy statement as Class II directors to the Board of Directors to serve until our 2027 annual meeting and until their respective successors have been duly elected and qualified: Parth Mehrotra DIRECTOR ELECTIONS ISSUER 321868.000000 0 FOR 321868.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/22/2024 To elect each of the four nominees listed in the accompanying proxy statement as Class II directors to the Board of Directors to serve until our 2027 annual meeting and until their respective successors have been duly elected and qualified: Dr. Jaewon Ryu DIRECTOR ELECTIONS ISSUER 321868.000000 0 FOR 321868.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/22/2024 To elect each of the four nominees listed in the accompanying proxy statement as Class II directors to the Board of Directors to serve until our 2027 annual meeting and until their respective successors have been duly elected and qualified: William (Bill) Sullivan DIRECTOR ELECTIONS ISSUER 321868.000000 0 FOR 321868.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/22/2024 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 321868.000000 0 FOR 321868.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/22/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2024; AUDIT-RELATED ISSUER 321868.000000 0 FOR 321868.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/22/2024 To amend and restate our amended and restated certificate of incorporation (the "Charter") to remove supermajority voting standards; and CORPORATE GOVERNANCE ISSUER 321868.000000 0 FOR 321868.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/22/2024 To amend and restate our Charter to remove or limit the personal liability of officers to the extent permitted by amendments to the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 321868.000000 0 FOR 321868.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Bradford Kyle Armbrester DIRECTOR ELECTIONS ISSUER 572359.000000 0 WITHHOLD 572359.000000 AGAINST S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Clay Ashdown DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Agnes Bundy Scanlan DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Jeremy Delinsky DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: David M. Dill DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Michael C. Feiner DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Joseph Flanagan DIRECTOR ELECTIONS ISSUER 572359.000000 0 WITHHOLD 572359.000000 AGAINST S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: John B. Henneman, III DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Matthew Holt DIRECTOR ELECTIONS ISSUER 572359.000000 0 WITHHOLD 572359.000000 AGAINST S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Neal Moszkowski DIRECTOR ELECTIONS ISSUER 572359.000000 0 WITHHOLD 572359.000000 AGAINST S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Dominic Nakis DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Lee Rivas DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Ian Sacks DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Jill Smith DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Anthony J. Speranzo DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Anthony R. Tersigni DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 Election of Directors: Erik G. Wexler DIRECTOR ELECTIONS ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 To approve our Fifth Amended and Restated 2010 Stock Incentive Plan, including to increase the number of shares authorized for issuance under our Fourth Amended and Restated 2010 Stock Incentive Plan by 9.3 million shares. COMPENSATION ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 To approve, on an advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 05/22/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 572359.000000 0 FOR 572359.000000 FOR S000004450 Rapt Therapeutics, Inc. 75382E109 US75382E1091 05/22/2024 Election of Directors: William J. Rieflin DIRECTOR ELECTIONS ISSUER 76292.000000 0 FOR 76292.000000 FOR S000004450 Rapt Therapeutics, Inc. 75382E109 US75382E1091 05/22/2024 Election of Directors: Linda Kozick DIRECTOR ELECTIONS ISSUER 76292.000000 0 FOR 76292.000000 FOR S000004450 Rapt Therapeutics, Inc. 75382E109 US75382E1091 05/22/2024 Election of Directors: Lori Lyons-Williams DIRECTOR ELECTIONS ISSUER 76292.000000 0 FOR 76292.000000 FOR S000004450 Rapt Therapeutics, Inc. 75382E109 US75382E1091 05/22/2024 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of RAPT Therapeutics, Inc. for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 76292.000000 0 FOR 76292.000000 FOR S000004450 Senseonics Holdings, Inc. 81727U105 US81727U1051 05/22/2024 Election of three directors: Steven Edelman M.D. DIRECTOR ELECTIONS ISSUER 1037635.000000 311400.000000 FOR 1037635.000000 FOR S000004450 Senseonics Holdings, Inc. 81727U105 US81727U1051 05/22/2024 Election of three directors: Edward J. Fiorentino DIRECTOR ELECTIONS ISSUER 1037635.000000 311400.000000 FOR 1037635.000000 FOR S000004450 Senseonics Holdings, Inc. 81727U105 US81727U1051 05/22/2024 Election of three directors: Anthony Raab DIRECTOR ELECTIONS ISSUER 1037635.000000 311400.000000 FOR 1037635.000000 FOR S000004450 Senseonics Holdings, Inc. 81727U105 US81727U1051 05/22/2024 Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1037635.000000 311400.000000 FOR 1037635.000000 FOR S000004450 Senseonics Holdings, Inc. 81727U105 US81727U1051 05/22/2024 Ratification of selection by the Audit Committee of the Board of Directors of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1037635.000000 311400.000000 FOR 1037635.000000 FOR S000004450 Senseonics Holdings, Inc. 81727U105 US81727U1051 05/22/2024 Amend Company's Certificate of Incorporation to increase authorized shares of common stock from 900,000,000 to 1,400,000,000. CAPITAL STRUCTURE ISSUER 1037635.000000 311400.000000 FOR 1037635.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Dick Allen DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Myoungil Cha DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Peyton Howell DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Joao Malagueira DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Kathleen McGroddy-Goetz DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: John Sheridan DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Rajwant Sodhi DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Christopher Twomey DIRECTOR ELECTIONS ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To approve the Company's 2013 Employee Stock Purchase Plan, as amended, to increase the number of shares authorized for issuance under the plan. COMPENSATION ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To approve the Company's 2023 Long-Term Incentive Plan, as amended, to increase the number of shares authorized for issuance under the plan. COMPENSATION ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/22/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 223005.000000 0 FOR 223005.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Saumya Sutaria DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Roy Blunt DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Richard W. Fisher DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Cecil D. Haney DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Richard J. Mark DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Tammy Romo DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Stephen H. Rusckowski DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 To approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2024. AUDIT-RELATED ISSUER 311469.000000 0 FOR 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 To report on risk mitigation regarding state restrictions for emergency abortions. OTHER SOCIAL ISSUES SECURITY HOLDER 311469.000000 0 AGAINST 311469.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2024 To report on plans to integrate ESG metrics into executive compensation. COMPENSATION CORPORATE GOVERNANCE ENVIRONMENT OR CLIMATE HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 311469.000000 0 AGAINST 311469.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: James C. Mullen DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2024. AUDIT-RELATED ISSUER 1319702.000000 0 FOR 1319702.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Shareholder Proposal: Simple Majority Vote. CORPORATE GOVERNANCE SECURITY HOLDER 1319702.000000 0 AGAINST 1319702.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Louise M. Parent DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Willie M. Reed DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Robert W. Scully DIRECTOR ELECTIONS ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Approval of an amendment to our Restated Certificate of Incorporation to provide for exculpation of officers as permitted by the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 1564143.000000 0 FOR 1564143.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Shareholder proposal regarding an improvement to our director resignation policy. CORPORATE GOVERNANCE SECURITY HOLDER 1564143.000000 0 AGAINST 1564143.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/23/2024 Election of Directors: E. Perot Bissell DIRECTOR ELECTIONS ISSUER 313924.000000 0 FOR 313924.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/23/2024 Election of Directors: Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 313924.000000 0 FOR 313924.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/23/2024 Election of Directors: Christopher H. Hunter DIRECTOR ELECTIONS ISSUER 313924.000000 0 FOR 313924.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/23/2024 Approve an amendment to the Certificate of Incorporation to declassify the Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 313924.000000 0 FOR 313924.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/23/2024 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 313924.000000 0 FOR 313924.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/23/2024 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 313924.000000 0 FOR 313924.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/23/2024 The election of two Class II directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Daniel M. Bradbury DIRECTOR ELECTIONS ISSUER 86301.000000 0 FOR 86301.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/23/2024 The election of two Class II directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Rodney Cotton DIRECTOR ELECTIONS ISSUER 86301.000000 0 FOR 86301.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/23/2024 To ratify the selection of KPMG LLP by the Audit Committee of the Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 86301.000000 0 FOR 86301.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/23/2024 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 86301.000000 0 FOR 86301.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 05/23/2024 Election of Class III Directors: Jeremy Bender DIRECTOR ELECTIONS ISSUER 162212.000000 0 FOR 162212.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 05/23/2024 Election of Class III Directors: Habib Dable DIRECTOR ELECTIONS ISSUER 162212.000000 0 FOR 162212.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 05/23/2024 Election of Class III Directors: Saira Ramasastry DIRECTOR ELECTIONS ISSUER 162212.000000 0 FOR 162212.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 05/23/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 162212.000000 0 FOR 162212.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 05/23/2024 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 162212.000000 0 FOR 162212.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 05/23/2024 Selection, on a non-binding advisory basis, of whether future advisory votes on the compensation of our named executive officers should be every one, two or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 162212.000000 0 ONE YEAR 162212.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 05/23/2024 To elect our three nominees for Class III directors to hold office until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Francis R. Cano, Ph.D. DIRECTOR ELECTIONS ISSUER 417888.000000 0 FOR 417888.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 05/23/2024 To elect our three nominees for Class III directors to hold office until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Peter R. Paradiso, Ph.D. DIRECTOR ELECTIONS ISSUER 417888.000000 0 FOR 417888.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 05/23/2024 To elect our three nominees for Class III directors to hold office until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Peggy V. Phillips DIRECTOR ELECTIONS ISSUER 417888.000000 0 FOR 417888.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 05/23/2024 To approve the amendment and restatement of the Dynavax Technologies Corporation 2018 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 11,400,000. COMPENSATION ISSUER 417888.000000 0 FOR 417888.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 05/23/2024 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this Notice. SECTION 14A SAY-ON-PAY VOTES ISSUER 417888.000000 0 FOR 417888.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 05/23/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 417888.000000 0 FOR 417888.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 05/23/2024 To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Donald DeGolyer DIRECTOR ELECTIONS ISSUER 182883.000000 0 FOR 182883.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 05/23/2024 To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Neal Fowler DIRECTOR ELECTIONS ISSUER 182883.000000 0 FOR 182883.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 05/23/2024 To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Marvin White DIRECTOR ELECTIONS ISSUER 182883.000000 0 FOR 182883.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 05/23/2024 To ratify the appointment by the audit and finance committee of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 182883.000000 0 FOR 182883.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 05/23/2024 To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 182883.000000 0 FOR 182883.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 05/23/2024 To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan. COMPENSATION ISSUER 182883.000000 0 FOR 182883.000000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 US56600D1072 05/23/2024 To elect four nominees to the Board of Directors (3-year term expiring in 2027): Benjamin Daverman DIRECTOR ELECTIONS ISSUER 387652.000000 0 FOR 387652.000000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 US56600D1072 05/23/2024 To elect four nominees to the Board of Directors (3-year term expiring in 2027): Susannah Gray DIRECTOR ELECTIONS ISSUER 387652.000000 0 FOR 387652.000000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 US56600D1072 05/23/2024 To elect four nominees to the Board of Directors (3-year term expiring in 2027): Carl Hull DIRECTOR ELECTIONS ISSUER 387652.000000 0 FOR 387652.000000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 US56600D1072 05/23/2024 To elect four nominees to the Board of Directors (3-year term expiring in 2027): Constantine Mihas DIRECTOR ELECTIONS ISSUER 387652.000000 0 FOR 387652.000000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 US56600D1072 05/23/2024 To ratify the appointment of Ernst & Young LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2024; AUDIT-RELATED ISSUER 387652.000000 0 FOR 387652.000000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 US56600D1072 05/23/2024 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers, and SECTION 14A SAY-ON-PAY VOTES ISSUER 387652.000000 0 FOR 387652.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: Christopher M. Smith DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: Dr. Alison L. Hannah DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: David B. Perez DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: Elizabeth Floegel DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Approval of the Fourth Amendment of the NeoGenomics, Inc. Employee Stock Purchase Plan (as amended and restated). COMPENSATION ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/23/2024 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 436586.000000 0 FOR 436586.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: D. Keith Grossman DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Michael DeMane DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Kevin Thornal DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Kirt P. Karros DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Sri Kosaraju DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Shawn T McCormick DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Kevin O'Boyle DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Karen Prange DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Susan Siegel DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 Election of directors to hold office until the 2025 annual meeting of stockholders or until their successors are elected: Elizabeth Weatherman DIRECTOR ELECTIONS ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 05/23/2024 To approve, on a non-binding, advisory basis, the compensation of the named executive officers as disclosed in the Company's proxy statement in accordance with the compensation disclosure rules of the Securities and Exchange Commission SECTION 14A SAY-ON-PAY VOTES ISSUER 111538.000000 0 FOR 111538.000000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/23/2024 To elect three class II directors to hold office until the 2027 Annual Meeting of Stockholders: Michael F. Cola DIRECTOR ELECTIONS ISSUER 24574.000000 72300.000000 WITHHOLD 24574.000000 AGAINST S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/23/2024 To elect three class II directors to hold office until the 2027 Annual Meeting of Stockholders: Frank Karbe DIRECTOR ELECTIONS ISSUER 24574.000000 72300.000000 WITHHOLD 24574.000000 AGAINST S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/23/2024 To elect three class II directors to hold office until the 2027 Annual Meeting of Stockholders: Asit Parikh, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 24574.000000 72300.000000 WITHHOLD 24574.000000 AGAINST S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/23/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 24574.000000 72300.000000 FOR 24574.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/23/2024 Election of Directors: Peter Anevski DIRECTOR ELECTIONS ISSUER 293813.000000 0 FOR 293813.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/23/2024 Election of Directors: Roger Holstein DIRECTOR ELECTIONS ISSUER 293813.000000 0 FOR 293813.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/23/2024 Election of Directors: Jeff Park DIRECTOR ELECTIONS ISSUER 293813.000000 0 FOR 293813.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/23/2024 Election of Directors: David Schlanger DIRECTOR ELECTIONS ISSUER 293813.000000 0 FOR 293813.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/23/2024 Ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 293813.000000 0 FOR 293813.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/23/2024 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 293813.000000 0 FOR 293813.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/23/2024 Elect the following Class I nominees for director to hold office until the 2027 Annual Meeting of Shareholders and until their successors have been duly elected and qualified: Constantine S. Mihas DIRECTOR ELECTIONS ISSUER 339129.000000 0 FOR 339129.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/23/2024 Elect the following Class I nominees for director to hold office until the 2027 Annual Meeting of Shareholders and until their successors have been duly elected and qualified: James C. Neary DIRECTOR ELECTIONS ISSUER 339129.000000 0 FOR 339129.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/23/2024 Elect the following Class I nominees for director to hold office until the 2027 Annual Meeting of Shareholders and until their successors have been duly elected and qualified: Michael B. Petras, Jr. DIRECTOR ELECTIONS ISSUER 339129.000000 0 FOR 339129.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/23/2024 Elect the following Class I nominees for director to hold office until the 2027 Annual Meeting of Shareholders and until their successors have been duly elected and qualified: David E. Wheadon, M.D. DIRECTOR ELECTIONS ISSUER 339129.000000 0 FOR 339129.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/23/2024 Approve, on an advisory, non-binding basis, our named executive officers' compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 339129.000000 0 FOR 339129.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/23/2024 Ratify the appointment of Ernst & Young LLP as our independent auditors for 2024. AUDIT-RELATED ISSUER 339129.000000 0 FOR 339129.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/23/2024 Approve an amendment to our amended and restated certificate of incorporation to adopt provisions allowing officer exculpation consistent with Delaware law. CORPORATE GOVERNANCE ISSUER 339129.000000 0 FOR 339129.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Elect eight directors, each for a term of one year: J. Eric Evans DIRECTOR ELECTIONS ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Elect eight directors, each for a term of one year: Sandra L. Fenwick DIRECTOR ELECTIONS ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Elect eight directors, each for a term of one year: Catherine A. Jacobson DIRECTOR ELECTIONS ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Elect eight directors, each for a term of one year: Thomas G. McKinley DIRECTOR ELECTIONS ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Elect eight directors, each for a term of one year: Kenneth H. Paulus DIRECTOR ELECTIONS ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Elect eight directors, each for a term of one year: David L. Shedlarz DIRECTOR ELECTIONS ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Elect eight directors, each for a term of one year: Mark Douglas Smith, M.D., MBA DIRECTOR ELECTIONS ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Elect eight directors, each for a term of one year: David B. Snow, Jr. DIRECTOR ELECTIONS ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Approve, on an advisory basis, the frequency of future advisory votes on the compensation of Teladoc Health's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 564350.000000 0 ONE YEAR 564350.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/23/2024 Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 564350.000000 0 FOR 564350.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/23/2024 Election of Directors: Scott E. Lamb DIRECTOR ELECTIONS ISSUER 96040.000000 0 FOR 96040.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/23/2024 Election of Directors: Gregory K. Morris, MD DIRECTOR ELECTIONS ISSUER 96040.000000 0 FOR 96040.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/23/2024 Election of Directors: Barry M. Smith DIRECTOR ELECTIONS ISSUER 96040.000000 0 FOR 96040.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/23/2024 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for fiscal year 2024. AUDIT-RELATED ISSUER 96040.000000 0 FOR 96040.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/23/2024 Advisory approval of the Company's named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 96040.000000 0 FOR 96040.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 Election of Directors: Waleed Hassanein, M.D. DIRECTOR ELECTIONS ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 Election of Directors: James R. Tobin DIRECTOR ELECTIONS ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 Election of Directors: Edward M. Basile DIRECTOR ELECTIONS ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 Election of Directors: Thomas J. Gunderson DIRECTOR ELECTIONS ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 Election of Directors: Edwin M. Kania, Jr. DIRECTOR ELECTIONS ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 Election of Directors: Stephanie Lovell DIRECTOR ELECTIONS ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 Election of Directors: Merilee Raines DIRECTOR ELECTIONS ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 Election of Directors: David Weill, M.D. DIRECTOR ELECTIONS ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/23/2024 To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 111404.000000 0 FOR 111404.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To elect directors to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To approve, by non-binding vote, executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/23/2024 To amend the Company's certificate of incorporation to provide for exculpation of certain officers of the Company as permitted by recent amendments to Delaware law; and CORPORATE GOVERNANCE ISSUER 201988.000000 0 FOR 201988.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/24/2024 To elect three Class II directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Jill Carroll DIRECTOR ELECTIONS ISSUER 97250.000000 0 FOR 97250.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/24/2024 To elect three Class II directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Kavita Patel DIRECTOR ELECTIONS ISSUER 97250.000000 0 FOR 97250.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/24/2024 To elect three Class II directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Olivia Ware DIRECTOR ELECTIONS ISSUER 97250.000000 0 FOR 97250.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/24/2024 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 97250.000000 0 FOR 97250.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/24/2024 To approve, on an advisory basis, the frequency of future Say-on-Pay Votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 97250.000000 0 ONE YEAR 97250.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/24/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 97250.000000 0 FOR 97250.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/24/2024 To elect two directors to serve for a one-year term: Ann Custin DIRECTOR ELECTIONS ISSUER 6109.000000 58700.000000 FOR 6109.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/24/2024 To elect two directors to serve for a one-year term: Bryan Slotkin DIRECTOR ELECTIONS ISSUER 6109.000000 58700.000000 FOR 6109.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/24/2024 To approve, on an advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 6109.000000 58700.000000 FOR 6109.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/24/2024 To ratify the appointment of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 6109.000000 58700.000000 FOR 6109.000000 FOR S000004450 Inhibrx, Inc. 45720L107 US45720L1070 05/24/2024 To adopt (i) the Agreement and Plan of Merger, dated as of January 22, 2024 (the "Merger Agreement"), as it may be amended from time to time, by and among Inhibrx, Inc. (the "Company"), Aventis Inc. ("Parent"), and Art Acquisition Sub, Inc. and (ii) the Distribution Agreement, dated as of January 22, 2024 (the "Distribution Agreement"), as it may be amended from time to time, by and among the Company, Parent (solely for certain sections set forth therein) and Inhibrx Biosciences, Inc. ("SpinCo"). EXTRAORDINARY TRANSACTIONS ISSUER 72366.000000 0 FOR 72366.000000 FOR S000004450 Inhibrx, Inc. 45720L107 US45720L1070 05/24/2024 To adjourn the Special Meeting, if necessary, desirable or appropriate, to solicit additional proxies if, at the time of the Special Meeting, there are an insufficient number of votes in favor of adopting the Merger Agreement and the Distribution Agreement. CORPORATE GOVERNANCE ISSUER 72366.000000 0 FOR 72366.000000 FOR S000004450 Inhibrx, Inc. 45720L107 US45720L1070 05/24/2024 To approve, by non-binding, advisory vote, certain compensation that may become payable to the Company's named executive officers in connection with the transactions contemplated by the Merger Agreement and Distribution Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 72366.000000 0 FOR 72366.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/24/2024 To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: David R. Bailey DIRECTOR ELECTIONS ISSUER 55504.000000 0 FOR 55504.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/24/2024 To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Marie C. Infante DIRECTOR ELECTIONS ISSUER 55504.000000 0 FOR 55504.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/24/2024 To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Jimmy D. McDonald DIRECTOR ELECTIONS ISSUER 55504.000000 0 FOR 55504.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/24/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 55504.000000 0 FOR 55504.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/24/2024 To approve the Company's 2024 Incentive Award Plan. COMPENSATION ISSUER 55504.000000 0 FOR 55504.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/24/2024 To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 55504.000000 0 FOR 55504.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Ratification of the appointment of the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 8632795.000000 0 FOR 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Shareholder proposal regarding a shareholder right to act by written consent CORPORATE GOVERNANCE SECURITY HOLDER 8632795.000000 0 AGAINST 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Shareholder proposal regarding a government censorship transparency report. OTHER SOCIAL ISSUES SECURITY HOLDER 8632795.000000 0 AGAINST 8632795.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Shareholder proposal regarding a report on respecting workforce civil liberties. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 8632795.000000 0 AGAINST 8632795.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/29/2024 Election of Directors: To be elected for terms expiring in 2027: Steven Altschuler, M.D. DIRECTOR ELECTIONS ISSUER 253850.000000 0 FOR 253850.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/29/2024 Election of Directors: To be elected for terms expiring in 2027: Michael Hayden, M.B. Ch.B., Ph.D. DIRECTOR ELECTIONS ISSUER 253850.000000 0 FOR 253850.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/29/2024 Election of Directors: To be elected for terms expiring in 2027: Kathleen LaPorte DIRECTOR ELECTIONS ISSUER 253850.000000 0 FOR 253850.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/29/2024 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 253850.000000 0 FOR 253850.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/29/2024 Approval of, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 253850.000000 0 FOR 253850.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/29/2024 Advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 253850.000000 0 ONE YEAR 253850.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2024 To elect three Class II directors to hold office until the Company's 2027 Annual Meeting of Stockholders: Julian C. Baker DIRECTOR ELECTIONS ISSUER 362653.000000 0 FOR 362653.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2024 To elect three Class II directors to hold office until the Company's 2027 Annual Meeting of Stockholders: Stephen R. Biggar, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 362653.000000 0 FOR 362653.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2024 To elect three Class II directors to hold office until the Company's 2027 Annual Meeting of Stockholders: Daniel B. Soland DIRECTOR ELECTIONS ISSUER 362653.000000 0 FOR 362653.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 362653.000000 0 FOR 362653.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2024 To approve the Company's 2024 Equity Incentive Plan. COMPENSATION ISSUER 362653.000000 0 FOR 362653.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2024 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 362653.000000 0 FOR 362653.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/29/2024 Election of Class III Directors: Ravi Sachdev DIRECTOR ELECTIONS ISSUER 1041438.000000 0 FOR 1041438.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/29/2024 Election of Class III Directors: Steven J. Sell DIRECTOR ELECTIONS ISSUER 1041438.000000 0 FOR 1041438.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/29/2024 Election of Class III Directors: William Wulf, M.D. DIRECTOR ELECTIONS ISSUER 1041438.000000 0 FOR 1041438.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/29/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 1041438.000000 0 FOR 1041438.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/29/2024 To approve, by advisory vote, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1041438.000000 0 FOR 1041438.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 05/29/2024 Election of Directors: Edward Kennedy, Jr. DIRECTOR ELECTIONS ISSUER 196734.000000 0 FOR 196734.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 05/29/2024 Election of Directors: Everett Cunningham DIRECTOR ELECTIONS ISSUER 196734.000000 0 FOR 196734.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 05/29/2024 Election of Directors: Briggs Morrison, M.D. DIRECTOR ELECTIONS ISSUER 196734.000000 0 FOR 196734.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 05/29/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 196734.000000 0 FOR 196734.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 05/29/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 196734.000000 0 FOR 196734.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 05/29/2024 To adopt and approve the Agreement and Plan of Merger, dated as of February 5, 2024, by and among Catalent, Creek Parent, Inc., and Creek Merger Sub, Inc. (the "Merger" and "Merger Proposal"); EXTRAORDINARY TRANSACTIONS ISSUER 613881.000000 0 FOR 613881.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 05/29/2024 To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Catalent's named executive officers that is based on or otherwise relates to the Merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 613881.000000 0 FOR 613881.000000 FOR S000004450 Catalent, Inc. 148806102 US1488061029 05/29/2024 To approve one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if a quorum is not present or there are not sufficient votes cast at the Special Meeting to approve the Merger Proposal. CORPORATE GOVERNANCE ISSUER 613881.000000 0 FOR 613881.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 05/29/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected: Lee N. Newcomer, MD DIRECTOR ELECTIONS ISSUER 338209.000000 0 FOR 338209.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 05/29/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected: Charles W. Newton DIRECTOR ELECTIONS ISSUER 338209.000000 0 FOR 338209.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 05/29/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected: Kimberly J. Tzoumakas DIRECTOR ELECTIONS ISSUER 338209.000000 0 FOR 338209.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 05/29/2024 To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 338209.000000 0 FOR 338209.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 05/29/2024 To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 338209.000000 0 FOR 338209.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 05/29/2024 To approve the amendment and restatement of the Company's 2014 Equity Incentive Award Plan (the "2014 Plan"). COMPENSATION ISSUER 338209.000000 0 FOR 338209.000000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/29/2024 To elect three Class I directors to serve until our 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Jeffrey S. Aronin DIRECTOR ELECTIONS ISSUER 109784.000000 0 FOR 109784.000000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/29/2024 To elect three Class I directors to serve until our 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: R. Mark Graf DIRECTOR ELECTIONS ISSUER 109784.000000 0 FOR 109784.000000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/29/2024 To elect three Class I directors to serve until our 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Jeffrey M. Dayno, M.D. DIRECTOR ELECTIONS ISSUER 109784.000000 0 FOR 109784.000000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/29/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 109784.000000 0 FOR 109784.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: C. Noel Bairey Merz, M.D. DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Quentin S. Blackford DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Bruce G. Bodaken DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karen Ling DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Mark J. Rubash DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Ralph Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Abhijit Y. Talwalkar DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To elect nine directors to serve until our 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brian Yoor DIRECTOR ELECTIONS ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To approve an amendment to our Amended and Restated Certificate of Incorporation to limit the liability of certain of our officers as permitted pursuant to recent amendments to the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 104430.000000 0 FOR 104430.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/29/2024 To select, on a non-binding advisory basis, whether future advisory votes on the compensation of our named executive officers should be every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 104430.000000 0 ONE YEAR 104430.000000 FOR S000004450 Outset Medical, Inc. 690145107 US6901451079 05/29/2024 Election of Class I Directors: Karen Drexler DIRECTOR ELECTIONS ISSUER 159745.000000 0 FOR 159745.000000 FOR S000004450 Outset Medical, Inc. 690145107 US6901451079 05/29/2024 Election of Class I Directors: Dale E. Jones DIRECTOR ELECTIONS ISSUER 159745.000000 0 FOR 159745.000000 FOR S000004450 Outset Medical, Inc. 690145107 US6901451079 05/29/2024 Election of Class I Directors: Leslie Trigg DIRECTOR ELECTIONS ISSUER 159745.000000 0 FOR 159745.000000 FOR S000004450 Outset Medical, Inc. 690145107 US6901451079 05/29/2024 Advisory vote to approve 2023 named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 159745.000000 0 FOR 159745.000000 FOR S000004450 Outset Medical, Inc. 690145107 US6901451079 05/29/2024 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 159745.000000 0 FOR 159745.000000 FOR S000004450 Shockwave Medical, Inc. 82489T104 US82489T1043 05/29/2024 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated April 4, 2024, by and among Shockwave Medical, Inc., a Delaware corporation ("Shockwave"), Johnson & Johnson, a New Jersey corporation ("Johnson & Johnson"), and Sweep Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson & Johnson ("Merger Sub"), pursuant to which the Merger Sub will merge with and into Shockwave (the "Merger"), with Shockwave surviving the Merger as a wholly owned subsidiary of Johnson & Johnson. EXTRAORDINARY TRANSACTIONS ISSUER 125358.000000 0 FOR 125358.000000 FOR S000004450 Shockwave Medical, Inc. 82489T104 US82489T1043 05/29/2024 To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Shockwave's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 125358.000000 0 AGAINST 125358.000000 AGAINST S000004450 Shockwave Medical, Inc. 82489T104 US82489T1043 05/29/2024 To adjourn the Special Meeting of Stockholders to a later date or dates as provided in the Merger Agreement, if necessary or appropriate, including to solicit additional votes if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting of Stockholders. CORPORATE GOVERNANCE ISSUER 125358.000000 0 FOR 125358.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2024 To elect the following four nominees for director to hold office until the 2027 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Marianne De Backer, M.Sc., Ph.D., MBA DIRECTOR ELECTIONS ISSUER 322390.000000 0 FOR 322390.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2024 To elect the following four nominees for director to hold office until the 2027 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Norbert Bischofberger, Ph.D. DIRECTOR ELECTIONS ISSUER 322390.000000 0 FOR 322390.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2024 To elect the following four nominees for director to hold office until the 2027 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Ramy Farid, Ph.D. DIRECTOR ELECTIONS ISSUER 322390.000000 0 FOR 322390.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2024 To elect the following four nominees for director to hold office until the 2027 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Robert Nelsen DIRECTOR ELECTIONS ISSUER 322390.000000 0 FOR 322390.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 322390.000000 0 FOR 322390.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2024 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 322390.000000 0 FOR 322390.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/30/2024 Election of three Class III directors to serve for a three-year term expiring in 2027: William A. Linton DIRECTOR ELECTIONS ISSUER 306496.000000 0 FOR 306496.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/30/2024 Election of three Class III directors to serve for a three-year term expiring in 2027: Adelene Q. Perkins DIRECTOR ELECTIONS ISSUER 306496.000000 0 FOR 306496.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/30/2024 Election of three Class III directors to serve for a three-year term expiring in 2027: Robert J. Rosenthal DIRECTOR ELECTIONS ISSUER 306496.000000 0 FOR 306496.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/30/2024 Approval on an advisory basis of the 2023 compensation of our named executive officers, as discussed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 306496.000000 0 FOR 306496.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/30/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 306496.000000 0 FOR 306496.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2023. CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Approval of the appropriation of financial results. CAPITAL STRUCTURE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Discharge of the members of the Board of Directors and the Executive Committee. CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Re-election of Samarth Kulkarni, Ph.D., as member and election as Chairman DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Re-election of Ali Behbahani, M.D. DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 AGAINST 185992.000000 AGAINST S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Re-election of Maria Fardis, Ph.D. DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Re-election of H. Edward Fleming, Jr., M.D. DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Re-election of Simeon J. George, M.D. DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Re-election of John T. Greene DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Re-election of Katherine A. High, M.D. DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Re-election of Douglas A. Treco, Ph.D. DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Election of Sandesh Mahatme, LL.M. DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Election or re-election of the members to the Board of Directors and the Chairman: Election of Christian Rommel, Ph.D. DIRECTOR ELECTIONS ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Re-election of the members of the Compensation Committee: Re-election of Ali Behbahani, M.D. DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 AGAINST 185992.000000 AGAINST S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Re-election of the members of the Compensation Committee: Re-election of H. Edward Fleming, Jr., M.D. DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Re-election of the members of the Compensation Committee: Re-election of Simeon J. George, M.D. DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Re-election of the members of the Compensation Committee: Re-election of John T. Greene DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2023 Compensation Report: Binding vote on maximum non-performance-related compensation for members of the Board of Directors from the 2024 Annual General Meeting to the 2025 annual general meeting of shareholders. COMPENSATION ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Binding vote on maximum equity for members of the Board of Directors from the 2024 Annual General Meeting to the 2025 annual general meeting of shareholders. COMPENSATION ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2024 to June 30, 2025. COMPENSATION ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2024. COMPENSATION ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Binding vote on maximum equity for members of the Executive Committee from the 2024 Annual General Meeting to the 2025 annual general meeting of shareholders. COMPENSATION ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Non-binding advisory vote on the 2023 Compensation Report. COMPENSATION ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. SECTION 14A SAY-ON-PAY VOTES ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Approval of an increase of the conditional share capital for employee equity plans. COMPENSATION ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Approval of an amendment to the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan. COMPENSATION ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Approval of amendments to the Articles of Association to facilitate the use of equity compensation and pension benefits programs consistent with current market practices. COMPENSATION CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Approval of an increase and certain adjustments to the Company's capital band. CAPITAL STRUCTURE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Re-election of the independent voting rights representative. CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Re-election of the auditors. AUDIT-RELATED ISSUER 185992.000000 70700.000000 FOR 185992.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 05/30/2024 Transact any other business that may properly come before the 2024 Annual General Meeting or any adjournment or postponement thereof. CORPORATE GOVERNANCE ISSUER 185992.000000 70700.000000 AGAINST 185992.000000 AGAINST S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/30/2024 Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Meeta Chatterjee, Ph.D. DIRECTOR ELECTIONS ISSUER 249312.000000 0 FOR 249312.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/30/2024 Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Andrew Hirsch DIRECTOR ELECTIONS ISSUER 249312.000000 0 FOR 249312.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/30/2024 Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Gilmore O'Neill, M.B. DIRECTOR ELECTIONS ISSUER 249312.000000 0 FOR 249312.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/30/2024 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 249312.000000 0 FOR 249312.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/30/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 249312.000000 0 FOR 249312.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Election of Directors: William Doyle DIRECTOR ELECTIONS ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Election of Directors: Art Garcia DIRECTOR ELECTIONS ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Election of Directors: Denise Scots-Knight DIRECTOR ELECTIONS ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Election of Directors: Jeffrey Simmons DIRECTOR ELECTIONS ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Advisory vote on the compensation of company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Approval of the amendment of the Articles of Incorporation to declassify the Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Approval of the amendment of the Articles of Incorporation to adopt a majority vote standard for uncontested elections of Directors. CORPORATE GOVERNANCE ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Approval of the amendment of the Articles of Incorporation to provide shareholders with the right to amend the company's Bylaws. CORPORATE GOVERNANCE ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Approval of the amendment of the Articles of Incorporation to provide shareholders with the right to request special meetings of shareholders. CORPORATE GOVERNANCE ISSUER 1673274.000000 0 FOR 1673274.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D. DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D. DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D. DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Tomas J. Heyman DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: David E. Johnson DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D. DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver, Jr. DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D. DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRS DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Julie Anne Smith DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the focal year ending January 3, 2025. AUDIT-RELATED ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To amend and restate the Exelixis 2000 Employee Stock Purchase Plan to, among other things, increase the number of shares authorized for issuance by 6,000,000 shares. COMPENSATION ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/30/2024 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 953044.000000 0 FOR 953044.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/30/2024 Election of Directors: Thomas W. Burns DIRECTOR ELECTIONS ISSUER 157748.000000 0 FOR 157748.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/30/2024 Election of Directors: Leana S. Wen, M.D. DIRECTOR ELECTIONS ISSUER 157748.000000 0 FOR 157748.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/30/2024 Election of Directors: Marc A. Stapley DIRECTOR ELECTIONS ISSUER 157748.000000 0 FOR 157748.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/30/2024 Approval of the Glaukos Corporation Amended and Restated 2015 Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 157748.000000 0 FOR 157748.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/30/2024 Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 157748.000000 0 ONE YEAR 157748.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/30/2024 Approval, on an advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 157748.000000 0 FOR 157748.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/30/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 157748.000000 0 FOR 157748.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/30/2024 To elect three Class III directors (Robert A. Frist, Jr.; Terry Allisen Rappuhn; Frank E. Gordon) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Robert A. Frist, Jr. DIRECTOR ELECTIONS ISSUER 81645.000000 0 FOR 81645.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/30/2024 To elect three Class III directors (Robert A. Frist, Jr.; Terry Allisen Rappuhn; Frank E. Gordon) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Terry Allison Rappuhn DIRECTOR ELECTIONS ISSUER 81645.000000 0 FOR 81645.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/30/2024 To elect three Class III directors (Robert A. Frist, Jr.; Terry Allisen Rappuhn; Frank E. Gordon) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Frank E. Gordon DIRECTOR ELECTIONS ISSUER 81645.000000 0 FOR 81645.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/30/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 81645.000000 0 FOR 81645.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/30/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 81645.000000 0 FOR 81645.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/30/2024 To determine, on an advisory basis, whether the Company will have future advisory votes regarding executive compensation every one year, every two years, or every three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 81645.000000 0 ONE YEAR 81645.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 05/30/2024 To elect the three (3) nominees for director named below to hold office until the 2027 Annual Meeting of Stockholders: Jasbir Seehra DIRECTOR ELECTIONS ISSUER 86088.000000 0 FOR 86088.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 05/30/2024 To elect the three (3) nominees for director named below to hold office until the 2027 Annual Meeting of Stockholders: Nima Farzan DIRECTOR ELECTIONS ISSUER 86088.000000 0 FOR 86088.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 05/30/2024 To elect the three (3) nominees for director named below to hold office until the 2027 Annual Meeting of Stockholders: Julius Knowles DIRECTOR ELECTIONS ISSUER 86088.000000 0 FOR 86088.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 05/30/2024 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 86088.000000 0 FOR 86088.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 05/30/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 86088.000000 0 FOR 86088.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 05/30/2024 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 86088.000000 0 ONE YEAR 86088.000000 FOR S000004450 Mural Oncology Plc G63365103 IE000LK2BOB4 05/30/2024 Election of directors to serve until the Company's 2025 Annual General Meeting: Scott Jackson, MBA DIRECTOR ELECTIONS ISSUER 50775.000000 0 FOR 50775.000000 FOR S000004450 Mural Oncology Plc G63365103 IE000LK2BOB4 05/30/2024 Election of directors to serve until the Company's 2025 Annual General Meeting: Francis Cuss, M.B., B.Chir., FRCP DIRECTOR ELECTIONS ISSUER 50775.000000 0 FOR 50775.000000 FOR S000004450 Mural Oncology Plc G63365103 IE000LK2BOB4 05/30/2024 Election of directors to serve until the Company's 2025 Annual General Meeting: Susan Altschuller, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 50775.000000 0 FOR 50775.000000 FOR S000004450 Mural Oncology Plc G63365103 IE000LK2BOB4 05/30/2024 Election of directors to serve until the Company's 2025 Annual General Meeting: Benjamin Hickey, MBA DIRECTOR ELECTIONS ISSUER 50775.000000 0 FOR 50775.000000 FOR S000004450 Mural Oncology Plc G63365103 IE000LK2BOB4 05/30/2024 Election of directors to serve until the Company's 2025 Annual General Meeting: Caroline Loew, Ph.D. DIRECTOR ELECTIONS ISSUER 50775.000000 0 FOR 50775.000000 FOR S000004450 Mural Oncology Plc G63365103 IE000LK2BOB4 05/30/2024 Ratification, in a non-binding advisory vote, of the selection of PricewaterhouseCoopers LLP as the Company's independent auditor for the fiscal year ending December 31, 2024 and authorization, in a binding vote, of the board of directors, acting through the audit committee, to set the independent auditor's remuneration AUDIT-RELATED ISSUER 50775.000000 0 FOR 50775.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Emily Peterson Alva DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: David A. Daglio, Jr. DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Richard B. Gaynor, M.D DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Nancy S. Lurker DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Richard F. Pops DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Nancy L. Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Frank Anders Wilson DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To elect as directors to serve a one-year term until the Company's 2025 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To approve, in a non-binding, advisory vote, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 541586.000000 0 ONE YEAR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. AUDIT-RELATED ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. COMPENSATION ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To renew Board authority to allot and issue shares under Irish law. CAPITAL STRUCTURE ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/31/2024 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. CAPITAL STRUCTURE ISSUER 541586.000000 0 FOR 541586.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To approve our Amgen Inc. Second Amended and Restated 2009 Equity incentive Plan. COMPENSATION ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/31/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1823254.000000 0 FOR 1823254.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 ELECTION OF DIRECTORS: Jay Flatley DIRECTOR ELECTIONS ISSUER 376375.000000 0 FOR 376375.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 ELECTION OF DIRECTORS: Marc Tessier-Lavigne, Ph.D. DIRECTOR ELECTIONS ISSUER 376375.000000 0 FOR 376375.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 ELECTION OF DIRECTORS: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 376375.000000 0 FOR 376375.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 376375.000000 0 FOR 376375.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 376375.000000 0 FOR 376375.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 05/31/2024 To elect two Class II directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected: Terry J. Rosen, Ph.D. DIRECTOR ELECTIONS ISSUER 191961.000000 0 FOR 191961.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 05/31/2024 To elect two Class II directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected: Wendy L. Yarno DIRECTOR ELECTIONS ISSUER 191961.000000 0 FOR 191961.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 05/31/2024 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 191961.000000 0 FOR 191961.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 05/31/2024 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; SECTION 14A SAY-ON-PAY VOTES ISSUER 191961.000000 0 FOR 191961.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 05/31/2024 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of the Company's named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 191961.000000 0 ONE YEAR 191961.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/31/2024 Election of Three Class III Directors: George Migausky DIRECTOR ELECTIONS ISSUER 140770.000000 0 FOR 140770.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/31/2024 Election of Three Class III Directors: Kenneth T. Mills DIRECTOR ELECTIONS ISSUER 140770.000000 0 FOR 140770.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/31/2024 Election of Three Class III Directors: David C. Stump, M.D. DIRECTOR ELECTIONS ISSUER 140770.000000 0 FOR 140770.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/31/2024 To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 140770.000000 0 FOR 140770.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/31/2024 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 140770.000000 0 FOR 140770.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/03/2024 To elect four Class II directors to serve until the Company's 2027 Annual Meeting of Stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Mary Ziping Luo DIRECTOR ELECTIONS ISSUER 130449.000000 0 FOR 130449.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/03/2024 To elect four Class II directors to serve until the Company's 2027 Annual Meeting of Stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Howard Lee DIRECTOR ELECTIONS ISSUER 130449.000000 0 FOR 130449.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/03/2024 To elect four Class II directors to serve until the Company's 2027 Annual Meeting of Stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Michael A. Zasloff DIRECTOR ELECTIONS ISSUER 130449.000000 0 FOR 130449.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/03/2024 To elect four Class II directors to serve until the Company's 2027 Annual Meeting of Stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Gayle Deflin DIRECTOR ELECTIONS ISSUER 130449.000000 0 FOR 130449.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/03/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 130449.000000 0 FOR 130449.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/03/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 130449.000000 0 FOR 130449.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/03/2024 To approve the amendment and restatement of our 2015 Equity Incentive Plan. COMPENSATION ISSUER 130449.000000 0 FOR 130449.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/03/2024 To elect two class II directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Catherine Bollard, MBChB, M.D. DIRECTOR ELECTIONS ISSUER 102076.000000 0 FOR 102076.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/03/2024 To elect two class II directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Richard Henriques, MBA DIRECTOR ELECTIONS ISSUER 102076.000000 0 FOR 102076.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/03/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 102076.000000 0 FOR 102076.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/03/2024 Election of Directors: Lawrence J. Jasinski DIRECTOR ELECTIONS ISSUER 67784.000000 0 FOR 67784.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/03/2024 Election of Directors: John J. O'Connor DIRECTOR ELECTIONS ISSUER 67784.000000 0 FOR 67784.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/03/2024 Election of Directors: Joseph P. Pellegrino, Jr. DIRECTOR ELECTIONS ISSUER 67784.000000 0 FOR 67784.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/03/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 67784.000000 0 FOR 67784.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/03/2024 To approve the Fourth Amended and Restated 2006 Stock Option and Incentive Plan. COMPENSATION ISSUER 67784.000000 0 FOR 67784.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/03/2024 To ratify Grant Thornton LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 67784.000000 0 FOR 67784.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/03/2024 Election of Directors: Karen A. Flynn DIRECTOR ELECTIONS ISSUER 123097.000000 0 FOR 123097.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/03/2024 Election of Directors: Martin D. Madaus, Ph.D. DIRECTOR ELECTIONS ISSUER 123097.000000 0 FOR 123097.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/03/2024 To approve, by a non-binding advisory vote, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 123097.000000 0 FOR 123097.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/03/2024 Ratification of the appointment of Ernst & Young LLP as the independent accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 123097.000000 0 FOR 123097.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/03/2024 Election of Directors: Blake Borgeson, Ph.D. DIRECTOR ELECTIONS ISSUER 531451.000000 0 FOR 531451.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/03/2024 Election of Directors: Dean Y. Li, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 531451.000000 0 FOR 531451.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/03/2024 Advisory vote to approve executive compensation as disclosed in the 2024 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 531451.000000 0 FOR 531451.000000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/03/2024 To elect two class I directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Sanjiv K. Patel, M.D. DIRECTOR ELECTIONS ISSUER 282459.000000 0 FOR 282459.000000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/03/2024 To elect two class I directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Linda A. Hill, Ph.D. DIRECTOR ELECTIONS ISSUER 282459.000000 0 FOR 282459.000000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/03/2024 To consider and act upon an advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 282459.000000 0 FOR 282459.000000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/03/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 282459.000000 0 FOR 282459.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Charles Baker DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Timothy Flynn DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Paul Garcia DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Kristen Gil DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Michele Hooper DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: F. William McNabb III DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Andrew Witty DIRECTOR ELECTIONS ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2024. AUDIT-RELATED ISSUER 3143781.000000 0.000000 FOR 3143781.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 If properly presented at the 2024 Annual Meeting of Shareholders, the shareholder proposal requiring a political contributions congruency report. OTHER SOCIAL ISSUES SECURITY HOLDER 3143781.000000 0.000000 AGAINST 3143781.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2024 To elect the following Class II directors for a term expiring at the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Steven A. Elms DIRECTOR ELECTIONS ISSUER 725480.000000 0 FOR 725480.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2024 To elect the following Class II directors for a term expiring at the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Adam S. Grossman DIRECTOR ELECTIONS ISSUER 725480.000000 0 FOR 725480.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2024 To elect the following Class II directors for a term expiring at the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Young T. Kwon DIRECTOR ELECTIONS ISSUER 725480.000000 0 FOR 725480.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2024 To ratify the appointment of CohnReznick LLP as the independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 725480.000000 0 FOR 725480.000000 FOR S000004450 Akoya Biosciences, Inc. 00974H104 US00974H1041 06/04/2024 To elect three directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Scott Mendel DIRECTOR ELECTIONS ISSUER 83537.000000 0 FOR 83537.000000 FOR S000004450 Akoya Biosciences, Inc. 00974H104 US00974H1041 06/04/2024 To elect three directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Thomas P. Schnettler DIRECTOR ELECTIONS ISSUER 83537.000000 0 FOR 83537.000000 FOR S000004450 Akoya Biosciences, Inc. 00974H104 US00974H1041 06/04/2024 To elect three directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Robert Shepler DIRECTOR ELECTIONS ISSUER 83537.000000 0 FOR 83537.000000 FOR S000004450 Akoya Biosciences, Inc. 00974H104 US00974H1041 06/04/2024 To consider and vote upon the ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 83537.000000 0 FOR 83537.000000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/04/2024 Election of two Class I Directors: Nancy B. Miller-Rich DIRECTOR ELECTIONS ISSUER 159100.000000 0 WITHHOLD 159100.000000 AGAINST S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/04/2024 Election of two Class I Directors: Ben R. Bronstein, M.D. DIRECTOR ELECTIONS ISSUER 159100.000000 0 WITHHOLD 159100.000000 AGAINST S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/04/2024 To ratify the appointment of BDO USA, P.C. as Aldeyra Therapeutics, Inc.'s independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 159100.000000 0 FOR 159100.000000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/04/2024 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 159100.000000 0 FOR 159100.000000 FOR S000004450 CARA Therapeutics, Inc. 140755109 US1407551092 06/04/2024 Election of the Board of Directors' two nominees for director to serve until the Company's 2027 Annual Meeting and until their successors are duly elected and qualified: Susan Shiff, Ph.D. DIRECTOR ELECTIONS ISSUER 166955.000000 0 FOR 166955.000000 FOR S000004450 CARA Therapeutics, Inc. 140755109 US1407551092 06/04/2024 Election of the Board of Directors' two nominees for director to serve until the Company's 2027 Annual Meeting and until their successors are duly elected and qualified: Helen M. Boudreau DIRECTOR ELECTIONS ISSUER 166955.000000 0 FOR 166955.000000 FOR S000004450 CARA Therapeutics, Inc. 140755109 US1407551092 06/04/2024 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 166955.000000 0 FOR 166955.000000 FOR S000004450 CARA Therapeutics, Inc. 140755109 US1407551092 06/04/2024 Ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 166955.000000 0 FOR 166955.000000 FOR S000004450 CARA Therapeutics, Inc. 140755109 US1407551092 06/04/2024 Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 shares to 200,000,000 shares. CAPITAL STRUCTURE ISSUER 166955.000000 0 FOR 166955.000000 FOR S000004450 CARA Therapeutics, Inc. 140755109 US1407551092 06/04/2024 Approval of a series of alternate amendments to the Company's Amended and Restated Certificate of Incorporation to effect, at the option of the Board of Directors, a reverse stock split of the Company's common stock at a reverse stock split ratio ranging from one-for-four (1:4) to one-for-twelve (1:12), inclusive, and a corresponding proportionate reduction in the total number of authorized shares of the Company's common stock, with the effectiveness of one of such amendments and the abandonment of the other amendments, or the abandonment of all amendments, to be determined by the Board of Directors prior to the date of the 2025 Annual Meeting of Stockholders. CAPITAL STRUCTURE ISSUER 166955.000000 0 FOR 166955.000000 FOR S000004450 Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Gustav Christensen, MBA DIRECTOR ELECTIONS ISSUER 101575.000000 0 FOR 101575.000000 FOR S000004450 Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Susannah Gray, MBA DIRECTOR ELECTIONS ISSUER 101575.000000 0 FOR 101575.000000 FOR S000004450 Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Amir Nashat, Sc.D. DIRECTOR ELECTIONS ISSUER 101575.000000 0 FOR 101575.000000 FOR S000004450 Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 101575.000000 0 FOR 101575.000000 FOR S000004450 Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 101575.000000 0 FOR 101575.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/04/2024 Election of Directors: Kevin Ali DIRECTOR ELECTIONS ISSUER 867966.000000 0 FOR 867966.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/04/2024 Election of Directors: Martha E. McGarry DIRECTOR ELECTIONS ISSUER 867966.000000 0 FOR 867966.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/04/2024 Election of Directors: Philip Ozuah, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 867966.000000 0 FOR 867966.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/04/2024 Election of Directors: Shalini Sharp DIRECTOR ELECTIONS ISSUER 867966.000000 0 FOR 867966.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/04/2024 Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 867966.000000 0 FOR 867966.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/04/2024 Ratify the appointment of PricewaterhouseCoopers LLP as Organon's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 867966.000000 0 FOR 867966.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/04/2024 Election of Class III directors to serve until 2027 annual meeting of shareholders and until their successors are duly elected and qualified: Amy Dodrill DIRECTOR ELECTIONS ISSUER 154686.000000 0 FOR 154686.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/04/2024 Election of Class III directors to serve until 2027 annual meeting of shareholders and until their successors are duly elected and qualified: Taylor Harris DIRECTOR ELECTIONS ISSUER 154686.000000 0 FOR 154686.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/04/2024 Election of Class III directors to serve until 2027 annual meeting of shareholders and until their successors are duly elected and qualified: Reza Zadno, Ph.D. DIRECTOR ELECTIONS ISSUER 154686.000000 0 FOR 154686.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/04/2024 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 154686.000000 0 FOR 154686.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/04/2024 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 154686.000000 0 FOR 154686.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Courtney Beers, Ph.D. DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Robert F. Carey DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Kenneth J. Hillan, M.B., Ch.B. DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Margaret A. Horn, J.D. DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Alexander D. Macrae, M.B., Ch.B., Ph.D. DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: John H. Markels, Ph.D. DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: James R. Meyers DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: H. Stewart Parker DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Karen L. Smith, M.D., Ph.D., M.B.A, L.L.M. DIRECTOR ELECTIONS ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To approve, on an advisory basis, the compensation of our named executive officers, or NEOs, as described in the accompanying Proxy Statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To approve the amendment and restatement of the Sangamo Therapeutics, Inc. 2018 Equity Incentive Plan, or the 2018 Plan, to, among other things, increase the aggregate number of shares of our common stock reserved for issuance under the 2018 Plan by 11,000,000 shares; COMPENSATION ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To approve an amendment of our Seventh Amended and Restated Certificate of Incorporation, as amended, or the Restated Certificate, to increase the total number of shares of our common stock authorized for issuance from 640,000,000 to 960,000,000 shares; CAPITAL STRUCTURE ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Sangamo Therapeutics, Inc. 800677106 US8006771062 06/04/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024 AUDIT-RELATED ISSUER 524788.000000 0 FOR 524788.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Dawn Svoronos DIRECTOR ELECTIONS ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Gillian Cannon DIRECTOR ELECTIONS ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Steven Gannon DIRECTOR ELECTIONS ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Elizabeth Garofalo DIRECTOR ELECTIONS ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Justin Gover DIRECTOR ELECTIONS ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Pat Machado DIRECTOR ELECTIONS ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Ian Mortimer DIRECTOR ELECTIONS ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Gary Patou DIRECTOR ELECTIONS ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Compensation of Named Executive Officers Approve, on an advisory basis, the compensation of the Corporation's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Amendment to the Amended and Restated 2014 Plan Approve certain amendments to the Amended and Restated 2014 Equity Incentive Plan, including to increase the maximum number of Common Shares available for issuance thereunder by 5,200,000 COMPENSATION ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Appointment of Auditor Appoint KPMG LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation or until their successors are duly elected AUDIT-RELATED ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Remuneration of Auditor Authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditor of the Corporation AUDIT-RELATED ISSUER 214014.000000 0 FOR 214014.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064107 US0080641071 06/05/2024 Election of Directors: Maha Katabi, Ph.D. DIRECTOR ELECTIONS ISSUER 28191.000000 0 FOR 28191.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064107 US0080641071 06/05/2024 Election of Directors: David Grayzel, M.D. DIRECTOR ELECTIONS ISSUER 28191.000000 0 FOR 28191.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064107 US0080641071 06/05/2024 RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS AEROVATE THERAPEUTICS, INC.'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024 AUDIT-RELATED ISSUER 28191.000000 0 FOR 28191.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/05/2024 Election of Directors: John DeYoung DIRECTOR ELECTIONS ISSUER 369134.000000 0 FOR 369134.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/05/2024 Election of Directors: Franz Humer, Ph.D. DIRECTOR ELECTIONS ISSUER 369134.000000 0 FOR 369134.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/05/2024 Election of Directors: Joshua Kazam DIRECTOR ELECTIONS ISSUER 369134.000000 0 FOR 369134.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/05/2024 Election of Directors: Stephen Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 369134.000000 0 FOR 369134.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/05/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 369134.000000 0 FOR 369134.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/05/2024 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 369134.000000 0 FOR 369134.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/05/2024 Election of two Class I directors to hold office until the 2027 annual meeting of stockholders: Paul Fonteyne DIRECTOR ELECTIONS ISSUER 241973.000000 0 FOR 241973.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/05/2024 Election of two Class I directors to hold office until the 2027 annual meeting of stockholders: Stephanie Monaghan O'Brien DIRECTOR ELECTIONS ISSUER 241973.000000 0 FOR 241973.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/05/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 241973.000000 0 FOR 241973.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/05/2024 Approval of an advisory vote on executive compensation; and SECTION 14A SAY-ON-PAY VOTES ISSUER 241973.000000 0 FOR 241973.000000 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/05/2024 Election of the following nominee as a Class I Director for a three-year term ending at our Annual Meeting of Stockholders to be held in 2027: Graham Cooper DIRECTOR ELECTIONS ISSUER 235720.000000 0 FOR 235720.000000 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/05/2024 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 235720.000000 0 FOR 235720.000000 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/05/2024 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 235720.000000 0 FOR 235720.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/05/2024 The election of the three nominees for director named in the Proxy Statement, to hold office until the 2027 Annual Meeting of Stockholders: Daniel N. Swisher Jr. DIRECTOR ELECTIONS ISSUER 610644.000000 0 FOR 610644.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/05/2024 The election of the three nominees for director named in the Proxy Statement, to hold office until the 2027 Annual Meeting of Stockholders: Frank Witney, Ph.D. DIRECTOR ELECTIONS ISSUER 610644.000000 0 FOR 610644.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/05/2024 The election of the three nominees for director named in the Proxy Statement, to hold office until the 2027 Annual Meeting of Stockholders: Eric Bjerkholt DIRECTOR ELECTIONS ISSUER 610644.000000 0 FOR 610644.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/05/2024 The approval of an amendment and restatement of the Company's Amended and Restated 2008 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 5 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. COMPENSATION ISSUER 610644.000000 0 FOR 610644.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/05/2024 The approval of an amendment and restatement of the Company's Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 2 million shares. COMPENSATION ISSUER 610644.000000 0 FOR 610644.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/05/2024 The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 610644.000000 0 FOR 610644.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/05/2024 The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 610644.000000 0 FOR 610644.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/05/2024 Election of the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Andrew Robbins DIRECTOR ELECTIONS ISSUER 211575.000000 0 FOR 211575.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/05/2024 Election of the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Peter Harwin DIRECTOR ELECTIONS ISSUER 211575.000000 0 FOR 211575.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/05/2024 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 211575.000000 0 FOR 211575.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/05/2024 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 211575.000000 0 FOR 211575.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/05/2024 Advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 211575.000000 0 ONE YEAR 211575.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/05/2024 Approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of the Company's common stock from 150,000,000 to 300,000,000. CAPITAL STRUCTURE ISSUER 211575.000000 0 FOR 211575.000000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/05/2024 To elect each of our two Class III director nominees to our Board of Directors for a three-year term, to hold office until our 2027 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal: Wenbin Jiang, Ph.D. DIRECTOR ELECTIONS ISSUER 369533.000000 0 FOR 369533.000000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/05/2024 To elect each of our two Class III director nominees to our Board of Directors for a three-year term, to hold office until our 2027 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal: Michael Holder DIRECTOR ELECTIONS ISSUER 369533.000000 0 FOR 369533.000000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/05/2024 To vote, on an advisory basis, regarding the compensation of our named executive officers for the year ended December 31, 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 369533.000000 0 FOR 369533.000000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/05/2024 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 369533.000000 0 FOR 369533.000000 FOR S000004450 FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 Election of Class I Directors to hold office until the 2027 Annual Meeting of Stockholders: Thane Wettig DIRECTOR ELECTIONS ISSUER 326199.000000 0 FOR 326199.000000 FOR S000004450 FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 Election of Class I Directors to hold office until the 2027 Annual Meeting of Stockholders: James A. Schoeneck DIRECTOR ELECTIONS ISSUER 326199.000000 0 FOR 326199.000000 FOR S000004450 FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 Election of Class I Directors to hold office until the 2027 Annual Meeting of Stockholders: Maykin Ho, Ph.D. DIRECTOR ELECTIONS ISSUER 326199.000000 0 FOR 326199.000000 FOR S000004450 FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 To approve the FibroGen, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 326199.000000 0 FOR 326199.000000 FOR S000004450 FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 326199.000000 0 FOR 326199.000000 FOR S000004450 FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 To ratify the selection, by the Audit Committee of the Board, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024. AUDIT-RELATED ISSUER 326199.000000 0 FOR 326199.000000 FOR S000004450 FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 326199.000000 0 ONE YEAR 326199.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/05/2024 Election of Directors: David D. Davidar DIRECTOR ELECTIONS ISSUER 292654.000000 0 WITHHOLD 292654.000000 AGAINST S000004450 Globus Medical, Inc. 379577208 US3795772082 06/05/2024 Election of Directors: James R. Tobin DIRECTOR ELECTIONS ISSUER 292654.000000 0 WITHHOLD 292654.000000 AGAINST S000004450 Globus Medical, Inc. 379577208 US3795772082 06/05/2024 Election of Directors: Stephen T. Zarrilli DIRECTOR ELECTIONS ISSUER 292654.000000 0 FOR 292654.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/05/2024 Election of Directors: Daniel J. Wolterman DIRECTOR ELECTIONS ISSUER 292654.000000 0 FOR 292654.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/05/2024 The approval of the amendment to the 2021 Equity Incentive Plan; COMPENSATION ISSUER 292654.000000 0 AGAINST 292654.000000 AGAINST S000004450 Globus Medical, Inc. 379577208 US3795772082 06/05/2024 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024; and AUDIT-RELATED ISSUER 292654.000000 0 FOR 292654.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/05/2024 To approve, in an advisory vote, the compensation of the Company's named executive officers (the Say-on-Pay Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 292654.000000 0 FOR 292654.000000 FOR S000004450 Inogen, Inc. 45780L104 US45780L1044 06/05/2024 Election of Class I Directors: Elizabeth Mora DIRECTOR ELECTIONS ISSUER 78985.000000 0 FOR 78985.000000 FOR S000004450 Inogen, Inc. 45780L104 US45780L1044 06/05/2024 Election of Class I Directors: Heather Rider DIRECTOR ELECTIONS ISSUER 78985.000000 0 FOR 78985.000000 FOR S000004450 Inogen, Inc. 45780L104 US45780L1044 06/05/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 78985.000000 0 FOR 78985.000000 FOR S000004450 Inogen, Inc. 45780L104 US45780L1044 06/05/2024 To approve, on an advisory and non-binding basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 78985.000000 0 FOR 78985.000000 FOR S000004450 Inogen, Inc. 45780L104 US45780L1044 06/05/2024 To approve the Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan. COMPENSATION ISSUER 78985.000000 0 FOR 78985.000000 FOR S000004450 Kiniksa Pharmaceuticals, Ltd. G52694109 GB00BRXB0C07 06/05/2024 Election of Class III Directors to serve until the 2027 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Felix J Baker, Ph.D. DIRECTOR ELECTIONS ISSUER 96121.000000 0 FOR 96121.000000 FOR S000004450 Kiniksa Pharmaceuticals, Ltd. G52694109 GB00BRXB0C07 06/05/2024 Election of Class III Directors to serve until the 2027 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Tracey L. McCain DIRECTOR ELECTIONS ISSUER 96121.000000 0 FOR 96121.000000 FOR S000004450 Kiniksa Pharmaceuticals, Ltd. G52694109 GB00BRXB0C07 06/05/2024 Election of Class III Directors to serve until the 2027 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Kimberly J. Popovits DIRECTOR ELECTIONS ISSUER 96121.000000 0 FOR 96121.000000 FOR S000004450 Kiniksa Pharmaceuticals, Ltd. G52694109 GB00BRXB0C07 06/05/2024 The appointment of PricewaterhouseCoopers LLP as the Company's auditor until the close of the Company's next Annual Meeting of Shareholders, the delegation to the Company's Board of Directors, through its Audit Committee, of the authority to set the auditor's remuneration for such period, and the ratification of the appointment of PricewaterhouseCoopers LLP, as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 96121.000000 0 FOR 96121.000000 FOR S000004450 Kiniksa Pharmaceuticals, Ltd. G52694109 GB00BRXB0C07 06/05/2024 To approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2024 Annual Meeting pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 96121.000000 0 FOR 96121.000000 FOR S000004450 Kiniksa Pharmaceuticals, Ltd. 06/05/2024 To approve the Scheme of Arrangement attached to the accompanying proxy statement as Annex A among the Company and its shareholders. EXTRAORDINARY TRANSACTIONS CORPORATE GOVERNANCE ISSUER 96121.000000 0 FOR 96121.000000 FOR S000004450 Kiniksa Pharmaceuticals, Ltd. 06/05/2024 To approve a motion to adjourn the Special Court-Ordered Meeting of the shareholders of the Company (the "Redomiciliation Meeting") to a later date to solicit additional proxies if there are insufficient proxies to approve the Scheme of Arrangement at the time of the Redomiciliation Meeting. CORPORATE GOVERNANCE ISSUER 96121.000000 0 FOR 96121.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2024 Election of two Class I directors for three-year terms: Troy E. Wilson, Ph.D, J.D. DIRECTOR ELECTIONS ISSUER 176050.000000 0 FOR 176050.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2024 Election of two Class I directors for three-year terms: Faheem Hasnain DIRECTOR ELECTIONS ISSUER 176050.000000 0 FOR 176050.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2024 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 176050.000000 0 FOR 176050.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2024 Approval, on an advisory basis, of the compensation of our named executive officers during the year ended December 31, 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 176050.000000 0 FOR 176050.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2024 Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. COMPENSATION ISSUER 176050.000000 0 FOR 176050.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: M. Kathleen Behrens, Ph.D. DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: Joseph H. Capper DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: William A. Hawkins, III DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: Cato T. Laurencin, M.D. DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: K. Todd Newton DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: Tiffany Olson DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: Dorothy Puhy DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Election of Directors: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Advisory approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/05/2024 Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 399676.000000 0 FOR 399676.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/05/2024 Election of three Class II nominees for director to hold office until the Company's 2027 annual meeting of stockholders: Laurent Fischer, M.D. DIRECTOR ELECTIONS ISSUER 103594.000000 0 WITHHOLD 103594.000000 AGAINST S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/05/2024 Election of three Class II nominees for director to hold office until the Company's 2027 annual meeting of stockholders: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 103594.000000 0 FOR 103594.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/05/2024 Election of three Class II nominees for director to hold office until the Company's 2027 annual meeting of stockholders: Saira Ramasastry, M.S., M.Phil. DIRECTOR ELECTIONS ISSUER 103594.000000 0 FOR 103594.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/05/2024 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 103594.000000 0 FOR 103594.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/05/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 103594.000000 0 FOR 103594.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/05/2024 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 103594.000000 0 ONE YEAR 103594.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Election of the two Class II director nominees to serve until the 2027 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 61521.000000 0 FOR 61521.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Election of the two Class II director nominees to serve until the 2027 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Ramnik Xavier DIRECTOR ELECTIONS ISSUER 61521.000000 0 FOR 61521.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 61521.000000 0 FOR 61521.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Approval of, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 61521.000000 0 FOR 61521.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Non-binding advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 61521.000000 0 ONE YEAR 61521.000000 FOR S000004450 Nektar Therapeutics 640268108 US6402681083 06/05/2024 Election of Directors: Jeff Ajer DIRECTOR ELECTIONS ISSUER 641982.000000 0 FOR 641982.000000 FOR S000004450 Nektar Therapeutics 640268108 US6402681083 06/05/2024 Election of Directors: Robert B. Chess DIRECTOR ELECTIONS ISSUER 641982.000000 0 FOR 641982.000000 FOR S000004450 Nektar Therapeutics 640268108 US6402681083 06/05/2024 Election of Directors: Roy A. Whitfield DIRECTOR ELECTIONS ISSUER 641982.000000 0 FOR 641982.000000 FOR S000004450 Nektar Therapeutics 640268108 US6402681083 06/05/2024 To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 8,000,000 shares. COMPENSATION ISSUER 641982.000000 0 FOR 641982.000000 FOR S000004450 Nektar Therapeutics 640268108 US6402681083 06/05/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 641982.000000 0 FOR 641982.000000 FOR S000004450 Nektar Therapeutics 640268108 US6402681083 06/05/2024 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 641982.000000 0 FOR 641982.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Asaf Danziger DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: William Doyle DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: David Hung DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Kinyip Gabriel Leung DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Martin Madden DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Allyson Ocean DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Timothy Scannell DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Kristin Stafford DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: William Vernon DIRECTOR ELECTIONS ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 The approval of our 2024 Omnibus Incentive Plan COMPENSATION ISSUER 347375.000000 0 FOR 347375.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 A non-binding advisory vote to approve the frequency of the advisory vote on execute compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 347375.000000 0 ONE YEAR 347375.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Election of Directors: William J. Febbo DIRECTOR ELECTIONS ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Election of Directors: Lynn O'Connor Vos DIRECTOR ELECTIONS ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Election of Directors: James Lang DIRECTOR ELECTIONS ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Election of Directors: Patrick Spangler DIRECTOR ELECTIONS ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Election of Directors: Gregory D. Wasson DIRECTOR ELECTIONS ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Election of Directors: Catherine Klema DIRECTOR ELECTIONS ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Advisory approval of the compensation of OptimizeRx's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Amendment to OptimizeRx Corporation 2021 Equity Incentive Plan to increase the aggregate number of shares of common stock available for awards by 1,950,000 shares to 4,450,000 shares. COMPENSATION ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 OptimizeRx Corporation 68401U204 US68401U2042 06/05/2024 Ratification of UHY LLP as OptimizeRx's independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED ISSUER 55507.000000 0 FOR 55507.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/05/2024 To elect the nominees for Class III director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Adam Elsesser DIRECTOR ELECTIONS ISSUER 124571.000000 0 FOR 124571.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/05/2024 To elect the nominees for Class III director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Harpreet Grewal DIRECTOR ELECTIONS ISSUER 124571.000000 0 FOR 124571.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/05/2024 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 124571.000000 0 FOR 124571.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/05/2024 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 124571.000000 0 FOR 124571.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/05/2024 Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Jennifer C. Burstein DIRECTOR ELECTIONS ISSUER 67628.000000 0 FOR 67628.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/05/2024 Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Arthur A. Levin DIRECTOR ELECTIONS ISSUER 67628.000000 0 FOR 67628.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/05/2024 Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Ian F. Smith DIRECTOR ELECTIONS ISSUER 67628.000000 0 FOR 67628.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/05/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 67628.000000 0 FOR 67628.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2024 Election of Class III Directors: Alexis Borisy DIRECTOR ELECTIONS ISSUER 137923.000000 0 FOR 137923.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2024 Election of Class III Directors: John Ketchum DIRECTOR ELECTIONS ISSUER 137923.000000 0 FOR 137923.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2024 Election of Class III Directors: Barbara Weber, M.D. DIRECTOR ELECTIONS ISSUER 137923.000000 0 FOR 137923.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2024 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 137923.000000 0 FOR 137923.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2024 To approve an amendment to our Second Amended and Restated Certificate of Incorporation to limit the liability of certain of our officers, as permitted by recent amendments to Delaware law. CORPORATE GOVERNANCE ISSUER 137923.000000 0 FOR 137923.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected: R. Jeffrey Bailly DIRECTOR ELECTIONS ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected: Thomas Oberdorf DIRECTOR ELECTIONS ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected: Marc Kozin DIRECTOR ELECTIONS ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected: Daniel C. Croteau DIRECTOR ELECTIONS ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected: Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected: Joseph John Hassett DIRECTOR ELECTIONS ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected: Symeria Hudson DIRECTOR ELECTIONS ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To vote on a non-binding, advisory resolution to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/05/2024 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 24652.000000 0 FOR 24652.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/05/2024 To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Onaiza Cadoret Manier, M.B.A. DIRECTOR ELECTIONS ISSUER 150598.000000 0 FOR 150598.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/05/2024 To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Allison Hulme, Ph.D. DIRECTOR ELECTIONS ISSUER 150598.000000 0 FOR 150598.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/05/2024 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 150598.000000 0 FOR 150598.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/05/2024 To approve, on an advisory basis, the frequency of future Say-on-Pay Votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 150598.000000 0 ONE YEAR 150598.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/05/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 150598.000000 0 FOR 150598.000000 FOR S000004450 Aclaris Therapeutics, Inc. 00461U105 US00461U1051 06/06/2024 Election of Directors: Christopher Molineaux DIRECTOR ELECTIONS ISSUER 170157.000000 0 FOR 170157.000000 FOR S000004450 Aclaris Therapeutics, Inc. 00461U105 US00461U1051 06/06/2024 Election of Directors: Vincent Milano DIRECTOR ELECTIONS ISSUER 170157.000000 0 FOR 170157.000000 FOR S000004450 Aclaris Therapeutics, Inc. 00461U105 US00461U1051 06/06/2024 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this proxy card. SECTION 14A SAY-ON-PAY VOTES ISSUER 170157.000000 0 FOR 170157.000000 FOR S000004450 Aclaris Therapeutics, Inc. 00461U105 US00461U1051 06/06/2024 To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 170157.000000 0 FOR 170157.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/06/2024 Election of Directors: Eiry W. Roberts DIRECTOR ELECTIONS ISSUER 748390.000000 0 FOR 748390.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/06/2024 Election of Directors: Craig A. Wheeler DIRECTOR ELECTIONS ISSUER 748390.000000 0 FOR 748390.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/06/2024 Election of Directors: Burke W. Whitman DIRECTOR ELECTIONS ISSUER 748390.000000 0 FOR 748390.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/06/2024 Approval of the Amended and Restated 2007 Equity Incentive Plan to add 7,000,000 shares to the equity pool. COMPENSATION ISSUER 748390.000000 0 FOR 748390.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/06/2024 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 748390.000000 0 FOR 748390.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/06/2024 Approval, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 748390.000000 0 FOR 748390.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/06/2024 Election of Directors: To elect the following persons to our board of directors, each to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Joshua B. Cohen DIRECTOR ELECTIONS ISSUER 149346.000000 0 FOR 149346.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/06/2024 Election of Directors: To elect the following persons to our board of directors, each to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Daphne Quimi DIRECTOR ELECTIONS ISSUER 149346.000000 0 FOR 149346.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/06/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 149346.000000 0 FOR 149346.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/06/2024 To approve, on a non-binding, advisory basis, the compensation of our named executives officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149346.000000 0 FOR 149346.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/06/2024 To vote, on a non-binding, advisory basis, on the preferred frequency of future advisory votes on the compensation of our named executives officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149346.000000 0 ONE YEAR 149346.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/06/2024 Election of Directors: Kathryn Falberg DIRECTOR ELECTIONS ISSUER 166618.000000 0 FOR 166618.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/06/2024 Election of Directors: Linda Higgins, Ph.D. DIRECTOR ELECTIONS ISSUER 166618.000000 0 FOR 166618.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/06/2024 Election of Directors: Terry Rosen, Ph.D. DIRECTOR ELECTIONS ISSUER 166618.000000 0 FOR 166618.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/06/2024 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 166618.000000 0 FOR 166618.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/06/2024 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 166618.000000 0 FOR 166618.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Pamela M. Arway DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Charles G. Berg DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Barbara J. Desoer DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Gregory J. Moore, MD, PhD DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Dennis W. Pullin DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Wendy L. Schoppert DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2024. AUDIT-RELATED ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/06/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 186109.000000 0 FOR 186109.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Seth Blackley DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: M. Bridget Duffy, MD DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Russell Glass DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Peter Grua DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Diane Holder DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Richard Jelinek DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Kim Keck DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Election of Directors: Cheryl Scott DIRECTOR ELECTIONS ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Proposal to approve the compensation of our named executive officers for 2023 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 351915.000000 0 FOR 351915.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/06/2024 Proposal to approve the selection of the frequency of future advisory votes on executive compensation on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 351915.000000 0 ONE YEAR 351915.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/06/2024 Election of Class III directors for a three-year term: David Moatazedi DIRECTOR ELECTIONS ISSUER 165351.000000 0 FOR 165351.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/06/2024 Election of Class III directors for a three-year term: Vikram Malik DIRECTOR ELECTIONS ISSUER 165351.000000 0 FOR 165351.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/06/2024 Election of Class III directors for a three-year term: Karah Parschauer DIRECTOR ELECTIONS ISSUER 165351.000000 0 FOR 165351.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/06/2024 Ratification of the appointment of Ernst & Young LLP as Evolus' independent auditor for the year ending December 31, 2024. AUDIT-RELATED ISSUER 165351.000000 0 FOR 165351.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/06/2024 The approval of the Evolus Inc. 2024 Employee Stock Purchase Plan. COMPENSATION ISSUER 165351.000000 0 FOR 165351.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/06/2024 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 165351.000000 0 FOR 165351.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/06/2024 Approval of, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 165351.000000 0 ONE YEAR 165351.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/06/2024 Election of Directors: Douglas Hirsch DIRECTOR ELECTIONS ISSUER 267207.000000 0 FOR 267207.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/06/2024 Election of Directors: Kelly J. Kennedy DIRECTOR ELECTIONS ISSUER 267207.000000 0 FOR 267207.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/06/2024 Election of Directors: Agnes Rey-Giraud DIRECTOR ELECTIONS ISSUER 267207.000000 0 FOR 267207.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/06/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 267207.000000 0 FOR 267207.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/06/2024 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 267207.000000 0 FOR 267207.000000 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/06/2024 Election of Class II Directors: Skye Drynan DIRECTOR ELECTIONS ISSUER 651543.000000 0 FOR 651543.000000 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/06/2024 Election of Class II Directors: John Quisel, Ph.D., J.D. DIRECTOR ELECTIONS ISSUER 651543.000000 0 FOR 651543.000000 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/06/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2024. AUDIT-RELATED ISSUER 651543.000000 0 FOR 651543.000000 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/06/2024 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 651543.000000 0 FOR 651543.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/06/2024 To elect three directors to serve as Class II directors for a three-year term to expire at the 2027 annual meeting of stockholders: Gary Dubin, M.D. DIRECTOR ELECTIONS ISSUER 65783.000000 0 FOR 65783.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/06/2024 To elect three directors to serve as Class II directors for a three-year term to expire at the 2027 annual meeting of stockholders: Patrick Heron DIRECTOR ELECTIONS ISSUER 65783.000000 0 FOR 65783.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/06/2024 To elect three directors to serve as Class II directors for a three-year term to expire at the 2027 annual meeting of stockholders: Jaime Sepulveda, M.D., D.Sc., M.P.H. DIRECTOR ELECTIONS ISSUER 65783.000000 0 FOR 65783.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/06/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 65783.000000 0 FOR 65783.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/06/2024 To approve an amendment to our Amended and Restated Certificate of Incorporation to reflect Delaware law provisions to permit exculpation of certain officers. CORPORATE GOVERNANCE ISSUER 65783.000000 0 FOR 65783.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Election of Directors: Andrew Dudum DIRECTOR ELECTIONS ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Election of Directors: Dr. Patrick Carroll, M.D. DIRECTOR ELECTIONS ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Election of Directors: Dr. Delos Cosgrove, M.D. DIRECTOR ELECTIONS ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Election of Directors: Anja Manuel DIRECTOR ELECTIONS ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Election of Directors: Christopher Payne DIRECTOR ELECTIONS ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Election of Directors: Christiane Pendarvis DIRECTOR ELECTIONS ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Election of Directors: Andrea Perez DIRECTOR ELECTIONS ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Election of Directors: David Wells DIRECTOR ELECTIONS ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/06/2024 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 484143.000000 0 FOR 484143.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 Election of Directors: Brett P. Monia DIRECTOR ELECTIONS ISSUER 438621.000000 0 FOR 438621.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 Election of Directors: Michael Yang DIRECTOR ELECTIONS ISSUER 438621.000000 0 FOR 438621.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 438621.000000 0 FOR 438621.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 To approve an amendment of the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 3,300,000 shares to an aggregate of 38,500,000 shares and to prohibit certain share recycling on full value awards. COMPENSATION ISSUER 438621.000000 0 FOR 438621.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2024 fiscal year. AUDIT-RELATED ISSUER 438621.000000 0 FOR 438621.000000 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/06/2024 Election of Directors: Alexandria Forbes, Ph.D. DIRECTOR ELECTIONS ISSUER 132396.000000 0 FOR 132396.000000 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/06/2024 Election of Directors: Keith R. Harris, Ph.D. DIRECTOR ELECTIONS ISSUER 132396.000000 0 FOR 132396.000000 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/06/2024 Election of Directors: Lord Mendoza DIRECTOR ELECTIONS ISSUER 132396.000000 0 FOR 132396.000000 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/06/2024 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132396.000000 0 FOR 132396.000000 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/06/2024 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132396.000000 0 ONE YEAR 132396.000000 AGAINST S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/06/2024 To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 132396.000000 0 FOR 132396.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/06/2024 Election of two Class I Directors to serve until the 2027 Annual Meeting of Stockholders: S. Louise Phanstiel DIRECTOR ELECTIONS ISSUER 301231.000000 0 FOR 301231.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/06/2024 Election of two Class I Directors to serve until the 2027 Annual Meeting of Stockholders: Daniel M. Skovronsky, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 301231.000000 0 FOR 301231.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/06/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 301231.000000 0 FOR 301231.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/06/2024 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 301231.000000 0 FOR 301231.000000 FOR S000004450 PMV Pharmaceuticals, Inc. 69353Y103 US69353Y1038 06/06/2024 Election of Class I Directors: Kirsten Flowers DIRECTOR ELECTIONS ISSUER 98886.000000 0 FOR 98886.000000 FOR S000004450 PMV Pharmaceuticals, Inc. 69353Y103 US69353Y1038 06/06/2024 Election of Class I Directors: Carol Gallagher, Pharm.D. DIRECTOR ELECTIONS ISSUER 98886.000000 0 FOR 98886.000000 FOR S000004450 PMV Pharmaceuticals, Inc. 69353Y103 US69353Y1038 06/06/2024 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 98886.000000 0 FOR 98886.000000 FOR S000004450 PMV Pharmaceuticals, Inc. 69353Y103 US69353Y1038 06/06/2024 Ratification of the appointment of Ernst & Young LLP as our independent public accounting firm. AUDIT-RELATED ISSUER 98886.000000 0 FOR 98886.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Election of Directors: Pablo Legorreta DIRECTOR ELECTIONS ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Election of Directors: Henry Fernandez DIRECTOR ELECTIONS ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Election of Directors: Bonnie Bassler , Ph.D. DIRECTOR ELECTIONS ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Election of Directors: Errol De Souza, Ph.D. DIRECTOR ELECTIONS ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Election of Directors: Catherine Engelbert DIRECTOR ELECTIONS ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Election of Directors: David Hodgson DIRECTOR ELECTIONS ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Election of Directors: Ted Love , M.D. DIRECTOR ELECTIONS ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Approve receipt of our U.K. audited annual report and accounts and related directors' and auditor's reports for the fiscal year ended December 31, 2023. CORPORATE GOVERNANCE ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Approve our U.K. directors' remuneration policy. COMPENSATION ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Approve on a non-binding advisory basis our U.K. directors' remuneration report (other than the part containing the directors' remuneration policy) for the fiscal year ended December 31, 2023. COMPENSATION ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Re-appoint Ernst & Young as our U.K. statutory auditor, to hold office until the conclusion of the next general meeting at which the U.K. annual report and accounts are presented to shareholders. AUDIT-RELATED ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Authorize the Board to determine the remuneration of Ernst & Young in its capacity as our U.K. statutory auditor. AUDIT-RELATED ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Authorize the Board to allot shares. CAPITAL STRUCTURE ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 06/06/2024 Authorize the Board to allot shares without rights of pre-emption (special resolution). CAPITAL STRUCTURE ISSUER 1290022.000000 0 FOR 1290022.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/06/2024 To elect three Class III directors to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Julie B. Andrews DIRECTOR ELECTIONS ISSUER 91487.000000 0 FOR 91487.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/06/2024 To elect three Class III directors to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Robert J. Palmisano DIRECTOR ELECTIONS ISSUER 91487.000000 0 FOR 91487.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/06/2024 To elect three Class III directors to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Tamara R. Fountain, M.D. DIRECTOR ELECTIONS ISSUER 91487.000000 0 FOR 91487.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/06/2024 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 91487.000000 0 FOR 91487.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/06/2024 To approve, on an advisory (non-binding) basis, the frequency of future Say-on-Pay Votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 91487.000000 0 ONE YEAR 91487.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/06/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 91487.000000 0 FOR 91487.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/06/2024 To elect three Class III directors to our Board of Directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The three nominees for election are: Joshua H. Bilenker, M.D. DIRECTOR ELECTIONS ISSUER 334237.000000 0 FOR 334237.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/06/2024 To elect three Class III directors to our Board of Directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The three nominees for election are: Richard Mulligan, Ph.D. DIRECTOR ELECTIONS ISSUER 334237.000000 0 FOR 334237.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/06/2024 To elect three Class III directors to our Board of Directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The three nominees for election are: Mary Agnes (Maggie) Wilderotter DIRECTOR ELECTIONS ISSUER 334237.000000 0 FOR 334237.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/06/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 334237.000000 0 FOR 334237.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 221079.000000 0 FOR 221079.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Hans Wigzell, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 221079.000000 0 FOR 221079.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 221079.000000 0 FOR 221079.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Michael Chambers DIRECTOR ELECTIONS ISSUER 221079.000000 0 FOR 221079.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 advisory vote to approve, on a non-binding basis, name executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 221079.000000 0 FOR 221079.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2024 AUDIT-RELATED ISSUER 221079.000000 0 FOR 221079.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2024 Election of Class III Directors: Clifford G. Adlerz DIRECTOR ELECTIONS ISSUER 236899.000000 0 FOR 236899.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2024 Election of Class III Directors: J. Eric Evans DIRECTOR ELECTIONS ISSUER 236899.000000 0 FOR 236899.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2024 Election of Class III Directors: Blair E. Hendrix DIRECTOR ELECTIONS ISSUER 236899.000000 0 FOR 236899.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2024 Election of Class III Directors: Andrew T. Kaplan DIRECTOR ELECTIONS ISSUER 236899.000000 0 FOR 236899.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2024 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 236899.000000 0 FOR 236899.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2024 Approval of the Surgery Partners, Inc. Employee Stock Purchase Plan. COMPENSATION ISSUER 236899.000000 0 FOR 236899.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 236899.000000 0 FOR 236899.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Annie Drapeau DIRECTOR ELECTIONS ISSUER 306214.000000 0 FOR 306214.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Teri Loxam DIRECTOR ELECTIONS ISSUER 306214.000000 0 FOR 306214.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Carlos Paya, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 306214.000000 0 FOR 306214.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 306214.000000 0 FOR 306214.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 306214.000000 0 FOR 306214.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/06/2024 Election of two Class III directors to our board of directors, each to serve until the 2027 annual meeting of stockholders: Burt Adelman, M.D. DIRECTOR ELECTIONS ISSUER 178071.000000 0 FOR 178071.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/06/2024 Election of two Class III directors to our board of directors, each to serve until the 2027 annual meeting of stockholders: Sekar Kathiresan, M.D. DIRECTOR ELECTIONS ISSUER 178071.000000 0 FOR 178071.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/06/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 178071.000000 0 FOR 178071.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/06/2024 Approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 178071.000000 0 FOR 178071.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/06/2024 Approval, on an advisory basis, of the frequency of future advisory votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 178071.000000 0 ONE YEAR 178071.000000 FOR S000004450 ACELYRIN, Inc. 00445A100 US00445A1007 06/07/2024 To elect the three Class I directors named below to hold office until the Company's 2027 annual meeting of stockholders: Alan Colowick, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 65942.000000 0 FOR 65942.000000 FOR S000004450 ACELYRIN, Inc. 00445A100 US00445A1007 06/07/2024 To elect the three Class I directors named below to hold office until the Company's 2027 annual meeting of stockholders: Patrick Machado, J.D. DIRECTOR ELECTIONS ISSUER 65942.000000 0 FOR 65942.000000 FOR S000004450 ACELYRIN, Inc. 00445A100 US00445A1007 06/07/2024 To elect the three Class I directors named below to hold office until the Company's 2027 annual meeting of stockholders: Beth Seidenberg, M.D. DIRECTOR ELECTIONS ISSUER 65942.000000 0 FOR 65942.000000 FOR S000004450 ACELYRIN, Inc. 00445A100 US00445A1007 06/07/2024 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 65942.000000 0 FOR 65942.000000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/07/2024 To elect two Class II director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2027 annual meeting of shareholders: Peter Neupert DIRECTOR ELECTIONS ISSUER 346341.000000 0 FOR 346341.000000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/07/2024 To elect two Class II director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2027 annual meeting of shareholders: Michelle Griffin DIRECTOR ELECTIONS ISSUER 346341.000000 0 FOR 346341.000000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/07/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 346341.000000 0 FOR 346341.000000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/07/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024; and AUDIT-RELATED ISSUER 346341.000000 0 FOR 346341.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/07/2024 Election of Class II Directors to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified: Seth L. Harrison, M.D. DIRECTOR ELECTIONS ISSUER 181532.000000 0 FOR 181532.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/07/2024 Election of Class II Directors to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified: Graham Walmsley, M.D., Ph.D DIRECTOR ELECTIONS ISSUER 181532.000000 0 FOR 181532.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/07/2024 Election of Class II Directors to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified: Yuan Xu, Ph.D DIRECTOR ELECTIONS ISSUER 181532.000000 0 FOR 181532.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/07/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 181532.000000 0 FOR 181532.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/07/2024 To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 181532.000000 0 FOR 181532.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/07/2024 To approve an Amendment to our Fourth Amended and Restated Certificate of Incorporation, to limit the liability of certain officers of Akero Therapeutics, Inc., as permitted by recent amendments to Delaware law. CORPORATE GOVERNANCE ISSUER 181532.000000 0 FOR 181532.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/07/2024 Election of Directors: Yon Jorden DIRECTOR ELECTIONS ISSUER 357453.000000 0 FOR 357453.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/07/2024 Election of Directors: John Kao DIRECTOR ELECTIONS ISSUER 357453.000000 0 FOR 357453.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/07/2024 Election of Directors: Joseph Konowiecki DIRECTOR ELECTIONS ISSUER 357453.000000 0 FOR 357453.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/07/2024 Election of Directors: Margaret McCarthy DIRECTOR ELECTIONS ISSUER 357453.000000 0 FOR 357453.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/07/2024 Approve an amendment to our certificate of incorporation to reflect new Delaware law provisions regarding exculpation of officers. CORPORATE GOVERNANCE ISSUER 357453.000000 0 FOR 357453.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/07/2024 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 357453.000000 0 FOR 357453.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/07/2024 Approve, on an advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 357453.000000 0 FOR 357453.000000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/07/2024 Election of Directors: Herriot Tabuteau, M.D. DIRECTOR ELECTIONS ISSUER 83744.000000 20900.000000 FOR 83744.000000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/07/2024 Election of Directors: Mark Coleman, M.D. DIRECTOR ELECTIONS ISSUER 83744.000000 20900.000000 FOR 83744.000000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/07/2024 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 83744.000000 20900.000000 FOR 83744.000000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/07/2024 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 83744.000000 20900.000000 FOR 83744.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To elect directors to serve one-year terms expiring in 2025: Joseph DeVivo DIRECTOR ELECTIONS ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To elect directors to serve one-year terms expiring in 2025: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To elect directors to serve one-year terms expiring in 2025: Larry Robbins DIRECTOR ELECTIONS ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To elect directors to serve one-year terms expiring in 2025: Dawn Carfora DIRECTOR ELECTIONS ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To elect directors to serve one-year terms expiring in 2025: Elazer Edelman, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To elect directors to serve one-year terms expiring in 2025: S. Louise Phanstiel DIRECTOR ELECTIONS ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To elect directors to serve one-year terms expiring in 2025: Erica Schwartz, M.D., J.D., M.P.H. DIRECTOR ELECTIONS ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To approve the 2024 Employee Stock Purchase Plan. COMPENSATION ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 To approve a proposed Third Amended and Restated Certificate of Incorporation, which will amend and restate our current Second Amended and Restated Certificate of Incorporation, to: add a provision with respect to the automatic conversion of our Class B common stock effective February 12, 2028, which is seven years from the date of the closing of our business combination by and among Longview Acquisition Corp., Clay Merger Sub Inc., and BFLY Operations, Inc. (formerly Butterfly Network, Inc); CAPITAL STRUCTURE ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 add a provision to provide for the exculpation of officers; and CORPORATE GOVERNANCE ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/07/2024 amend the exclusive forum provision. SHAREHOLDER RIGHTS AND DEFENSES CORPORATE GOVERNANCE ISSUER 304464.000000 212700.000000 FOR 304464.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/07/2024 To elect two directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Camille Bedrosian, M.D. DIRECTOR ELECTIONS ISSUER 217949.000000 0 FOR 217949.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/07/2024 To elect two directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 217949.000000 0 FOR 217949.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/07/2024 To consider and vote upon the ratification of the selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 217949.000000 0 FOR 217949.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/07/2024 To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and SECTION 14A SAY-ON-PAY VOTES ISSUER 217949.000000 0 FOR 217949.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/07/2024 Election of Class II Directors: William H. Rastetter, Ph.D. DIRECTOR ELECTIONS ISSUER 271365.000000 0 FOR 271365.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/07/2024 Election of Class II Directors: Michael Lee DIRECTOR ELECTIONS ISSUER 271365.000000 0 FOR 271365.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/07/2024 Election of Class II Directors: Yuan Xu, Ph.D. DIRECTOR ELECTIONS ISSUER 271365.000000 0 FOR 271365.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/07/2024 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 271365.000000 0 FOR 271365.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/07/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 271365.000000 0 FOR 271365.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/07/2024 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain of its officers as permitted under current Delaware law. CORPORATE GOVERNANCE ISSUER 271365.000000 0 FOR 271365.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/07/2024 To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. COMPENSATION ISSUER 271365.000000 0 FOR 271365.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/07/2024 To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals. CORPORATE GOVERNANCE ISSUER 271365.000000 0 FOR 271365.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 06/07/2024 To elect five directors, each to serve until the annual meeting next succeeding their relection and until their successor is elected and qualified: McCord Christensen DIRECTOR ELECTIONS ISSUER 94348.000000 0 FOR 94348.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 06/07/2024 To elect five directors, each to serve until the annual meeting next succeeding their relection and until their successor is elected and qualified: Allan Hall DIRECTOR ELECTIONS ISSUER 94348.000000 0 FOR 94348.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 06/07/2024 To elect five directors, each to serve until the annual meeting next succeeding their relection and until their successor is elected and qualified: Kimberly Lefko DIRECTOR ELECTIONS ISSUER 94348.000000 0 FOR 94348.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 06/07/2024 To elect five directors, each to serve until the annual meeting next succeeding their relection and until their successor is elected and qualified: Sheryl O'Loughlin DIRECTOR ELECTIONS ISSUER 94348.000000 0 FOR 94348.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 06/07/2024 To elect five directors, each to serve until the annual meeting next succeeding their relection and until their successor is elected and qualified: Kenneth Walker DIRECTOR ELECTIONS ISSUER 94348.000000 0 FOR 94348.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 06/07/2024 To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 94348.000000 0 FOR 94348.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 06/07/2024 To approve, on an advisory, non-binding basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 94348.000000 0 FOR 94348.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 06/07/2024 To approve the PetIQ, Inc. 2024 Omnibus Incentive Plan. COMPENSATION ISSUER 94348.000000 0 FOR 94348.000000 FOR S000004450 2seventy Bio, Inc. 901384107 US9013841070 06/10/2024 Election of Class III Directors: Denice Torres DIRECTOR ELECTIONS ISSUER 157422.000000 0 FOR 157422.000000 FOR S000004450 2seventy Bio, Inc. 901384107 US9013841070 06/10/2024 Election of Class III Directors: Marcela Maus, MD, PhD DIRECTOR ELECTIONS ISSUER 157422.000000 0 FOR 157422.000000 FOR S000004450 2seventy Bio, Inc. 901384107 US9013841070 06/10/2024 Election of Class III Directors: Eli Casdin DIRECTOR ELECTIONS ISSUER 157422.000000 0 FOR 157422.000000 FOR S000004450 2seventy Bio, Inc. 901384107 US9013841070 06/10/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 157422.000000 0 FOR 157422.000000 FOR S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 Election of Directors: William K. Heiden DIRECTOR ELECTIONS ISSUER 176143.000000 100000.000000 FOR 176143.000000 FOR S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 Election of Directors: Ameet Mallik DIRECTOR ELECTIONS ISSUER 176143.000000 100000.000000 FOR 176143.000000 FOR S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 176143.000000 100000.000000 FOR 176143.000000 FOR S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 176143.000000 100000.000000 FOR 176143.000000 FOR S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 To approve the Company's 2024 Equity Incentive Plan. COMPENSATION ISSUER 176143.000000 100000.000000 FOR 176143.000000 FOR S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 To approve an automatic annual increase to the Company's 2024 Equity Incentive Plan. COMPENSATION ISSUER 176143.000000 100000.000000 AGAINST 176143.000000 AGAINST S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 To approve an increase in the number of shares of common stock available for issuance under the Company's 2014 Employee Stock Purchase Plan. COMPENSATION ISSUER 176143.000000 100000.000000 FOR 176143.000000 FOR S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 To approve an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-4 and 1-for-30, as determined by the Board of Directors in its discretion, subject to the Board of Directors' authority to abandon such amendments (the "Charter Amendment Proposal"). CAPITAL STRUCTURE ISSUER 176143.000000 100000.000000 FOR 176143.000000 FOR S000004450 Atara Biotherapeutics, Inc. 046513206 US0465132068 06/10/2024 To approve the adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Charter Amendment Proposal. CORPORATE GOVERNANCE ISSUER 176143.000000 100000.000000 FOR 176143.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2024 ELECTION OF DIRECTORS: Chelsea Clinton DIRECTOR ELECTIONS ISSUER 784136.000000 495000.000000 FOR 784136.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2024 ELECTION OF DIRECTORS: Carladenise Armbrister Edwards DIRECTOR ELECTIONS ISSUER 784136.000000 495000.000000 FOR 784136.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2024 ELECTION OF DIRECTORS: Vivek Garipalli DIRECTOR ELECTIONS ISSUER 784136.000000 495000.000000 FOR 784136.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2024 Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 784136.000000 495000.000000 FOR 784136.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2024 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 784136.000000 495000.000000 FOR 784136.000000 FOR S000004450 SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To elect two directors, Elizabeth Barrett and Geno Germano, each to serve as a Class I director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation, or removal: Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 182559.000000 0 WITHHOLD 182559.000000 AGAINST S000004450 SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To elect two directors, Elizabeth Barrett and Geno Germano, each to serve as a Class I director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation, or removal: Geno Germano DIRECTOR ELECTIONS ISSUER 182559.000000 0 FOR 182559.000000 FOR S000004450 SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 182559.000000 0 FOR 182559.000000 FOR S000004450 SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To hold a non-binding advisory vote to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 182559.000000 0 FOR 182559.000000 FOR S000004450 SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To approve the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 182559.000000 0 FOR 182559.000000 FOR S000004450 Terns Pharmaceuticals, Inc. 880881107 US8808811074 06/10/2024 Election of Class III Directors for a three-year term: Jeffrey Kindler DIRECTOR ELECTIONS ISSUER 105224.000000 0 FOR 105224.000000 FOR S000004450 Terns Pharmaceuticals, Inc. 880881107 US8808811074 06/10/2024 Election of Class III Directors for a three-year term: Amy Burroughs DIRECTOR ELECTIONS ISSUER 105224.000000 0 FOR 105224.000000 FOR S000004450 Terns Pharmaceuticals, Inc. 880881107 US8808811074 06/10/2024 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 105224.000000 0 FOR 105224.000000 FOR S000004450 10X Genomics, Inc. 88025U109 US88025U1097 06/11/2024 Election of Directors: Election of the one Class II director listed in the accompanying proxy statement, to serve a three-year term expiring at the 2027 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal; Kimberly J. Popovits DIRECTOR ELECTIONS ISSUER 301341.000000 0 FOR 301341.000000 FOR S000004450 10X Genomics, Inc. 88025U109 US88025U1097 06/11/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 301341.000000 0 FOR 301341.000000 FOR S000004450 10X Genomics, Inc. 88025U109 US88025U1097 06/11/2024 A vote to approve an amendment to our amended and restated bylaws such that the bylaws may be amended by our board of directors without requiring stockholder approval; CORPORATE GOVERNANCE ISSUER 301341.000000 0 AGAINST 301341.000000 AGAINST S000004450 10X Genomics, Inc. 88025U109 US88025U1097 06/11/2024 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 301341.000000 0 FOR 301341.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/11/2024 Election of Directors: Susan Hirsch DIRECTOR ELECTIONS ISSUER 52074.000000 0 FOR 52074.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/11/2024 To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan. COMPENSATION ISSUER 52074.000000 0 FOR 52074.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/11/2024 To approve an amendment to our Amended and Restated Directors' Deferred Compensation Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 38,750 shares to 63,750 shares. COMPENSATION ISSUER 52074.000000 0 FOR 52074.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/11/2024 To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 52074.000000 0 FOR 52074.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/11/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 52074.000000 0 FOR 52074.000000 FOR S000004450 Codexis, Inc. 192005106 US1920051067 06/11/2024 Election of the two Class II directors named in the Proxy Statement to hold office for a three-year term expiring at the 2027 Annual Meeting: Esther Martinborough, Ph.D. DIRECTOR ELECTIONS ISSUER 237270.000000 0 FOR 237270.000000 FOR S000004450 Codexis, Inc. 192005106 US1920051067 06/11/2024 Election of the two Class II directors named in the Proxy Statement to hold office for a three-year term expiring at the 2027 Annual Meeting: H. Stewart Parker DIRECTOR ELECTIONS ISSUER 237270.000000 0 FOR 237270.000000 FOR S000004450 Codexis, Inc. 192005106 US1920051067 06/11/2024 To ratify the selection by the Audit Committee of our board of directors of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 237270.000000 0 FOR 237270.000000 FOR S000004450 Codexis, Inc. 192005106 US1920051067 06/11/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 237270.000000 0 FOR 237270.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/11/2024 Election of six Class III directors to serve until the 2027 annual meeting of stockholders: John P. Bamforth DIRECTOR ELECTIONS ISSUER 229215.000000 0 FOR 229215.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/11/2024 Election of six Class III directors to serve until the 2027 annual meeting of stockholders: Emery N. Brown DIRECTOR ELECTIONS ISSUER 229215.000000 0 FOR 229215.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/11/2024 Election of six Class III directors to serve until the 2027 annual meeting of stockholders: Michael T. Constantino DIRECTOR ELECTIONS ISSUER 229215.000000 0 FOR 229215.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/11/2024 Election of six Class III directors to serve until the 2027 annual meeting of stockholders: Keith Anthony Jones DIRECTOR ELECTIONS ISSUER 229215.000000 0 FOR 229215.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/11/2024 Election of six Class III directors to serve until the 2027 annual meeting of stockholders: Laura E. Niklason DIRECTOR ELECTIONS ISSUER 229215.000000 0 FOR 229215.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/11/2024 Election of six Class III directors to serve until the 2027 annual meeting of stockholders: Susan Windham-Bannister DIRECTOR ELECTIONS ISSUER 229215.000000 0 FOR 229215.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/11/2024 Ratification of the selection of PricewaterhouseCoopers LLP by the Board of Directors as Humacyte, Inc.'s independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 229215.000000 0 FOR 229215.000000 FOR S000004450 IGM Biosciences, Inc. 449585108 US4495851085 06/11/2024 Election of Directors: M. Kathleen Behrens, Ph.D. DIRECTOR ELECTIONS ISSUER 367.000000 38887.000000 FOR 367.000000 FOR S000004450 IGM Biosciences, Inc. 449585108 US4495851085 06/11/2024 Election of Directors: Elizabeth H.Z. Thompson, Ph.D. DIRECTOR ELECTIONS ISSUER 367.000000 38887.000000 FOR 367.000000 FOR S000004450 IGM Biosciences, Inc. 449585108 US4495851085 06/11/2024 Election of Directors: Christina Teng Topsoe DIRECTOR ELECTIONS ISSUER 367.000000 38887.000000 FOR 367.000000 FOR S000004450 IGM Biosciences, Inc. 449585108 US4495851085 06/11/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 367.000000 38887.000000 FOR 367.000000 FOR S000004450 IGM Biosciences, Inc. 449585108 US4495851085 06/11/2024 Approval of an amendment to our amended and restated certificate of incorporation to limit the liability of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 367.000000 38887.000000 FOR 367.000000 FOR S000004450 IGM Biosciences, Inc. 449585108 US4495851085 06/11/2024 Approval of a stock option exchange program for employees (excluding our chief executive officer and non-employee directors). COMPENSATION ISSUER 367.000000 38887.000000 AGAINST 367.000000 AGAINST S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: Patrick Soon-Shiong, M.D. DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 FOR 24693.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 FOR 24693.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: Richard Adcock DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 FOR 24693.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: Michael D. Blaszyk DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 WITHHOLD 24693.000000 AGAINST S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: John Owen Brennan DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 FOR 24693.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: Wesley Clark DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 FOR 24693.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 WITHHOLD 24693.000000 AGAINST S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: Christobel Selecky DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 WITHHOLD 24693.000000 AGAINST S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 Election of Directors: Barry J. Simon, M.D. DIRECTOR ELECTIONS ISSUER 24693.000000 427400.000000 FOR 24693.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 To approve an amendment to the ImmunityBio, Inc. 2015 Equity Incentive Plan to increase the number of shares of the company's common stock authorized for issuance under the plan by 19,900,000 shares. COMPENSATION ISSUER 24693.000000 427400.000000 AGAINST 24693.000000 AGAINST S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 To approve, on an advisory (non-binding) basis, the compensation of our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 24693.000000 427400.000000 FOR 24693.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/11/2024 To ratify the selection of Ernst & Young LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 24693.000000 427400.000000 FOR 24693.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Iain Dukes, D. Phil. DIRECTOR ELECTIONS ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Athena Countouriotis, M.D. DIRECTOR ELECTIONS ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Ryan Maynard DIRECTOR ELECTIONS ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Wayne P. Rothbaum DIRECTOR ELECTIONS ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Frederick G. Vogt, Ph.D., J.D. DIRECTOR ELECTIONS ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Michael Weiser M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Wendy Yarno DIRECTOR ELECTIONS ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To approve, by non-binding advisory vote, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To approve an amendment to our 2018 Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder from 29,700,000 shares to 36,700,000 shares and permit share recapture from our 2014 Equity Incentive Plan; and COMPENSATION ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder from 1,400,000 shares to 1,900,000 shares. COMPENSATION ISSUER 652048.000000 0 FOR 652048.000000 FOR S000004450 iTeos Therapeutics, Inc. 46565G104 US46565G1040 06/11/2024 Election of the Class I director nominees to serve until the 2027 Annual Meeting of Stockholders: Jill M. DeSimone DIRECTOR ELECTIONS ISSUER 78779.000000 0 FOR 78779.000000 FOR S000004450 iTeos Therapeutics, Inc. 46565G104 US46565G1040 06/11/2024 Election of the Class I director nominees to serve until the 2027 Annual Meeting of Stockholders: David K. Lee DIRECTOR ELECTIONS ISSUER 78779.000000 0 FOR 78779.000000 FOR S000004450 iTeos Therapeutics, Inc. 46565G104 US46565G1040 06/11/2024 To ratify the appointment of Deloitte Bedrijfsrevisoren / Reviseurs d'Entreprises BV/SRL as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 78779.000000 0 FOR 78779.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: J. Christopher Barry DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: Francesco Bianchi DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: Stacy Enxing Seng DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: William Kozy DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: Vladimir Makatsaria DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: Dr. Sharon O'Kane DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: Todd Schermerhorn DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: Brooke Story DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: Election of Directors: Peter Wilver DIRECTOR ELECTIONS ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("US Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To approve Amendment No. 1 to the Amended and Restated LivaNova PLC 2022 Incentive Award Plan. COMPENSATION ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To approve Amendment No. 2 to the LivaNova PLC 2015 Incentive Award Plan. COMPENSATION ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act") to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of pounds10,830,212, provided that: (A) (unless previously revoked, varied or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or arrangements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or arrangement as if this authority had not expired; and (B) this authority replaces all subsisting authorities previously granted to the directors for the purposes of section 551 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered or agreed to be made under such authorities. CAPITAL STRUCTURE ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Special Resolution: Subject to the passing of resolution 6 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 6, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' pre-emption rights) did not apply to any such allotment or sale, provided that this power is limited to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of pounds10,830,212, provided that: (A) unless previously revoked, varied or renewed by the Company) this power will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this powers expires, make offers or agreements which would or might require equity securities to be allotted and/or treasury shares to be sold after its expiry and the directors may allot equity securities and/or sell treasury shares pursuant to such offers or agreement as if this power had not expired; and (B) this power replaces (except for any power conferred by resolution 6) all subsisting powers previously granted to the directors for the purposes of section 570 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect, without prejudice to any allotment of equity securities already made, offered or agreed to be made under such powers. CAPITAL STRUCTURE ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the period ended December 31, 2023. COMPENSATION ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2023, together with the reports of the directors and auditors thereon. CORPORATE GOVERNANCE ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2024. AUDIT-RELATED ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 LivaNova PLC G5509L101 GB00BYMT0J19 06/11/2024 Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. AUDIT-RELATED ISSUER 182716.000000 0 FOR 182716.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/11/2024 Election of Class III Directors: Will Brooke DIRECTOR ELECTIONS ISSUER 297298.000000 0 FOR 297298.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/11/2024 Election of Class III Directors: John Johnston DIRECTOR ELECTIONS ISSUER 297298.000000 0 FOR 297298.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/11/2024 Election of Class III Directors: Richard Douglas DIRECTOR ELECTIONS ISSUER 297298.000000 0 FOR 297298.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/11/2024 To approve an amendment to the MaxCyte, Inc. 2022 Equity Incentive Plan to increase the shares available for issuance. COMPENSATION ISSUER 297298.000000 0 FOR 297298.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/11/2024 To ratify the selection by the Audit Committee of the Board of Directors of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 297298.000000 0 FOR 297298.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/11/2024 Election of Directors: Todd J. Carter DIRECTOR ELECTIONS ISSUER 38424.000000 0 FOR 38424.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/11/2024 Election of Directors: David A. Coulter DIRECTOR ELECTIONS ISSUER 38424.000000 0 FOR 38424.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/11/2024 Election of Directors: Garth Graham DIRECTOR ELECTIONS ISSUER 38424.000000 0 FOR 38424.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/11/2024 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 38424.000000 0 FOR 38424.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/11/2024 Election of Directors: Rahul Samant DIRECTOR ELECTIONS ISSUER 38424.000000 0 FOR 38424.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/11/2024 Election of Directors: L. Heath Sampson DIRECTOR ELECTIONS ISSUER 38424.000000 0 FOR 38424.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/11/2024 A non-binding advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 38424.000000 0 FOR 38424.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/11/2024 To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company to serve for the 2024 fiscal year. AUDIT-RELATED ISSUER 38424.000000 0 FOR 38424.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/11/2024 Election of Directors: Laura Brege DIRECTOR ELECTIONS ISSUER 157400.000000 0 WITHHOLD 157400.000000 AGAINST S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/11/2024 Election of Directors: Mark Froimson DIRECTOR ELECTIONS ISSUER 157400.000000 0 FOR 157400.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/11/2024 Election of Directors: Mark Kronenfeld DIRECTOR ELECTIONS ISSUER 157400.000000 0 FOR 157400.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/11/2024 Election of Directors: Michael Yang DIRECTOR ELECTIONS ISSUER 157400.000000 0 FOR 157400.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/11/2024 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 157400.000000 0 FOR 157400.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/11/2024 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157400.000000 0 FOR 157400.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Jaymie A. Durnan DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Harold E. Ford, Jr. DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Evan A. Knisely DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Joseph W. Marshall, III DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Gary J. Nabel DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Julian Nemirovsky DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Diem Nguyen DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Holly L. Phillips DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 Election of Directors: Jay K. Varma DIRECTOR ELECTIONS ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/11/2024 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of SIGA Technologies, Inc. for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 144252.000000 0 FOR 144252.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 Election of Directors: Michael J. Finney, Ph.D. DIRECTOR ELECTIONS ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 Election of Directors: Elaine J. Heron, Ph.D. DIRECTOR ELECTIONS ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 Election of Directors: Steven Lo DIRECTOR ELECTIONS ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 Election of Directors: W. Mark Watson DIRECTOR ELECTIONS ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 Election of Directors: David Wheadon, M.D. DIRECTOR ELECTIONS ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 Election of Directors: Robert A. Yedid DIRECTOR ELECTIONS ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 To adopt an amendment to our Restated Certificate of Incorporation to increase the authorized number of shares of our common stock to 350,000,000 shares. CAPITAL STRUCTURE ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 To approve an amendment and restatement of cur 2019 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 15,000,000 shares to 43,200,000 shares. COMPENSATION ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 To approve an amendment and restatement of our 2022 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 1,800,000 shares to 3,600,000 shares. COMPENSATION ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 To ratify the selection by our Audit Committee of WithumSmith+Brown, PC as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Vaxart, Inc. 92243A200 US92243A2006 06/11/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 345215.000000 184900.000000 FOR 345215.000000 FOR S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 06/11/2024 Election of Directors: Michael Rossi DIRECTOR ELECTIONS ISSUER 118656.000000 0 FOR 118656.000000 FOR S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 06/11/2024 Election of Directors: Thomas Gad DIRECTOR ELECTIONS ISSUER 118656.000000 0 FOR 118656.000000 FOR S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 06/11/2024 Election of Directors: Johan Wedell-Wedellsborg DIRECTOR ELECTIONS ISSUER 118656.000000 0 FOR 118656.000000 FOR S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 06/11/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 118656.000000 0 FOR 118656.000000 FOR S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 06/11/2024 To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 118656.000000 0 FOR 118656.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/12/2024 Election of Directors: R. Dirk Allison DIRECTOR ELECTIONS ISSUER 55105.000000 0 FOR 55105.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/12/2024 Election of Directors: Mark L. First DIRECTOR ELECTIONS ISSUER 55105.000000 0 FOR 55105.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/12/2024 Election of Directors: Darin J. Gordon DIRECTOR ELECTIONS ISSUER 55105.000000 0 FOR 55105.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/12/2024 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 55105.000000 0 FOR 55105.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/12/2024 To approve, on an advisory, non-binding basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 55105.000000 0 FOR 55105.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/12/2024 ELECTION OF DIRECTORS: Louis J. Lavigne, Jr. DIRECTOR ELECTIONS ISSUER 224587.000000 0 FOR 224587.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/12/2024 ELECTION OF DIRECTORS: Richard H. Scheller, Ph.D. DIRECTOR ELECTIONS ISSUER 224587.000000 0 FOR 224587.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/12/2024 ELECTION OF DIRECTORS: Mark Altmeyer DIRECTOR ELECTIONS ISSUER 224587.000000 0 FOR 224587.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/12/2024 Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 224587.000000 0 FOR 224587.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/12/2024 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 224587.000000 0 FOR 224587.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; Evan Bakst DIRECTOR ELECTIONS ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; Mortimer Berkowitz III DIRECTOR ELECTIONS ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; Quentin Blackford DIRECTOR ELECTIONS ISSUER 324520.000000 0 WITHHOLD 324520.000000 AGAINST S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; David Demski DIRECTOR ELECTIONS ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; Patrick S. Miles DIRECTOR ELECTIONS ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; David R. Pelizzon DIRECTOR ELECTIONS ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; Jeffrey P. Rydin DIRECTOR ELECTIONS ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To elect nine persons to our Board of Directors; Ward W. Woods DIRECTOR ELECTIONS ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/12/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 324520.000000 0 FOR 324520.000000 FOR S000004450 ALX Oncology Holdings, Inc. 00166B105 US00166B1052 06/12/2024 Election of Directors: Corey Goodman, Ph.D. DIRECTOR ELECTIONS ISSUER 53740.000000 22600.000000 FOR 53740.000000 FOR S000004450 ALX Oncology Holdings, Inc. 00166B105 US00166B1052 06/12/2024 Election of Directors: Jason Lettmann DIRECTOR ELECTIONS ISSUER 53740.000000 22600.000000 FOR 53740.000000 FOR S000004450 ALX Oncology Holdings, Inc. 00166B105 US00166B1052 06/12/2024 Election of Directors: Sophia Randolph, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 53740.000000 22600.000000 FOR 53740.000000 FOR S000004450 ALX Oncology Holdings, Inc. 00166B105 US00166B1052 06/12/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 53740.000000 22600.000000 FOR 53740.000000 FOR S000004450 ALX Oncology Holdings, Inc. 00166B105 US00166B1052 06/12/2024 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 53740.000000 22600.000000 FOR 53740.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/12/2024 To elect three Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Daniel Faga DIRECTOR ELECTIONS ISSUER 36361.000000 0 FOR 36361.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/12/2024 To elect three Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Dennis Fenton, Ph.D. DIRECTOR ELECTIONS ISSUER 36361.000000 0 FOR 36361.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/12/2024 To elect three Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Oleg Nodelman DIRECTOR ELECTIONS ISSUER 36361.000000 0 FOR 36361.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/12/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 36361.000000 0 FOR 36361.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/12/2024 To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 36361.000000 0 FOR 36361.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/12/2024 To approve the amendment and restatement of our 2017 Equity Incentive Plan. COMPENSATION ISSUER 36361.000000 0 FOR 36361.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: Kenneth Sim, M.D. DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: Thomas S. Lam, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: Mitchell W. Kitayama DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: David G. Schmidt DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: Linda Marsh DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: John Chiang DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: Matthew Mazdyasni DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: J. Lorraine Estradas, R.N., B.S.N., M.P.H. DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To elect nine directors to the Board of Directors, each to hold office until the 2025 annual meeting of stockholders of the Company: Weili Dai DIRECTOR ELECTIONS ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To approve the Company's 2024 Equity Incentive Plan. COMPENSATION ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/12/2024 To approve an amendment to the Company's Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 158481.000000 0 FOR 158481.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2024 Election of Directors: Nancy J. Hutson, Ph.D. DIRECTOR ELECTIONS ISSUER 627622.000000 0 FOR 627622.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2024 Election of Directors: Vincent J. Milano DIRECTOR ELECTIONS ISSUER 627622.000000 0 FOR 627622.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2024 Election of Directors: A. Machelle Sanders DIRECTOR ELECTIONS ISSUER 627622.000000 0 FOR 627622.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2024 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accountants for 2024. AUDIT-RELATED ISSUER 627622.000000 0 FOR 627622.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2024 To approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 627622.000000 0 FOR 627622.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2024 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan by 7,000,000 shares. COMPENSATION ISSUER 627622.000000 0 FOR 627622.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/12/2024 The election of Thomas Butler and Michael J. M. Hitchcock, Ph.D., as Class III Directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2027: Thomas Butler DIRECTOR ELECTIONS ISSUER 40095.000000 37900.000000 FOR 40095.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/12/2024 The election of Thomas Butler and Michael J. M. Hitchcock, Ph.D., as Class III Directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2027: J.M. Hitchcock, Ph.D. DIRECTOR ELECTIONS ISSUER 40095.000000 37900.000000 FOR 40095.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/12/2024 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 40095.000000 37900.000000 FOR 40095.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Election of Directors: Daniella Beckman DIRECTOR ELECTIONS ISSUER 196044.000000 0 FOR 196044.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Election of Directors: Habib Dable DIRECTOR ELECTIONS ISSUER 196044.000000 0 FOR 196044.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Election of Directors: Lynn Seely DIRECTOR ELECTIONS ISSUER 196044.000000 0 FOR 196044.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Approval of a non-binding advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 196044.000000 0 ONE YEAR 196044.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Approval of a non-binding advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 196044.000000 0 FOR 196044.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Approval of the Blueprint Medicines Corporation 2024 Stock Incentive Plan. COMPENSATION ISSUER 196044.000000 0 FOR 196044.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 196044.000000 0 FOR 196044.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/12/2024 ELECTION OF DIRECTORS: Mona Ashiya DIRECTOR ELECTIONS ISSUER 40997.000000 0 FOR 40997.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/12/2024 ELECTION OF DIRECTORS: Kevin Bitterman DIRECTOR ELECTIONS ISSUER 40997.000000 0 FOR 40997.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/12/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 40997.000000 0 FOR 40997.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Election of Class III Directors: Helmy Eltoukhy DIRECTOR ELECTIONS ISSUER 392463.000000 0 FOR 392463.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Election of Class III Directors: Steve Krognes DIRECTOR ELECTIONS ISSUER 392463.000000 0 FOR 392463.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Election of Class III Directors: AmirAli Talasaz DIRECTOR ELECTIONS ISSUER 392463.000000 0 FOR 392463.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 392463.000000 0 FOR 392463.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 392463.000000 0 FOR 392463.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Julian C. Baker DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Katherine A. High DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Herve Hoppenot DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Susanne Schaffert DIRECTOR ELECTIONS ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/12/2024 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 646813.000000 0 FOR 646813.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/12/2024 Election of Directors. Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2027: Fred Cohen, M.D., D.Phil. DIRECTOR ELECTIONS ISSUER 289863.000000 0 FOR 289863.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/12/2024 Election of Directors. Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2027: Frank Verwiel, M.D. DIRECTOR ELECTIONS ISSUER 289863.000000 0 FOR 289863.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/12/2024 Ratification of the appointment of Deloitte & Touche LLP as Intellia's independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 289863.000000 0 FOR 289863.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/12/2024 Approve, on a non-binding advisory basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 289863.000000 0 FOR 289863.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/12/2024 Approval of a second amendment to our Second Amended and Restated Certificate of Incorporation, as amended, to limit the liability of certain officers of the Company as permitted by recent amendments to the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 289863.000000 0 FOR 289863.000000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/12/2024 To elect two Class III director nominees to our board of directors, to serve until the Company's 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Markus Warmuth DIRECTOR ELECTIONS ISSUER 119432.000000 0 FOR 119432.000000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/12/2024 To elect two Class III director nominees to our board of directors, to serve until the Company's 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Ali Behbahani DIRECTOR ELECTIONS ISSUER 119432.000000 0 WITHHOLD 119432.000000 AGAINST S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/12/2024 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 and AUDIT-RELATED ISSUER 119432.000000 0 FOR 119432.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2024 To elect the three directors named below and in the proxy statement to serve as Class III directors until the annual meeting of stockholders to be held in 2027 and until their successors are duly elected and qualified: Roelof Botha DIRECTOR ELECTIONS ISSUER 387579.000000 0 FOR 387579.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2024 To elect the three directors named below and in the proxy statement to serve as Class III directors until the annual meeting of stockholders to be held in 2027 and until their successors are duly elected and qualified: Steven Chapman DIRECTOR ELECTIONS ISSUER 387579.000000 0 FOR 387579.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2024 To elect the three directors named below and in the proxy statement to serve as Class III directors until the annual meeting of stockholders to be held in 2027 and until their successors are duly elected and qualified: Matthew Rabinowitz DIRECTOR ELECTIONS ISSUER 387579.000000 0 FOR 387579.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2024 To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 387579.000000 0 FOR 387579.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2024 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 387579.000000 0 FOR 387579.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2024 To approve Natera, Inc.'s amended and restated 2015 Equity Incentive Plan. COMPENSATION ISSUER 387579.000000 0 FOR 387579.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/12/2024 Election of the following nominees as Class III directors: Emily Drabant Conley, Ph.D. DIRECTOR ELECTIONS ISSUER 87564.000000 0 FOR 87564.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/12/2024 Election of the following nominees as Class III directors: Sapna Srivastava, Ph.D. DIRECTOR ELECTIONS ISSUER 87564.000000 0 FOR 87564.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/12/2024 Election of the following nominees as Class III directors: Cameron Wheeler, Ph.D. DIRECTOR ELECTIONS ISSUER 87564.000000 0 FOR 87564.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/12/2024 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 87564.000000 0 FOR 87564.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/12/2024 To approve, on an advisory basis, the frequency of future advisory votes to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 87564.000000 0 ONE YEAR 87564.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/12/2024 To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 87564.000000 0 FOR 87564.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Wendy Chung, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 143048.000000 0 FOR 143048.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Kaye Foster DIRECTOR ELECTIONS ISSUER 143048.000000 0 FOR 143048.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Keith Gottesdiener, M.D. DIRECTOR ELECTIONS ISSUER 143048.000000 0 FOR 143048.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Jeffrey Marrazzo DIRECTOR ELECTIONS ISSUER 143048.000000 0 FOR 143048.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To approve an amendment to our Third Amended and Restated Certificate of Incorporation to limit the liability of certain of our officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 143048.000000 0 FOR 143048.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our Independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 143048.000000 0 FOR 143048.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified: Howard G. Berger, M.D. DIRECTOR ELECTIONS ISSUER 196118.000000 0 FOR 196118.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified: Christine N. Gordon DIRECTOR ELECTIONS ISSUER 196118.000000 0 FOR 196118.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified: A. Gregory Sorensen, M.D. DIRECTOR ELECTIONS ISSUER 196118.000000 0 FOR 196118.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified: Laura P. Jacobs DIRECTOR ELECTIONS ISSUER 196118.000000 0 WITHHOLD 196118.000000 AGAINST S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified: Lawrence L. Levitt DIRECTOR ELECTIONS ISSUER 196118.000000 0 FOR 196118.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified: Gregory E. Spurlock DIRECTOR ELECTIONS ISSUER 196118.000000 0 FOR 196118.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified: David L. Swartz DIRECTOR ELECTIONS ISSUER 196118.000000 0 FOR 196118.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 196118.000000 0 FOR 196118.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/12/2024 A non-binding advisory vote to approve the compensation of our Named Executive Officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 196118.000000 0 FOR 196118.000000 FOR S000004450 Seer, Inc. 81578P106 US81578P1066 06/12/2024 Election of Directors: Omid Farokhzad, M.D. DIRECTOR ELECTIONS ISSUER 152202.000000 0 FOR 152202.000000 FOR S000004450 Seer, Inc. 81578P106 US81578P1066 06/12/2024 Election of Directors: Meeta Gulyani DIRECTOR ELECTIONS ISSUER 152202.000000 0 FOR 152202.000000 FOR S000004450 Seer, Inc. 81578P106 US81578P1066 06/12/2024 Election of Directors: David Hallal DIRECTOR ELECTIONS ISSUER 152202.000000 0 FOR 152202.000000 FOR S000004450 Seer, Inc. 81578P106 US81578P1066 06/12/2024 Election of Directors: Terrance McGuire DIRECTOR ELECTIONS ISSUER 152202.000000 0 FOR 152202.000000 FOR S000004450 Seer, Inc. 81578P106 US81578P1066 06/12/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 152202.000000 0 FOR 152202.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Tim Cabral DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Mark Carges DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Peter P. Gassner DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Priscilla Hung DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Tina Hunt DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Marshall Mohr DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Gordon Ritter DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Paul Sekhri DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To elect the following to serve as directors until the annual meeting to be held in 2025 or until their successors are duly elected and qualified: Matthew J. Wallach DIRECTOR ELECTIONS ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2025. AUDIT-RELATED ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To approve an amendment and restatement of our Certificate of Incorporation to reflect the Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/12/2024 To hold an advisory (non-binding) vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 519712.000000 0 FOR 519712.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/12/2024 The election of two directors to serve until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji DIRECTOR ELECTIONS ISSUER 248324.000000 0 FOR 248324.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/12/2024 The election of two directors to serve until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc Stapley DIRECTOR ELECTIONS ISSUER 248324.000000 0 FOR 248324.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/12/2024 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 248324.000000 0 FOR 248324.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/12/2024 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 248324.000000 0 FOR 248324.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/12/2024 The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 248324.000000 0 FOR 248324.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/13/2024 To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Carsten Boess DIRECTOR ELECTIONS ISSUER 242429.000000 0 FOR 242429.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/13/2024 To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Sarah Boyce DIRECTOR ELECTIONS ISSUER 242429.000000 0 FOR 242429.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/13/2024 To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Dr. Troy Wilson DIRECTOR ELECTIONS ISSUER 242429.000000 0 WITHHOLD 242429.000000 AGAINST S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/13/2024 To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 242429.000000 0 FOR 242429.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/13/2024 To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in the related proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and SECTION 14A SAY-ON-PAY VOTES ISSUER 242429.000000 0 FOR 242429.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/13/2024 Election of Directors: George W. Bickerstaff III DIRECTOR ELECTIONS ISSUER 183538.000000 0 FOR 183538.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/13/2024 Election of Directors: Christine M. Cournoyer DIRECTOR ELECTIONS ISSUER 183538.000000 0 FOR 183538.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/13/2024 Election of Directors: Hannah Valantine, M.D. DIRECTOR ELECTIONS ISSUER 183538.000000 0 FOR 183538.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/13/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 183538.000000 0 FOR 183538.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/13/2024 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 183538.000000 0 FOR 183538.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/13/2024 Approval of 2024 Equity Incentive Plan. COMPENSATION ISSUER 183538.000000 0 FOR 183538.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: Karen L. Shoos DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: James J. Marino DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: Garry Neil, M.D. DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 Election of Directors: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of shares reserved for issuance thereunder by 3,200,000 shares to 7,500,000 shares. COMPENSATION ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/13/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 196855.000000 0 FOR 196855.000000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/13/2024 Election of Director: Gina Chapman DIRECTOR ELECTIONS ISSUER 38541.000000 0 FOR 38541.000000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/13/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 38541.000000 0 FOR 38541.000000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/13/2024 Approval of an amendment to the Company's Fourth Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 38541.000000 0 FOR 38541.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Michael Barber DIRECTOR ELECTIONS ISSUER 614113.000000 0 FOR 614113.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Paul Clancy DIRECTOR ELECTIONS ISSUER 614113.000000 0 FOR 614113.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Daniel Levangie DIRECTOR ELECTIONS ISSUER 614113.000000 0 FOR 614113.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 614113.000000 0 FOR 614113.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 614113.000000 0 FOR 614113.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 06/13/2024 Election of three Class II Directors for a term of three years until the 2027 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Daniel Burton DIRECTOR ELECTIONS ISSUER 192001.000000 0 FOR 192001.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 06/13/2024 Election of three Class II Directors for a term of three years until the 2027 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: John A. Kane DIRECTOR ELECTIONS ISSUER 192001.000000 0 FOR 192001.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 06/13/2024 Election of three Class II Directors for a term of three years until the 2027 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Julie Larson-Green DIRECTOR ELECTIONS ISSUER 192001.000000 0 FOR 192001.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 06/13/2024 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of Health Catalyst, Inc. for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 192001.000000 0 FOR 192001.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 06/13/2024 To approve, on an advisory, non-binding basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 192001.000000 0 FOR 192001.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Craig Collard DIRECTOR ELECTIONS ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sharmila Dissanaike, M.D., FACS, FCCM DIRECTOR ELECTIONS ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Craig Johnson DIRECTOR ELECTIONS ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Adam Morgan DIRECTOR ELECTIONS ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Susan Rodriguez DIRECTOR ELECTIONS ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Christian Waage DIRECTOR ELECTIONS ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To amend the Company's Certificate of Incorporation to increase the aggregate number of authorized shares of common stock by 175,000,000 from 225,000,000 to 400,000,000. CAPITAL STRUCTURE ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To amend the 2007 Plan to increase the number of shares of common stock authorized for issuance thereunder by 7,500,000 from 39,190,000 to 46,690,000. COMPENSATION ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/13/2024 To amend the ESPP to increase the number of shares of common stock authorized for issuance thereunder by 1,200,000 from 2,225,000 to 3,425,000. COMPENSATION ISSUER 358074.000000 0 FOR 358074.000000 FOR S000004450 Nautilus Biotechnology, Inc. 63909J108 US63909J1088 06/13/2024 Election of Class III Directors: Melissa Epperly DIRECTOR ELECTIONS ISSUER 126355.000000 0 FOR 126355.000000 FOR S000004450 Nautilus Biotechnology, Inc. 63909J108 US63909J1088 06/13/2024 Election of Class III Directors: Matthew L. Posard DIRECTOR ELECTIONS ISSUER 126355.000000 0 FOR 126355.000000 FOR S000004450 Nautilus Biotechnology, Inc. 63909J108 US63909J1088 06/13/2024 Election of Class III Directors: Karen Akinsanya DIRECTOR ELECTIONS ISSUER 126355.000000 0 FOR 126355.000000 FOR S000004450 Nautilus Biotechnology, Inc. 63909J108 US63909J1088 06/13/2024 Ratification of the appointment of PricewaterhouseCoopers, LLP as our independent registered public accounting firm for the year ended December 31, 2024. AUDIT-RELATED ISSUER 126355.000000 0 FOR 126355.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/13/2024 Election of Class II directors to serve on the Board of Directors, each for a three-year term expiring at the 2027 Annual Meeting of Stockholders: Richard H. Douglas, Ph.D. DIRECTOR ELECTIONS ISSUER 57373.000000 305900.000000 FOR 57373.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/13/2024 Election of Class II directors to serve on the Board of Directors, each for a three-year term expiring at the 2027 Annual Meeting of Stockholders: Margaret G. McGlynn, R.Ph. DIRECTOR ELECTIONS ISSUER 57373.000000 305900.000000 FOR 57373.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/13/2024 Election of Class II directors to serve on the Board of Directors, each for a three-year term expiring at the 2027 Annual Meeting of Stockholders: David Mott DIRECTOR ELECTIONS ISSUER 57373.000000 305900.000000 FOR 57373.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/13/2024 The approval, on an advisory basis, of the compensation paid to our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 57373.000000 305900.000000 FOR 57373.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/13/2024 Amendment and Restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 6,500,000 shares. COMPENSATION ISSUER 57373.000000 305900.000000 FOR 57373.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/13/2024 Amendment and restatement of the Novavax, Inc. Amended and Restated 2013 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,000,000 shares, such that the number of shares available for issuance thereunder is the lesser of (a) 2,155,000 shares of common stock increased on January 1 of each year by 5% of the share pool on such January 1 (rounded down to the nearest whole share) and (b) 3,510,264 shares of common stock. COMPENSATION ISSUER 57373.000000 305900.000000 FOR 57373.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/13/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 57373.000000 305900.000000 FOR 57373.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/13/2024 To elect three class III directors named in the proxy statement to our Board of Directors: Hoyoung Huh, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 151847.000000 0 FOR 151847.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/13/2024 To elect three class III directors named in the proxy statement to our Board of Directors: Darren Cline, MBA DIRECTOR ELECTIONS ISSUER 151847.000000 0 FOR 151847.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/13/2024 To elect three class III directors named in the proxy statement to our Board of Directors: David Pyott, MA, MBA DIRECTOR ELECTIONS ISSUER 151847.000000 0 FOR 151847.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/13/2024 To approve, by non-binding advisory vote, the resolution approving named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 151847.000000 0 FOR 151847.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/13/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 151847.000000 0 FOR 151847.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Elisabeth Bjork, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Carsten Boess DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Pedro Granadillo DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Gotham Makker, M.D. DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: David P. Southwell DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: R. Keith Woods DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Naveen Yalamanchi, M.D. DIRECTOR ELECTIONS ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock. CAPITAL STRUCTURE ISSUER 214402.000000 0 FOR 214402.000000 FOR S000004450 Sharecare, Inc. 81948W104 US81948W1045 06/13/2024 Elect the three Class III nominees named in the accompanying Proxy Statement as Class III directors for a term expiring at the 2027 Annual Meeting of Stockholders: Jeff Arnold DIRECTOR ELECTIONS ISSUER 1037149.000000 0 FOR 1037149.000000 FOR S000004450 Sharecare, Inc. 81948W104 US81948W1045 06/13/2024 Elect the three Class III nominees named in the accompanying Proxy Statement as Class III directors for a term expiring at the 2027 Annual Meeting of Stockholders: John Chadwick DIRECTOR ELECTIONS ISSUER 1037149.000000 0 FOR 1037149.000000 FOR S000004450 Sharecare, Inc. 81948W104 US81948W1045 06/13/2024 Elect the three Class III nominees named in the accompanying Proxy Statement as Class III directors for a term expiring at the 2027 Annual Meeting of Stockholders: Rajeev Ronanki DIRECTOR ELECTIONS ISSUER 1037149.000000 0 FOR 1037149.000000 FOR S000004450 Sharecare, Inc. 81948W104 US81948W1045 06/13/2024 To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation to effect a reverse stock split of all of the outstanding shares of our common stock at a ratio in the range of 1-for-5 to 1-for-20, with the final decision of whether to proceed with the reverse stock split and the exact ratio and timing of the reverse split to be determined by our Board of Directors, in its discretion, following stockholder approval (if obtained), but no later than the first anniversary of the Annual Meeting, and a reduction in the authorized shares of our common stock. CAPITAL STRUCTURE ISSUER 1037149.000000 0 FOR 1037149.000000 FOR S000004450 Sharecare, Inc. 81948W104 US81948W1045 06/13/2024 Ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 1037149.000000 0 FOR 1037149.000000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/13/2024 To re-elect the following two nominees as Class I directors, to serve until the 2027 annual meeting of stockholders or until their respective successor have been elected or appointed: Bhaskar Chaudhuri DIRECTOR ELECTIONS ISSUER 73172.000000 0 FOR 73172.000000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/13/2024 To re-elect the following two nominees as Class I directors, to serve until the 2027 annual meeting of stockholders or until their respective successor have been elected or appointed: William J. Link DIRECTOR ELECTIONS ISSUER 73172.000000 0 FOR 73172.000000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/13/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 73172.000000 0 FOR 73172.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Bassil I. Dahiyat DIRECTOR ELECTIONS ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Ellen G. Feigal DIRECTOR ELECTIONS ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Kurt A. Gustafson DIRECTOR ELECTIONS ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Barbara Klencke DIRECTOR ELECTIONS ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. A. Bruce Montgomery DIRECTOR ELECTIONS ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Richard J. Ranieri DIRECTOR ELECTIONS ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Ms. Dagmar Rosa-Bjorkeson DIRECTOR ELECTIONS ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To ratify the selection by the Audit Committee of the Board of Directors of RSM US LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/13/2024 To approve, by non-binding advisory vote, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement; and SECTION 14A SAY-ON-PAY VOTES ISSUER 187029.000000 0 FOR 187029.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell DIRECTOR ELECTIONS ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne DIRECTOR ELECTIONS ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Andy Sassine DIRECTOR ELECTIONS ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow DIRECTOR ELECTIONS ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes DIRECTOR ELECTIONS ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet DIRECTOR ELECTIONS ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz DIRECTOR ELECTIONS ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels DIRECTOR ELECTIONS ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 To approve an amendment to the Amended and Restated 2019 Omnibus Equity Incentive Plan (as amended, the "Plan") to, among other things, increase the maximum number of shares of common stock available to Plan participants thereunder by 2,000,000 shares to an aggregate of 10,750,000 shares, as provided in Proposal Number 2 of the Proxy Statement. COMPENSATION ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 3 of the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/14/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 81061.000000 0 FOR 81061.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/14/2024 To elect two Class I directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Onaiza Cadoret-Manier DIRECTOR ELECTIONS ISSUER 789311.000000 0 FOR 789311.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/14/2024 To elect two Class I directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: William A. Bertrand, Jr., Esq. DIRECTOR ELECTIONS ISSUER 789311.000000 0 FOR 789311.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/14/2024 To approve the Amended and Restated 2014 Equity Incentive Award Plan; COMPENSATION ISSUER 789311.000000 0 FOR 789311.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/14/2024 To approve the Amended and Restated 2014 Employee Stock Purchase Plan; COMPENSATION ISSUER 789311.000000 0 FOR 789311.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/14/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); SECTION 14A SAY-ON-PAY VOTES ISSUER 789311.000000 0 FOR 789311.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/14/2024 To ratify the selection, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 789311.000000 0 FOR 789311.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: Peter Greenleaf DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: Dr. David R. W. Jayne DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: Dr. Daniel G. Billen DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: R. Hector MacKay-Dunn DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: Jill Leversage DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: Dr. Brinda Balakrishnan DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: Dr. Karen Smith DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: Jeffrey A. Bailey DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Election of Directors: Dr. Robert T. Foster DIRECTOR ELECTIONS ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Appointment of Auditors Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the 2025 annual general meeting of shareholders or until a successor its appointed. AUDIT-RELATED ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Amendment to Equity Incentive Plan To approve the amendment to the Company's Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company's Proxy Statement/Circular. COMPENSATION ISSUER 462317.000000 0 FOR 462317.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/14/2024 Election of Directors: Mark L. Baum DIRECTOR ELECTIONS ISSUER 101551.000000 0 FOR 101551.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/14/2024 Election of Directors: Adrienne L. Graves DIRECTOR ELECTIONS ISSUER 101551.000000 0 FOR 101551.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/14/2024 Election of Directors: Martin A. Makary DIRECTOR ELECTIONS ISSUER 101551.000000 0 FOR 101551.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/14/2024 Election of Directors: Lauren P. Silvernail DIRECTOR ELECTIONS ISSUER 101551.000000 0 FOR 101551.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/14/2024 Election of Directors: Perry J. Sternberg DIRECTOR ELECTIONS ISSUER 101551.000000 0 FOR 101551.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/14/2024 Ratification of the selection of KMJ Corbin & Company LLP, or its successor, as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 101551.000000 0 FOR 101551.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/14/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 101551.000000 0 FOR 101551.000000 FOR S000004450 Intra-Cellular Therapies, Inc. 46116X101 US46116X1019 06/14/2024 To elect one director to serve a three-year term expiring in 2027: Joel S. Marcus DIRECTOR ELECTIONS ISSUER 293550.000000 0 WITHHOLD 293550.000000 AGAINST S000004450 Intra-Cellular Therapies, Inc. 46116X101 US46116X1019 06/14/2024 To approve the amendment and restatement of the Company's Amended and Restated 2018 Equity Incentive Plan. COMPENSATION ISSUER 293550.000000 0 FOR 293550.000000 FOR S000004450 Intra-Cellular Therapies, Inc. 46116X101 US46116X1019 06/14/2024 To ratify of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 293550.000000 0 FOR 293550.000000 FOR S000004450 Intra-Cellular Therapies, Inc. 46116X101 US46116X1019 06/14/2024 To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 293550.000000 0 FOR 293550.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Election of Directors: Jason M. Aryeh DIRECTOR ELECTIONS ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Election of Directors: Todd C. Davis DIRECTOR ELECTIONS ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Election of Directors: Nancy R. Gray, Ph.D. DIRECTOR ELECTIONS ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Election of Directors: Jason Haas DIRECTOR ELECTIONS ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Election of Directors: John W. Kozarich, Ph.D. DIRECTOR ELECTIONS ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Election of Directors: John L. LaMattina, Ph.D. DIRECTOR ELECTIONS ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Election of Directors: Stephen L. Sabba, M.D.. DIRECTOR ELECTIONS ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Election of Directors: Martine Zimmermann, Pharm.D. DIRECTOR ELECTIONS ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm AUDIT-RELATED ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Approval, on an advisory basis, of the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/14/2024 Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan COMPENSATION ISSUER 56367.000000 0 FOR 56367.000000 FOR S000004450 Lyell Immunopharma, Inc. 55083R104 US55083R1041 06/14/2024 Election of Class III Directors: Elizabeth Nabel, M.D. DIRECTOR ELECTIONS ISSUER 423768.000000 0 FOR 423768.000000 FOR S000004450 Lyell Immunopharma, Inc. 55083R104 US55083R1041 06/14/2024 Election of Class III Directors: Lynn Seely, M.D. DIRECTOR ELECTIONS ISSUER 423768.000000 0 FOR 423768.000000 FOR S000004450 Lyell Immunopharma, Inc. 55083R104 US55083R1041 06/14/2024 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 423768.000000 0 FOR 423768.000000 FOR S000004450 Lyell Immunopharma, Inc. 55083R104 US55083R1041 06/14/2024 Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 423768.000000 0 AGAINST 423768.000000 AGAINST S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: N. Anthony Coles, M.D. DIRECTOR ELECTIONS ISSUER 363710.000000 0 FOR 363710.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: Kathryn Guarini, Ph.D. DIRECTOR ELECTIONS ISSUER 363710.000000 0 FOR 363710.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: Arthur F. Ryan DIRECTOR ELECTIONS ISSUER 363710.000000 0 FOR 363710.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 363710.000000 0 FOR 363710.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: George L. Sing DIRECTOR ELECTIONS ISSUER 363710.000000 0 FOR 363710.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 363710.000000 0 FOR 363710.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Proposal to approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 363710.000000 0 FOR 363710.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Non-binding shareholder proposal requesting simple majority voting requirements, if properly presented. CORPORATE GOVERNANCE SECURITY HOLDER 363710.000000 0 FOR 363710.000000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Mahkam Zanganeh DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Kenneth A. Clark DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Robert Booth DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Ujwala Mahatme DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Alessandra Cesano DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 WITHHOLD 4874.000000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Yu Xia DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 ELECTION OF DIRECTORS: Mostafa Ronaghi DIRECTOR ELECTIONS ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 4874.000000 467700.000000 FOR 4874.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/14/2024 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4874.000000 467700.000000 AGAINST 4874.000000 AGAINST S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/14/2024 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Georges Gemayel, Ph.D. DIRECTOR ELECTIONS ISSUER 186177.000000 0 FOR 186177.000000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/14/2024 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Bethany L. Sensenig DIRECTOR ELECTIONS ISSUER 186177.000000 0 FOR 186177.000000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/14/2024 to approve, on a non-binding basis, the compensation paid to our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 186177.000000 0 FOR 186177.000000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/14/2024 to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 186177.000000 0 FOR 186177.000000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/14/2024 to consider and act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan and make certain technical updates; and COMPENSATION ISSUER 186177.000000 0 FOR 186177.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 Election of Directors: Laurence Charney DIRECTOR ELECTIONS ISSUER 489458.000000 0 FOR 489458.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 Election of Directors: Yann Echelard DIRECTOR ELECTIONS ISSUER 489458.000000 0 WITHHOLD 489458.000000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 Election of Directors: Kenneth Hoberman DIRECTOR ELECTIONS ISSUER 489458.000000 0 FOR 489458.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 Election of Directors: Daniel Hume DIRECTOR ELECTIONS ISSUER 489458.000000 0 WITHHOLD 489458.000000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 Election of Directors: Sagar Lonial, MD DIRECTOR ELECTIONS ISSUER 489458.000000 0 WITHHOLD 489458.000000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 Election of Directors: Michael S. Weiss DIRECTOR ELECTIONS ISSUER 489458.000000 0 FOR 489458.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 489458.000000 0 FOR 489458.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 489458.000000 0 FOR 489458.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock from 175,000,000 to 190,000,000. CAPITAL STRUCTURE ISSUER 489458.000000 0 FOR 489458.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 To approve amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit. COMPENSATION ISSUER 489458.000000 0 FOR 489458.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 06/17/2024 Elect six directors to serve until the 2025 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. DIRECTOR ELECTIONS ISSUER 194560.000000 0 FOR 194560.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 06/17/2024 Elect six directors to serve until the 2025 Annual Meeting of Stockholders: Jules Haimovitz DIRECTOR ELECTIONS ISSUER 194560.000000 0 FOR 194560.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 06/17/2024 Elect six directors to serve until the 2025 Annual Meeting of Stockholders: Odysseas D. Kostas, M.D. DIRECTOR ELECTIONS ISSUER 194560.000000 0 FOR 194560.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 06/17/2024 Elect six directors to serve until the 2025 Annual Meeting of Stockholders: Sarah J. Schlesinger, M.D. DIRECTOR ELECTIONS ISSUER 194560.000000 0 FOR 194560.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 06/17/2024 Elect six directors to serve until the 2025 Annual Meeting of Stockholders: Sapna Srivastava, Ph.D. DIRECTOR ELECTIONS ISSUER 194560.000000 0 FOR 194560.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 06/17/2024 Elect six directors to serve until the 2025 Annual Meeting of Stockholders: Derek A. Small DIRECTOR ELECTIONS ISSUER 194560.000000 0 FOR 194560.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 06/17/2024 Approval of a non-binding advisory resolution regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 194560.000000 0 FOR 194560.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 06/17/2024 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 194560.000000 0 FOR 194560.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2024 To elect the two nominees of our board of directors, Susan M. Molineaux, Ph.D. and Ann D. Rhoads, to our board of directors as Class I directors, each to hold office until our Annual Meeting of Shareholders in 2027 and until such director's successor has been duly elected, or if sooner, until the director's death, resignation or removal: Susan M. Molineaux, Ph.D. DIRECTOR ELECTIONS ISSUER 615.000000 55100.000000 FOR 615.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2024 To elect the two nominees of our board of directors, Susan M. Molineaux, Ph.D. and Ann D. Rhoads, to our board of directors as Class I directors, each to hold office until our Annual Meeting of Shareholders in 2027 and until such director's successor has been duly elected, or if sooner, until the director's death, resignation or removal: Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 615.000000 55100.000000 FOR 615.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2024 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 615.000000 55100.000000 FOR 615.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2024 To appoint Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024, and to authorize our board of directors to fix Ernst & Young LLP's remuneration. AUDIT-RELATED ISSUER 615.000000 55100.000000 FOR 615.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/17/2024 To elect the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Stephen Mahoney DIRECTOR ELECTIONS ISSUER 141479.000000 0 FOR 141479.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/17/2024 To elect the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Arlene M. Morris DIRECTOR ELECTIONS ISSUER 141479.000000 0 FOR 141479.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/17/2024 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 141479.000000 0 FOR 141479.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/17/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 141479.000000 0 FOR 141479.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/17/2024 To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including to increase the number of shares available for issuance thereunder. COMPENSATION ISSUER 141479.000000 0 FOR 141479.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/18/2024 To elect three Class I directors to serve until the 2027 annual meeting of stockholders: Mr. Derek Ross DIRECTOR ELECTIONS ISSUER 810149.000000 0 FOR 810149.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/18/2024 To elect three Class I directors to serve until the 2027 annual meeting of stockholders: Ms. Deborah Jackson DIRECTOR ELECTIONS ISSUER 810149.000000 0 FOR 810149.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/18/2024 To elect three Class I directors to serve until the 2027 annual meeting of stockholders: Mr. Rob Webb DIRECTOR ELECTIONS ISSUER 810149.000000 0 FOR 810149.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/18/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 810149.000000 0 FOR 810149.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/18/2024 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the compensation discussion and analysis and the related compensation tables and narrative disclosure in the Company's proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 810149.000000 0 FOR 810149.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/18/2024 To approve amendment to the Company's certificate of certificate of incorporation to effect a reverse stock split CAPITAL STRUCTURE ISSUER 810149.000000 0 FOR 810149.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Election of Directors. To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Christopher Missling DIRECTOR ELECTIONS ISSUER 76877.000000 200600.000000 FOR 76877.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Election of Directors. To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Jiong Ma DIRECTOR ELECTIONS ISSUER 76877.000000 200600.000000 FOR 76877.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Election of Directors. To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Claus van der Velden DIRECTOR ELECTIONS ISSUER 76877.000000 200600.000000 FOR 76877.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Election of Directors. To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Athanasios Skarpelos DIRECTOR ELECTIONS ISSUER 76877.000000 200600.000000 FOR 76877.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Election of Directors. To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Steffen Thomas DIRECTOR ELECTIONS ISSUER 76877.000000 200600.000000 FOR 76877.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Election of Directors. To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Peter Donhauser, D.O. DIRECTOR ELECTIONS ISSUER 76877.000000 200600.000000 FOR 76877.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Ratification of Grant Thornton LLP as the Company's Independent Registered Public Accounting Firm for 2024. AUDIT-RELATED ISSUER 76877.000000 200600.000000 FOR 76877.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 76877.000000 200600.000000 FOR 76877.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/18/2024 Shareholder Proposal regarding Shareholder Opportunity to Vote on Excessive Golden Parachutes. COMPENSATION SECURITY HOLDER 76877.000000 200600.000000 AGAINST 76877.000000 FOR S000004450 Bionano Genomics, Inc. 09075F305 US09075F3055 06/18/2024 Election of Class III Directors: Yvonne Linney, Ph.D. DIRECTOR ELECTIONS ISSUER 66295.000000 51600.000000 FOR 66295.000000 FOR S000004450 Bionano Genomics, Inc. 09075F305 US09075F3055 06/18/2024 Election of Class III Directors: Aleksandar Rajkovic, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 66295.000000 51600.000000 FOR 66295.000000 FOR S000004450 Bionano Genomics, Inc. 09075F305 US09075F3055 06/18/2024 Election of Class III Directors: Christopher Twomey DIRECTOR ELECTIONS ISSUER 66295.000000 51600.000000 FOR 66295.000000 FOR S000004450 Bionano Genomics, Inc. 09075F305 US09075F3055 06/18/2024 Approval, on an advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 66295.000000 51600.000000 FOR 66295.000000 FOR S000004450 Bionano Genomics, Inc. 09075F305 US09075F3055 06/18/2024 To ratify the selection of BDO USA, P.C. by the Audit Committee of the Board of Directors to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 66295.000000 51600.000000 FOR 66295.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Election of Directors: Jordan R. Asher DIRECTOR ELECTIONS ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Election of Directors: Lucinda M. Baier DIRECTOR ELECTIONS ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Election of Directors: Frank M. Bumstead DIRECTOR ELECTIONS ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Election of Directors: Claudia Napal Drayton DIRECTOR ELECTIONS ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Election of Directors: Victoria L. Freed DIRECTOR ELECTIONS ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Election of Directors: Elizabeth B. Mace DIRECTOR ELECTIONS ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Election of Directors: Denise W. Warren DIRECTOR ELECTIONS ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Election of Directors: Lee S. Wielansky DIRECTOR ELECTIONS ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Advisory approval of named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/18/2024 Approval of the Brookdale Senior Living Inc. 2024 Omnibus Incentive Plan COMPENSATION ISSUER 605569.000000 0 FOR 605569.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/18/2024 Election of Directors: Steven Katz DIRECTOR ELECTIONS ISSUER 298694.000000 0 FOR 298694.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/18/2024 Election of Directors: Michael Burdiek DIRECTOR ELECTIONS ISSUER 298694.000000 0 FOR 298694.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/18/2024 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 298694.000000 0 FOR 298694.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/18/2024 To vote on a non-binding, advisory basis on the frequency of future advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 298694.000000 0 ONE YEAR 298694.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/18/2024 Ratification of the appointment of Urish Popeck & Co., LLC as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 298694.000000 0 FOR 298694.000000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/18/2024 Election of the two Class I directors named in this proxy statement to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Mika Derynck, M.D. DIRECTOR ELECTIONS ISSUER 45368.000000 18200.000000 FOR 45368.000000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/18/2024 Election of the two Class I directors named in this proxy statement to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Rishi Gupta, J.D. DIRECTOR ELECTIONS ISSUER 45368.000000 18200.000000 WITHHOLD 45368.000000 AGAINST S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/18/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 45368.000000 18200.000000 FOR 45368.000000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/18/2024 Amendment to our restated certificate of incorporation to limit the liability of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 45368.000000 18200.000000 FOR 45368.000000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/18/2024 Amendment and restatement of the Amended and Restated 2020 Equity Incentive Plan, which increases the number of shares authorized for issuance thereunder by 2,900,000 shares. COMPENSATION ISSUER 45368.000000 18200.000000 AGAINST 45368.000000 AGAINST S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Mark Currie, Ph.D. DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Alexander Denner, Ph.D. DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Andrew Dreyfus DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jon Duane DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Marla Kessler DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Thomas McCourt DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Julie McHugh DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jay Shepard DIRECTOR ELECTIONS ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/18/2024 Ratification of the selection of Ernst & Young LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 476472.000000 0 FOR 476472.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/18/2024 To elect three class I directors to our Board of Directors, to serve until the 2027 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Pamela Esposito, Ph.D. DIRECTOR ELECTIONS ISSUER 137253.000000 0 FOR 137253.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/18/2024 To elect three class I directors to our Board of Directors, to serve until the 2027 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Gorjan Hrustanovic, Ph.D. DIRECTOR ELECTIONS ISSUER 137253.000000 0 FOR 137253.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/18/2024 To elect three class I directors to our Board of Directors, to serve until the 2027 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Victor Sandor, M.D.C.M. DIRECTOR ELECTIONS ISSUER 137253.000000 0 FOR 137253.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/18/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 137253.000000 0 FOR 137253.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/18/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 137253.000000 0 FOR 137253.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/18/2024 To approve an amendment to the Kymera Therapeutics, Inc. 2020 Stock Option and Incentive Plan. COMPENSATION ISSUER 137253.000000 0 AGAINST 137253.000000 AGAINST S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/18/2024 Election of Directors: Sarah Boyce DIRECTOR ELECTIONS ISSUER 293157.000000 0 FOR 293157.000000 FOR S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/18/2024 Election of Directors: Steve Love DIRECTOR ELECTIONS ISSUER 293157.000000 0 FOR 293157.000000 FOR S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/18/2024 Ratification of Ernst & Young LLP as OmniAb, Inc.'s independent registered accounting firm AUDIT-RELATED ISSUER 293157.000000 0 FOR 293157.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: Alan L. Bazaar DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: Wayne Burris DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: Massimo Calafiore DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: Michael M. Finegan DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: Jason M. Hannon DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: John B. Henneman, III DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: Shweta Singh Maniar DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Election of Directors: Michael E. Paolucci DIRECTOR ELECTIONS ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Advisory and Non-Binding Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024. AUDIT-RELATED ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Approval of Amendment No. 5 to the Amended and Restated 2012 Long-Term Incentive Plan to Increase the Number of Shares of Common Stock Authorized for Issuance Thereunder by 5,000,000. COMPENSATION ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2024 Approval of Amendment No. 4 to the Second Amended and Restated Stock Purchase Plan to Increase the Number of Shares of Common Stock Authorized for Issuance Thereunder by 1,250,000. COMPENSATION ISSUER 112756.000000 0 FOR 112756.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 Election of Directors: Randy Livingston DIRECTOR ELECTIONS ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 Election of Directors: David Meline DIRECTOR ELECTIONS ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 Election of Directors: Marshall Mohr DIRECTOR ELECTIONS ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 Election of Directors: Hannah A. Valantine, M.D. DIRECTOR ELECTIONS ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 To approve an amendment to our certificate of incorporation to declassify our board of directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 To approve an amendment to our certificate of incorporation to limit the liability of officers as permitted by law. CORPORATE GOVERNANCE ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/18/2024 To approve one or more adjournments of the meeting from time to time, if necessary or appropriate (as determined by our board of directors or the chairperson of the meeting), including to solicit additional proxies to vote in favor of any of Proposals 1-6 above in the event that there are insufficient votes at the time of the meeting to establish a quorum or approve any of Proposals 1-6 above. CORPORATE GOVERNANCE ISSUER 818780.000000 0 FOR 818780.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Election of Four Class II Directors: Emma Reeve DIRECTOR ELECTIONS ISSUER 229825.000000 0 FOR 229825.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Election of Four Class II Directors: Michael Schmertzler DIRECTOR ELECTIONS ISSUER 229825.000000 0 FOR 229825.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Election of Four Class II Directors: Mary Smith DIRECTOR ELECTIONS ISSUER 229825.000000 0 FOR 229825.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Election of Four Class II Directors: Glenn D. Steele, Jr., M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 229825.000000 0 FOR 229825.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 229825.000000 0 FOR 229825.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 229825.000000 0 FOR 229825.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2024 Election of Class I Directors to serve until the 2027 Annual Meeting of Stockholders: Ramy Farid DIRECTOR ELECTIONS ISSUER 213886.000000 0 FOR 213886.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2024 Election of Class I Directors to serve until the 2027 Annual Meeting of Stockholders: Gary Ginsberg DIRECTOR ELECTIONS ISSUER 213886.000000 0 FOR 213886.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2024 Election of Class I Directors to serve until the 2027 Annual Meeting of Stockholders: Arun Oberoi DIRECTOR ELECTIONS ISSUER 213886.000000 0 FOR 213886.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2024 Approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 213886.000000 0 FOR 213886.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2024 Approval of an amendment to the Schrodinger, Inc. 2022 Equity Incentive Plan to increase the number of shares of our common stock available for issuance thereunder by 5,000,000 shares. COMPENSATION ISSUER 213886.000000 0 FOR 213886.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2024 Approval of an amendment to the Schrodinger, Inc. 2020 Employee Stock Purchase Plan to increase the number of shares of our common stock available for issuance thereunder by 413,155 shares. COMPENSATION ISSUER 213886.000000 0 FOR 213886.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2024 Approval of an amendment to the Schrodinger, Inc. Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 213886.000000 0 FOR 213886.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2024 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 213886.000000 0 FOR 213886.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To elect eight directors to serve until our 2025 annual meeting of stockholders: Jack W. Lasersohn DIRECTOR ELECTIONS ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To elect eight directors to serve until our 2025 annual meeting of stockholders: Charles (Chas) S. McKhann DIRECTOR ELECTIONS ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To elect eight directors to serve until our 2025 annual meeting of stockholders: Rick D. Anderson DIRECTOR ELECTIONS ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To elect eight directors to serve until our 2025 annual meeting of stockholders: Kevin J. Ballinger DIRECTOR ELECTIONS ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To elect eight directors to serve until our 2025 annual meeting of stockholders: Tanisha V. Carino, Ph.D. DIRECTOR ELECTIONS ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To elect eight directors to serve until our 2025 annual meeting of stockholders: Tony M. Chou, M.D. DIRECTOR ELECTIONS ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To elect eight directors to serve until our 2025 annual meeting of stockholders: Elizabeth H. Weatherman DIRECTOR ELECTIONS ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To elect eight directors to serve until our 2025 annual meeting of stockholders: Donald J. Zurbay DIRECTOR ELECTIONS ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To approve, on an advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 06/18/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 125054.000000 0 FOR 125054.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Nominees: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 251386.000000 0 FOR 251386.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Nominees: Michael Narachi DIRECTOR ELECTIONS ISSUER 251386.000000 0 FOR 251386.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Nominees: Corsee D. Sanders, Ph.D. DIRECTOR ELECTIONS ISSUER 251386.000000 0 FOR 251386.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Approval of the Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 251386.000000 0 FOR 251386.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 251386.000000 0 FOR 251386.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251386.000000 0 FOR 251386.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Adoption of the 2023 Dutch statutory annual accounts for the fiscal year ended December 3, 2023. CORPORATE GOVERNANCE ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2023. CORPORATE GOVERNANCE ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Reappointment of Rachelle Jacques as non-executive director. DIRECTOR ELECTIONS ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Reappointment of David Meek as non-executive director. DIRECTOR ELECTIONS ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Authorization of the Board to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares. CAPITAL STRUCTURE ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Authorization of the Board to exclude or limit preemptive rights upon the issuance of Ordinary Shares. CAPITAL STRUCTURE ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Authorization of the Board to repurchase Ordinary Shares. CAPITAL STRUCTURE ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Appointment of KPMG as external auditors of the Company for the financial year 2024. AUDIT-RELATED ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/18/2024 Resolution to adopt the Amendment to the 2014 Share Incentive Plan. COMPENSATION ISSUER 145189.000000 0 FOR 145189.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Declassification Amendment - To approve an amendment and restatement of the Company's Current Certificate, to eliminate the classified structure of the board of directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Election of Directors - To elect four directors to our board of directors, each to serve as a Class II director for a term of three years expiring at the 2025 annual meeting of stockholders and until his successor is duly elected and qualified. The following persons have been nominated as Class Il directors: Terence Connors DIRECTOR ELECTIONS ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Election of Directors - To elect four directors to our board of directors, each to serve as a Class II director for a term of three years expiring at the 2025 annual meeting of stockholders and until his successor is duly elected and qualified. The following persons have been nominated as Class Il directors: Ted Lundberg DIRECTOR ELECTIONS ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Election of Directors - To elect four directors to our board of directors, each to serve as a Class II director for a term of three years expiring at the 2025 annual meeting of stockholders and until his successor is duly elected and qualified. The following persons have been nominated as Class Il directors: Joshua Parnes DIRECTOR ELECTIONS ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Election of Directors - To elect four directors to our board of directors, each to serve as a Class II director for a term of three years expiring at the 2025 annual meeting of stockholders and until his successor is duly elected and qualified. The following persons have been nominated as Class Il directors: David Williams III DIRECTOR ELECTIONS ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Exculpation Amendment - To approve the amendment and restatement of the Company's Current Certificate to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Amendment and Restatement of 2019 Stock Incentive Plan - To approve the amendment and restatement of the 2019 Stock Incentive Plan. COMPENSATION ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Ratification of Appointment of KPMG LLP - To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/20/2024 Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 255355.000000 0 FOR 255355.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/20/2024 To elect each of the four Class II director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Kaye Foster DIRECTOR ELECTIONS ISSUER 190342.000000 0 FOR 190342.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/20/2024 To elect each of the four Class II director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Maykin Ho, Ph.D. DIRECTOR ELECTIONS ISSUER 190342.000000 0 FOR 190342.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/20/2024 To elect each of the four Class II director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Jeffrey Capello DIRECTOR ELECTIONS ISSUER 190342.000000 0 FOR 190342.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/20/2024 To elect each of the four Class II director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Catherine Owen DIRECTOR ELECTIONS ISSUER 190342.000000 0 FOR 190342.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/20/2024 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 190342.000000 0 FOR 190342.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/20/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 190342.000000 0 FOR 190342.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision. CORPORATE GOVERNANCE ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 To approve the Biogen Inc. 2024 Omnibus Plan. COMPENSATION ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/20/2024 To approve the Biogen Inc. 2024 Employee Stock Purchase Plan. COMPENSATION ISSUER 492050.000000 0 FOR 492050.000000 FOR S000004450 Century Therapeutics, Inc. 15673T100 US15673T1007 06/20/2024 Election of Class III directors for a three year term expiring in 2027: Kimberly Blackwell, M.D. DIRECTOR ELECTIONS ISSUER 70574.000000 0 WITHHOLD 70574.000000 AGAINST S000004450 Century Therapeutics, Inc. 15673T100 US15673T1007 06/20/2024 Election of Class III directors for a three year term expiring in 2027: Joseph Jimenez DIRECTOR ELECTIONS ISSUER 70574.000000 0 FOR 70574.000000 FOR S000004450 Century Therapeutics, Inc. 15673T100 US15673T1007 06/20/2024 Election of Class III directors for a three year term expiring in 2027: Brent Pfeiffenberger, Pharm.D. DIRECTOR ELECTIONS ISSUER 70574.000000 0 FOR 70574.000000 FOR S000004450 Century Therapeutics, Inc. 15673T100 US15673T1007 06/20/2024 Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for 2024. AUDIT-RELATED ISSUER 70574.000000 0 FOR 70574.000000 FOR S000004450 Century Therapeutics, Inc. 15673T100 US15673T1007 06/20/2024 Approval of an amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by recent amendments to Delaware law (the "Charter Amendment Proposal"). CORPORATE GOVERNANCE ISSUER 70574.000000 0 FOR 70574.000000 FOR S000004450 Century Therapeutics, Inc. 15673T100 US15673T1007 06/20/2024 Approval of adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve the Charter Amendment Proposal. CORPORATE GOVERNANCE ISSUER 70574.000000 0 FOR 70574.000000 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/20/2024 To elect two directors to serve as Class III directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Jean I. Liu, J.D. DIRECTOR ELECTIONS ISSUER 256402.000000 0 FOR 256402.000000 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/20/2024 To elect two directors to serve as Class III directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Pratik S. Multani, M.D. DIRECTOR ELECTIONS ISSUER 256402.000000 0 FOR 256402.000000 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/20/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 256402.000000 0 FOR 256402.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/20/2024 Election of Directors: Damian deGoa DIRECTOR ELECTIONS ISSUER 153625.000000 0 FOR 153625.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/20/2024 Election of Directors: Arthur Kirsch DIRECTOR ELECTIONS ISSUER 153625.000000 0 FOR 153625.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/20/2024 Election of Directors: Paul B. Manning DIRECTOR ELECTIONS ISSUER 153625.000000 0 WITHHOLD 153625.000000 AGAINST S000004450 Liquidia Corporation 53635D202 US53635D2027 06/20/2024 To approve an amendment to our Charter to increase the total number of authorized shares of our common stock from 100,000,000 shares to 115,000,000 shares. CAPITAL STRUCTURE ISSUER 153625.000000 0 FOR 153625.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/20/2024 To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2024. AUDIT-RELATED ISSUER 153625.000000 0 FOR 153625.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/20/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 153625.000000 0 FOR 153625.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/20/2024 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 153625.000000 0 ONE YEAR 153625.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Alan A. Ades DIRECTOR ELECTIONS ISSUER 200679.000000 0 WITHHOLD 200679.000000 AGAINST S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Robert Ades DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Michael J. Driscoll DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Prathyusha Duraibabu DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: David Erani DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Jon Giacomin DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Gary S. Gillheeney, Sr. DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Michele Korfin DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Arthur S. Leibowitz DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Glenn H. Nussdorf DIRECTOR ELECTIONS ISSUER 200679.000000 0 WITHHOLD 200679.000000 AGAINST S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Election of Directors: Gilberto Quintero DIRECTOR ELECTIONS ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2024 annual meeting of shareholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Approval of an amendment to our 2018 Equity Incentive Plan to increase the number of shares of Class A common stock reserved for issuance thereunder by 15,900,000 shares. COMPENSATION ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/20/2024 Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2024. AUDIT-RELATED ISSUER 200679.000000 0 FOR 200679.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sarah A. O'Dowd DIRECTOR ELECTIONS ISSUER 155719.000000 0 FOR 155719.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: William D. Waddill DIRECTOR ELECTIONS ISSUER 155719.000000 0 FOR 155719.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lewis T. "Rusty" Williams, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 155719.000000 0 FOR 155719.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 155719.000000 0 FOR 155719.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 155719.000000 0 FOR 155719.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 90,000,000 to 180,000,000. CAPITAL STRUCTURE ISSUER 155719.000000 0 FOR 155719.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 345673.000000 0 FOR 345673.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Flavia Borellini, Ph.D. DIRECTOR ELECTIONS ISSUER 345673.000000 0 FOR 345673.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Lorence Kim, M.D. DIRECTOR ELECTIONS ISSUER 345673.000000 0 FOR 345673.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 345673.000000 0 FOR 345673.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 345673.000000 0 FOR 345673.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Election of Directors: Arthur C. Butcher DIRECTOR ELECTIONS ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Election of Directors: Stephen C. Farrell DIRECTOR ELECTIONS ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Election of Directors: Thomas G. Frinzi DIRECTOR ELECTIONS ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Election of Directors: Wei Jiang DIRECTOR ELECTIONS ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Election of Directors: Aimee S. Weisner DIRECTOR ELECTIONS ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Election of Directors: Elizabeth Yeu, MD DIRECTOR ELECTIONS ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Election of Directors: Lilian Zhou DIRECTOR ELECTIONS ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Approval of an amendment to our Amended and Restated Omnibus Equity Incentive Plan to increase the number of shares reserved for issuance under the plan. COMPENSATION ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Ratification of the appointment of BDO USA, P.C. as our independent registered public accounting firm for the year ending December 27, 2024. AUDIT-RELATED ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/20/2024 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132952.000000 0 FOR 132952.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/21/2024 Election of Class I Directors: Franklin Berger DIRECTOR ELECTIONS ISSUER 213269.000000 0 FOR 213269.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/21/2024 Election of Class I Directors: Jean-Pierre Sommadossi, Ph.D. DIRECTOR ELECTIONS ISSUER 213269.000000 0 FOR 213269.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/21/2024 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 213269.000000 0 FOR 213269.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/21/2024 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 213269.000000 0 FOR 213269.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Eric Aguiar, M.D. DIRECTOR ELECTIONS ISSUER 354704.000000 0 FOR 354704.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Jennifer E. Cook DIRECTOR ELECTIONS ISSUER 354704.000000 0 FOR 354704.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Andrea J. Ellis DIRECTOR ELECTIONS ISSUER 354704.000000 0 FOR 354704.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Fred Hassan DIRECTOR ELECTIONS ISSUER 354704.000000 0 FOR 354704.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Ali J. Satvat DIRECTOR ELECTIONS ISSUER 354704.000000 0 FOR 354704.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 354704.000000 0 FOR 354704.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 354704.000000 0 FOR 354704.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 6,500,000 shares. COMPENSATION ISSUER 354704.000000 0 FOR 354704.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/21/2024 Election of Class I Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Kimberly Blackwell, M.D. DIRECTOR ELECTIONS ISSUER 167923.000000 0 FOR 167923.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/21/2024 Election of Class I Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Enoch Kariuki, Pharm.D. DIRECTOR ELECTIONS ISSUER 167923.000000 0 FOR 167923.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/21/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 167923.000000 0 FOR 167923.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/21/2024 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 167923.000000 0 FOR 167923.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/25/2024 Re-election of Class II directors: Bill Sibold DIRECTOR ELECTIONS ISSUER 40234.000000 0 FOR 40234.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/25/2024 Re-election of Class II directors: Rebecca Taub, M.D. DIRECTOR ELECTIONS ISSUER 40234.000000 0 FOR 40234.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/25/2024 Re-election of Class II directors: Fred B. Craves, Ph.D. DIRECTOR ELECTIONS ISSUER 40234.000000 0 FOR 40234.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/25/2024 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 40234.000000 0 FOR 40234.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/25/2024 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 40234.000000 0 FOR 40234.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/25/2024 To approve an amendment to the Madrigal Pharmaceuticals, Inc. 2015 Amended Stock Plan to increase the total number of shares of our common stock available for issuance by 750,000 shares and extend its duration by 10 years until April 23, 2035. COMPENSATION ISSUER 40234.000000 0 FOR 40234.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/25/2024 Election of Directors: Mika Nishimura DIRECTOR ELECTIONS ISSUER 123882.000000 0 FOR 123882.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/25/2024 Election of Directors: Thomas A. West DIRECTOR ELECTIONS ISSUER 123882.000000 0 FOR 123882.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/25/2024 To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as SI-BONE, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 123882.000000 0 FOR 123882.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/25/2024 Advisory vote to approve executive compensation "Say-on-Pay". SECTION 14A SAY-ON-PAY VOTES ISSUER 123882.000000 0 FOR 123882.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/25/2024 Approve an amendment to SI-BONE Inc.'s Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted pursuant to recent amendments to the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 123882.000000 0 FOR 123882.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/26/2024 Election of the following individuals nominated to serve as Class I directors, for a three-year term ending at the annual meeting of stockholders to be held in 2027: Anne-Marie Martin, Ph.D. DIRECTOR ELECTIONS ISSUER 126280.000000 0 FOR 126280.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/26/2024 Election of the following individuals nominated to serve as Class I directors, for a three-year term ending at the annual meeting of stockholders to be held in 2027: David Meek DIRECTOR ELECTIONS ISSUER 126280.000000 0 FOR 126280.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/26/2024 Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 126280.000000 0 FOR 126280.000000 FOR S000004450 Foghorn Therapeutics Inc. 344174107 US3441741077 06/26/2024 Elect Class I directors each for a three-year term: Scott Biller DIRECTOR ELECTIONS ISSUER 61788.000000 0 FOR 61788.000000 FOR S000004450 Foghorn Therapeutics Inc. 344174107 US3441741077 06/26/2024 Elect Class I directors each for a three-year term: Thomas J. Lynch DIRECTOR ELECTIONS ISSUER 61788.000000 0 FOR 61788.000000 FOR S000004450 Foghorn Therapeutics Inc. 344174107 US3441741077 06/26/2024 Elect Class I directors each for a three-year term: Michael Mendelsohn DIRECTOR ELECTIONS ISSUER 61788.000000 0 FOR 61788.000000 FOR S000004450 Foghorn Therapeutics Inc. 344174107 US3441741077 06/26/2024 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 61788.000000 0 FOR 61788.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/26/2024 To elect the three nominees for Class III director named in the proxy statement to serve for three-year terms until the 2027 Annual Meeting of Stockholders: Vickie Capps DIRECTOR ELECTIONS ISSUER 54844.000000 0 FOR 54844.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/26/2024 To elect the three nominees for Class III director named in the proxy statement to serve for three-year terms until the 2027 Annual Meeting of Stockholders: Jay Lichter DIRECTOR ELECTIONS ISSUER 54844.000000 0 FOR 54844.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/26/2024 To elect the three nominees for Class III director named in the proxy statement to serve for three-year terms until the 2027 Annual Meeting of Stockholders: Jake Simson DIRECTOR ELECTIONS ISSUER 54844.000000 0 FOR 54844.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/26/2024 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 54844.000000 0 FOR 54844.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/26/2024 To elect three Class II directors to serve until our 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lisa Egbuonu-Davis, M.D. DIRECTOR ELECTIONS ISSUER 179652.000000 0 FOR 179652.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/26/2024 To elect three Class II directors to serve until our 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lainie Goldstein DIRECTOR ELECTIONS ISSUER 179652.000000 0 FOR 179652.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/26/2024 To elect three Class II directors to serve until our 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Ramin Sayar DIRECTOR ELECTIONS ISSUER 179652.000000 0 FOR 179652.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/26/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2025. AUDIT-RELATED ISSUER 179652.000000 0 FOR 179652.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/26/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 179652.000000 0 FOR 179652.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Christopher Causey DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Raymond Dwek DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Richard Giltner DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Jan Malcolm DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Nilda Mesa DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Judy Olian DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Christopher Patusky DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Louis Sullivan DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Election of Directors: Tommy Thompson DIRECTOR ELECTIONS ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan. COMPENSATION ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 159636.000000 0 FOR 159636.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Jon Kessler DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Paul Black DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 Election of ten directors to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn DIRECTOR ELECTIONS ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2025. AUDIT-RELATED ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 To approve, on a non-binding, advisory basis, the fiscal 2024 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/27/2024 To approve the HealthEquity, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 291500.000000 0 FOR 291500.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/27/2024 To vote to elect two (2) nominees as Class II Directors, each to a term expiring at our 2027 annual meeting of stockholders and to hold office until his successor is duly elected and qualified: Troy Cox DIRECTOR ELECTIONS ISSUER 735985.000000 0 FOR 735985.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/27/2024 To vote to elect two (2) nominees as Class II Directors, each to a term expiring at our 2027 annual meeting of stockholders and to hold office until his successor is duly elected and qualified: Fenel M. Eloi DIRECTOR ELECTIONS ISSUER 735985.000000 0 FOR 735985.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/27/2024 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 735985.000000 0 FOR 735985.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/27/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 735985.000000 0 FOR 735985.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/27/2024 To approve an amendment to our Amended and Restated 2011 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 19,125,000 shares. COMPENSATION ISSUER 735985.000000 0 FOR 735985.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/28/2024 The election of Class I Directors for a Three-Year Term Expiring in 2027: Shankar Musunuri, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 99584.000000 772900.000000 FOR 99584.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/28/2024 The election of Class I Directors for a Three-Year Term Expiring in 2027: Junge Zhang, Ph.D. DIRECTOR ELECTIONS ISSUER 99584.000000 772900.000000 FOR 99584.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/28/2024 Approval, on an advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 99584.000000 772900.000000 FOR 99584.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/28/2024 Approval of an amendment to Ocugen, Inc.'s Sixth Amended and Restated Certificate of Incorporation, as amended (the "Charter") to limit the liability of certain officers of Ocugen, Inc. as permitted by recent amendments to the Delaware General Corporation Law ("DGCL"). CORPORATE GOVERNANCE ISSUER 99584.000000 772900.000000 FOR 99584.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/28/2024 Approval of an amendment to our Charter to increase the number of authorized shares of common stock from 295,000,000 to 390,000,000. CAPITAL STRUCTURE ISSUER 99584.000000 772900.000000 FOR 99584.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/28/2024 Approval of an amendment to Ocugen, Inc.'s Charter to adjust voting requirements for certain future amendments to Ocugen, Inc.'s Charter in accordance with recent amendments to Section 242(d) of the DGCL. CORPORATE GOVERNANCE ISSUER 99584.000000 772900.000000 FOR 99584.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/28/2024 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 1-6. CORPORATE GOVERNANCE ISSUER 99584.000000 772900.000000 FOR 99584.000000 FOR S000004450